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Abstract 
 
 
 
 
 
There is a delicate evolutionary balance between viruses and their hosts. The 
host  has  evolved  the  intrinsic,  innate  and  adaptive  immunity  to  fight  viral 
infections. However, viruses have acquired several  counteracting measures to 
evade  host  defences.  Ovine  Betaretroviruses,  including  the  exogenous  and 
pathogenic Jaagsiekte sheep retrovirus (JSRV) and the highly related endogenous 
enJSRVs are a unique model system to investigate virus-host interaction over 
long evolutionary periods. Sheep have co-opted some defective enJSRV loci to (i) 
counteract  infection  by  exogenous  viruses  and  likely  (ii)  to  cope  with  the 
continuous retroviral invasion of their genome. In addition, various genes of the 
innate and intrinsic immunity of the host have evolved to block viral replication. 
The work presented in this thesis focuses on the ovine bone marrow stromal cell 
antigen 2 (Bst-2)/ tetherin, a recently identified cellular restriction factor with a 
broad  antiviral  activity,  and  its  interaction  with  sheep  Betaretroviruses.  In 
sheep, the BST-2 gene is duplicated into two paralogs termed oBST-2A and -2B. 
Studies presented in this thesis show that oBST-2B possesses several biological 
properties  distinct  from  the  paralog  oBST-2A  and  from  all  the  other  BST-2 
orthologs.  oBST-2A  prevents  the  release  of  JSRV/enJSRV  viral  particles  by 
‘tethering’  them  at  the cell  membrane  similarly  to  what  observed  by human 
BST-2.  On  the  other  hand,  oBST-2B,  does  not  reach  the  cell  membrane  but 
remains within the Golgi stacks and the trans-Golgi network. Several lines of 
evidence obtained in this thesis suggest that oBST-2B reduces significantly Env 
incorporation  into  viral  particles.  Therefore,  oBST-2B  possesses  a  unique 
antiviral activity that complements the classical tethering restriction provided 
by oBST-2A. 
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1.1 Overview of retroviruses 
1.1.1  Taxonomy  
Retroviruses are positive-sense single-stranded RNA viruses, which infect a wide 
range of vertebrates (Coffin, Hughes et al. 1997). The defining feature common 
to all retroviruses is their ability to reverse-transcribe their RNA genome into 
double stranded DNA (“provirus”) that is then inserted into the host genome 
(Vogt  1997).  The  family  Retroviridae  encompasses  a  large  number  of  diverse 
retroviruses  divided  into  two  sub-families  (Orthoretrovirinae  and 
Spumaretrovirinae) (Fauquet, Mayo et al. 2010). The majority of retroviruses are 
included in the Orthoretrovirinae, which is the further divided into six genera 
(Alpharetroviruses,  Betaretroviruses,  Gammaretroviruses,  Deltaretroviruses, 
Epsilonretroviruses,  Lentiviruses)  based  upon  genome  divergence  (defined  by 
reverse transcriptase sequence similarity and genome complexity), virion site of 
assembly, and morphology, as detailed in Figure 1 (Coffin, Hughes et al. 1997) 
(Vogt 1997).  
Retroviruses  were  also  classified  as  one  of  four  groups  (A-D)  based  on  the 
appearance  of  virion  morphology  by  electron  microscopy.  Type  A  retroviral 
particles are used to describe the intracisternal particles of rodent endogenous 
retroviruses. These particles are non-enveloped virions with a structure similar 
to that of immature virions with an electron-lucent centre (Vogt 1997).  
In contrast, type B, C and D group retroviruses demonstrate morphology similar 
to that of mature particles, with differences observed within their core region. 
Type  B  and  type  D  retroviruses,  such  as  the  Betaretrovirus  Jaagsiekte  Sheep 
Retrovirus  (JSRV)  and  Mason-Pfizer  Monkey  Virus  (M-PMV),  assemble  in  the 
cytoplasm and are distinguishable by their round, eccentrically positioned or bar 
shaped cores respectively (Payne, Verwoerd et al. 1983; Sfakianos, LaCasse et 
al.  2003;  Murcia,  Arnaud  et  al.  2007).  Type  C  retroviruses,  such  as  the 
Lentiviruses  or  Gammaretroviruses,  assemble  at  the  plasma  membrane  and 
possess a central spherical inner core (Yeger, Kalnins et al. 1978; Coffin, Hughes 
et al. 1997; Swanstrom and Wills 1997).  Chapter 1    18 
 
 
Figure 1. Overview of the taxonomy of the Retroviridae 
 
 
1.1.2 Genomic Structure 
The retroviral genome consists of two identical copies of single stranded positive 
sense RNA molecules of approximately 7-10 kb in length. The two molecules of 
RNA  are  held  together  by  hydrogen  bonds  and  are  similar  to  the  cellular 
messenger  RNA  as  they  possess  a  cap  structure  at  the  5’  end  and  are 
polyadenylated at the 3’ end (Beemon, Duesberg et al. 1974; Vogt 1997).  
All  retroviruses  possess  the  same  genomic  arrangement  with  at  least  the 
canonical gag, pro, pol and env genes flanked by the R (“repeated”) and U5 
(“unique region at the 5’ end) region at the 5’ end and by a U3- R region at the 
3’ end (see 1.2.2.2 Reverse Transcription for details) (Wang, Galehouse et al. 
1976; Wang, Duesberg et al. 1976; Wang, Duesberg et al. 1976; Vogt 1997). Upon 
entry the RNA genome is reverse transcribed into double-stranded DNA following 
entry into the host cell (Baltimore 1970; Temin and Mizutani 1970). The end of 
the RNA viral genome is duplicated during reverse transcription into two LTRs 
(“long terminal repeats”) arranged invariable as U3 – R – U5. The DNA copy of 
the  viral  genome  (termed  “provirus”)  is  stably  integrated  into  the  host 
chromosomal  DNA  (Hughes,  Shank  et  al.  1978).  The  site  for  transcription 
initiation, known as the primer binding site (PBS), is found immediately after the Chapter 1    19 
5’ LTR, whereas the site for polyadenylation is found within the U5-R region of 
the 3’ LTR (Vogt 1997).  
Retroviruses can be also defined as either ‘simple’ or ‘complex’ viruses based 
upon their genomic structure. Simple retroviruses rely upon the minimal number 
of genes sufficient for viral replication (gag, pro, pol and env). Jaagsiekte Sheep 
retrovirus (JSRV) and the endogenous enJSRVs, the viruses studied in this thesis, 
are  “simple”  Betaretroviruses  (Palmarini  and  Fan  2003).  However,  complex 
retroviruses, such as the HIV, encode a number of additional “accessory” and 
“regulatory” genes which play roles in supporting replication and evading host 
immune responses, as summarised in Figure 2 (see 1.5 Host vs. Virus) (Coffin, 
Hughes et al. 1997) 
 
1.1.3 Viral Proteins 
Retroviruses  possess  a  lipidic  envelope  that  surrounds  the  viral  particle  and 
incorporates the Env glycoproteins (Swanstrom and Wills 1997). Env mediates 
retroviral  infection  and  contributes  to  virion  structure  and  stability.  The  Env 
glycoprotein is translated from the env gene as a single polyprotein. Env forms a 
trimer in the ER (Chan, Fass et al. 1997) before passing into the Golgi for further 
post-translational modifications such as glycosylation. Env eventually enters the 
Trans  Golgi  Network  (TGN)  where  it  is  cleaved  (processed)  into  the 
transmembrane (TM) and the surface (SU) domains (Henderson, Sowder et al. 
1984; Coffin, Hughes et al. 1997; Swanstrom and Wills 1997). SU is the external, 
hydrophilic region of Env that mediates the interaction with the host receptor/s, 
whereas TM is the membrane spanning portion of Env that anchors the SU to the 
lipid  membrane.  This  cleavage  is  essential  both  for  the  arrangement  and 
stabilisation of virions as well as the functional aspect of retroviral entry. For 
most retroviruses Env must be transported to the surface where it is incorporate 
into  virions  as  they  bud  from  the  cell.  Mutational  analysis  of  MLV,  which 
assembles at the plasma membrane suggests that cleavage plays an important 
role in the intracellular trafficking of the protein. Uncleaved Env will not traffic 
to  the  cell  surface  and  is  retained  within  the  Golgi.  Therefore  it  is  not 
incorporated  into  viral  particles  which  in  turn  reduce  the  infectivity  of  VLPs 
assembled  void  of  Env  (Apte  and  Sanders  2010).  The  necessity  of  correct Chapter 1    20 
cleavage has been shown for other retroviruses including HIV (Bosch and Pawlita 
1990) as well as Betaretrovirus MMTV (Goodman, Kain et al. 1993).  
Env is critical in mediating viral entry and it is under strong immune pressure 
from the host as it is targeted by neutralizing antibodies. Consequently, the Env 
glycoproteins  are  highly  divergent  between  different  retroviruses  and contain 
the  most  variable  regions  within  different  strains  of  the  same virus.  TM  also 
undergoes conformational changes in order to assist the fusion of the cellular 
receptor and viral proteins during cell entry. Env is arranged as an oligomeric 
complex on the cell surface and in this way is thought to increase Env stability 
(Coffin, Hughes et al. 1997). 
All of the structural proteins required to drive the process of virion assembly and 
encapsidate the viral genomic RNA, are derived from the gag gene product. Gag 
is  regarded  as  the  determinant  of  virion  size  and  morphology  (Ako-Adjei, 
Johnson et al. 2005). Gag is cleaved by the viral protease (PR, encoded by pro) 
during maturation to form the matrix (MA), the major capsid protein (CA) and 
the nucleocapsid (NC) (Swanstrom and Wills 1997). All of the proteins derived 
from Gag provide similar structural functions among retroviruses although their 
sequence  varies  considerably  between  different  genus.  The  major  homology 
region (MHR) within CA is, like the name suggests, the region with the greater 
degree  of  homology  between  retroviruses  (Strambio-de-Castillia  and  Hunter 
1992).  
The pol gene encodes both the reverse transcriptase (RT) and the integrase (IN) 
required for reverse transcription of the gRNA and integration of the proviral 
DNA into the host genome, respectively (Swanstrom and Wills 1997).  
 
1.1.4 Virion structure 
The structure of the virion after exit from the host cell is distinctly different 
from the structure of the virion during assembly. This difference is likely due to 
the  different  requirements  of  these  two  processes.  Whereas  the  assembly 
process  is  largely  focused  upon  gathering  together  all  of  the  required 
components of the virion, the infectious virus released from the cell must be Chapter 1    21 
competent to infect, reverse transcribe and finally integrate into a new host cell 
(see 1.2, Overview of the retroviral cycle). The difference in structure has been 
highlighted  by  HIV  where  the  immature  virions  have  an  incomplete  spherical 
shape with the N terminal of MA arranged adjacent to the virion surface. The 
inner  layers  comprise  of  the  CA,  NC  and  genomic  RNA.  Following  budding, 
cleavage  of  viral  proteins  by  the  viral  encoded  protease  allows  NC  and  the 
genomic  RNA  to  condense  into  the  “mature”  morphology  observed  in  the 
extracellular  virions  by  electron  microscopy  (de  Marco,  Muller  et  al.  2010) 
(Figure 2B).  
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Figure 2. Schematic diagram of the retroviral genomic organisation and virion morphology. 
The genomic organisation as both proviral DNA and viral RNA is shown (adapted from 
(Coffin, Hughes et al. 1997)). In addition, the distinction between immature and mature 
virions morphology is shown based upon HIV as an example (B, adapted from (de Marco, 
Muller et al. 2010)). This schematic diagram does not take into account the arrangement 
of the virion core that contributes to the A-D morphological classification. 
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1.2 Overview of the retroviral cycle  
The major steps of retroviral replication are common among all retroviruses. 
However, each retroviral genera, including the Betaretroviruses, possess unique 
aspects to their replication cycle (Vogt 1997; Vogt 1997).  
 
 
Figure 3. An illustration of the key steps of the retroviral replication cycle. 
Viral  entry  (1),  reverse  transcription  (2),  integration  (3),  transcription  (4),  translation  (5),  viral 
assembly (6) and exit (7). Note that, in contrast to the majority of retroviruses (which assemble at 
the cell membrane), Betaretroviruses assemble at the perinuclear region prior to exit (8 & 9). Note 
the exact stage at which Env incorporation occurs for Betaretroviruses is currently unknown. 
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1.2.1 Viral Entry 
Viral entry, the first phase of the retroviral lifecycle, is mediated by a direct 
interaction between the retroviral Env glycoprotein and the cellular receptor/s 
on the host cell (Hunter 1997). Virus-cell receptor interaction is a key point in 
the  viral  replication  cycle  and  one  of  the  primary  determinants  of  host  and 
tissue/cell tropism. Each retrovirus utilises a specific cellular receptor that may 
function independently or with the aid of a co-receptor (Hunter 1997).  
 
1.2.1.1   Receptor recognition and entry 
Virions must directly engage a specific host cellular receptor to gain access into 
the cell and initiate the replication cycle.  
The initial virion “attachment” or “adsorption” to the host plasma membrane is 
independent  of  the  receptor  and  is  mediated  by  surface  molecules  such  as 
lectins and heparan sulphate proteoglycans (Roderiquez, Oravecz et al. 1995; 
Pizzato, Marlow et al. 1999). Following attachment  of the virions to the cell 
membrane, there is evidence suggesting that virions ‘surf’ the membrane and 
filopodia  in  order  to  reach  and  interact  with  the  target  receptor  that  will 
ultimately  allow  proper  “penetration”  into  the  cell  (Lehmann,  Sherer  et  al. 
2005). The virion movement across the cell surface stimulates the underlying 
intracellular actin and initiates the oligomerisation of receptors which in turn 
primes the membrane for virus entry (Ewers, Smith et al. 2005; Lehmann, Sherer 
et al. 2005) 
The specificity of the receptor and viral Env interaction largely determines the 
cellular tropism of the virus. For example, ecotropic Murine Leukaemia Virus 
(MLV) only infects mouse cells while xenotropic MLV infects non mouse cells, 
whereas amphotropic viruses can infect both (Boeke and Stoye 1997). 
It is usual for the host cell receptor to be downregulated from the cell surface 
upon  virus  entry  and  replication  within  the  cell.  This  mechanism  prevents 
apoptosis of the cell following superinfection and  inhibits the entry of newly 
assembled and released virions into the cell (Hunter 1997). For example, HIV-1 
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target receptor (CD4) from the host cell surface by a mechanism not yet fully 
understood (Wildum, Schindler et al. 2006). 
In many ways, environmental cues are necessary for the viral envelope fusion 
with the cell membrane and entry of the virus into the cell. In some cases virus 
entry may be driven simply by receptor recognition alone at the cell surface, as 
has been shown for HIV (Maddon, McDougal et al. 1988). Alternatively, a virus 
may initially be internalised by endocytosis and, following exposure to the low 
internal pH, be released from the endosome into the cell,  as is the case for 
both MMTV and JSRV (Redmond, Peters et al. 1984; Bertrand, Cote et al. 2008). 
However,  different  entry  pathways  are  not  always  mutually  exclusive.  For 
example, a combination of both pH-dependent and pH-independent entry has 
been observed for HIV, although in this case only the direct entry route appears 
to result in a productive infection (Nisole and Saib 2004). Some viruses require 
additional co-factors to allow successful entry, for example HIV-1 engages both 
the receptor CD4 and in addition co-receptors CCR5 and/ or CXCR4, as reviewed 
by (Doms 2000). Alternative co-receptors such as CCR3 and FPRL1 have also been 
associated with HIV-1 infection (Nedellec, Coetzer et al. 2009). 
 
1.2.2 Reverse transcription and Integration 
 
The synthesis of proviral DNA and its integration into the host genome are key 
events in the retroviral replication cycle. Following entry, the incoming virion 
uncoats and utilises the microtubule network for particle progression towards 
the  nucleus  (Goff  2007).  Reverse  transcription  occurs  after  entry  and  before 
provirus integration in a complex known as the “reverse transcriptase complex”, 
Following  reverse  transcription,  the  “preintegration  complex”  (PIC)  which 
contains the proviral DNA ready for integration enters the nucleus and mediates 
successful  integration  within  the host  genome  (Brown  1997),  as  illustrated in 
Figure 4.  
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1.2.2.1   Reverse transcriptase complex (RTC)  
 
The primary role of the RTC is the generation of proviral DNA. It consists of the 
retroviral  RNA  genome  and  co-packaged  virion  proteins  necessary  for  reverse 
transcription,  including  reverse  transcriptase  and  RNase  H.  A  tRNA  (carried 
within the virion core) initiates reverse transcription by binding to the primer 
binding site (PBS) of the 5’LTR. The RTC is a continually evolving nucleoprotein 
complex that varies in composition and activity as it progresses from the cell 
periphery to the nucleus and will also carry components of the downstream PIC 
into which it develops, such as integrase proteins (Telesnitsky and Goff 1997).  
Following  successful  viral  entry  of  the  virion,  the  capsid  is  gradually 
disassembled as the formation of the RTC is initiated. The speed and extent of 
the viral particle uncoating process is unique to specific retroviruses, but the 
capsid protein may not be completely removed during this process, as there is 
evidence of its presence further downstream at the nuclear import level (Risco, 
Menendez-Arias et al. 1995). There has been some debate as to whether reverse 
transcription is initiated prior to, or after, the uncoating process has begun and 
cDNA can be detected within newly produced viral particles of HIV and Moloney 
murine leukaemia virus (MoMLV) (Trono 1992). In addition, it has been observed 
that viral particles with HIV Capsid mutants are deficient in reverse transcriptase 
activity (Forshey, von Schwedler et al. 2002). Therefore, it is likely that the 
Capsid has a role in the reverse transcription process. An alternative explanation 
is  that  uncoating  occurs  directly  at  the  nuclear  pore  prior  to  import  (Arhel, 
Souquere-Besse et al. 2007). Extensive RT activity in mature viral particles is 
thought to be prevented by the presence of the nucleocapsid (NC), confirming 
the control it exerts over the timing of reverse transcription (Telesnitsky and 
Goff 1997).  
The RTC cannot simply diffuse from the cellular periphery to the nucleus. The 
“crowded”  nature  of  the  cytoplasm  heavily  restricts  intracellular  movements 
and provides many obstacles that hinder RTC progression (Luby-Phelps 2000). 
The RTC therefore utilises the host microtubule network (McDonald, Vodicka et 
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recruitment onto the host cytoskeleton for transport to occur (Allain, Lapadat-
Tapolsky et al. 1994; Bukrinskaya, Brichacek et al. 1998). 
 
 
 
1.2.2.2   Reverse transcription (RT) 
 
Reverse transcription is the unique feature of the retroviral replication cycle and 
involves the conversion of the viral RNA genome into the double-stranded DNA 
provirus.  Reverse  transcription  is  a  multi-step  process  mediated  by  the  viral 
encoded enzyme reverse transcriptase, an RNA dependent DNA polymerase, and 
RNase H (Fig. 4) (Telesnitsky and Goff 1997).  
 
 
Figure 4.  Illustration highlighting the major steps of the process of reverse transcription. 
The reverse transcription complex generates proviral DNA for insertion into the host genome from 
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DNA (-ssDNA) (2). This –ssDNA undergoes first strand transfer shifting from the 5’ end to the 3’ 
end (3). Elongation of the –ssDNA continues to generate the minus strand. This is accompanied by 
the  degradation  of  the  viral  gRNA  template  by  RNaseH  (4).  A  short  polypurine  tract  is  non 
degradable by RNaseH and this primes synthesis of the corresponding plus strand (5 and 6).  
 
The first action (Figure 4, step 2) involves the production of the short minus 
strand DNA (–ssDNA). Reverse transcription is initiated by the recognition of the 
primer  binding  site  (PBS)  at  the  end  of  the  U5  region  contained  within  the 
flanking  5’  region  of  the  genome  by  an  approximately  eighteen  nucleotide 
stretch of a tRNA. Binding of the tRNA to the PBS results in elongation from the 
PBS to the 5’ cap.  Each viral genus utilises a distinct pattern of tRNAs to initiate 
RT. For example, M-PMV uses tRNALys1-2 (Sonigo, Barker et al. 1986) whereas  
MMTV and HIV exclusively utilise tRNA Lys3 as a primer for reverse transcription 
(Peters and Glover 1980; Ratner, Fisher et al. 1987). Production of HIV mutants 
with an altered PBS site that utilises a selection of other tRNAs results in the 
emergence of reverse mutants that use the preferred tRNA Lys3 (Ni and Morrow 
2007). However, MLV is more versatile and can use alternative tRNAs for priming 
reverse transcription although the maximum efficiency of the process is reached 
when using its preferred tRNA Pro (Palmer, McPherson et al. 2005). 
The –ssDNA undergoes first strand transfer (Figure 4 step 3), shifting from the 5’ 
end to the 3’ end which serves as a template for further transcription (in an 
intra or intermolecular fashion). The R region of the –ssDNA anneals with that of 
the 3’ end and elongation of the –ssDNA in the direction of the 5’LTR continues, 
generating the minus strand DNA. RNase H activity is essential for successful first 
strand  transfer  as  it  degrades  the  RNA  from  the  -ssDNA:RNA  complex  and 
mutations  within  RNaseH  have  been  shown  to  inhibit  the  process  of  reverse 
transcription  (Figure 4  step  4)  (Telesnitsky  and Goff  1997).  The  RNA  genome 
contains a short polypurine tract (PPT) resistant to degradation by RNaseH from 
which the +ssDNA is generated (Figure 4 step 5 & 6). Annealing of the PBS of the 
+ssDNA to that of the 5’ end of the minus strand DNA generates the second 
strand transferred where after the plus strand of DNA is synthesised and proviral 
DNA has been fully generated. During the process of reverse transcription both 
the 5’ and 3’LTRs of the proviral DNA generated are identical containing U3-R-U5 
arrangement, in contrast to the viral mRNA where the 5’ and 3’LTRs only contain 
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Whilst  the  process  of  reverse  transcription  is  uniform  the  structure  of  the 
enzyme  reverse  transcriptase  varies  between  retroviruses.  For  example,  the 
Betaretrovirus  MMTV  has  a  reverse  transcriptase  (RT)  protein  which  is  a 
functional monomer (Taube, Loya et al. 1998) whilst the lentivirus HIV-1 RT is a 
dimer.  Reverse  transcription  per  se  is  an  error  prone  process  as  the  reverse 
transcriptase has no proof reading activity and therefore contributing to viral 
genetic  diversity  (Moya  1999).  Far  from  being  detrimental,  the  lack  of  proof 
reading  activity  by  RT  allows  retroviruses  the  flexibility  required  to  rapidly 
evolve and meet the requirements of their environment and also to evade host 
immune responses (see section 1.5 Host vs Virus ). 
 
1.2.2.3   The Preintegration complex (PIC) and nuclear import 
 
During  the  progression  from  the  plasma  membrane  to  the  nucleus  along  the 
microtubule  network,  the  properties  of  the  RTC  are  modified  allowing  it  to 
mature into  the PIC.  This  is  reflected  in the change  of  viral particle  density 
following infection (Fassati and Goff 1999; Fassati and Goff 2001). The PIC is 
defined as a complex containing proviral DNA ready for integration. The ends of 
the cDNA generated within the RTC are closely associated with integrase (IN) 
(Wei, Mizuuchi et al. 1998) which drives integration. The PIC must first cross the 
nuclear membrane to gain access to the genome. Generally, most retroviruses 
including  Betaretroviruses  require  the  host  cells  to  be  actively  dividing  (i.e. 
passing through M phase with the nuclear membrane disassembled) in order to 
successfully  enter  the  nucleus  and  integrate.  However,  HIV  and  other 
lentiviruses are capable of infecting non dividing cells due to the presence of a 
nuclear localisation signal (NLS) (Brown 1997).  
 
1.2.2.4   Integration 
 
Following nuclear import it is essential that the proviral DNA is integrated into 
the  host  genome.  Successful  retroviral  infection  requires  that  the  provirus  is 
permanently integrated in the host cell genome, otherwise the DNA is unstable 
and  decays  within  the  nucleus.  Stable  integration  of  proviral  DNA  allows  the 
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expression.  The  physical  process  of  integration  involves  DNA  cleavage  and 
ligation in two distinct stages. First, the 3’ end processing of proviral DNA to be 
integrated  occurs  with  the  removal  of  two  nucleotides  from  the  3’  end  by 
integrase, thus exposing the hydroxyl group that will join to the host DNA. The 
second step is called ‘DNA strand transfer’ whereby the exposed proviral 3’ end 
hydroxyl group joins the 5’ end of the host target genome and is repaired by 
cellular enzymes (Brown 1997).  
Generally,  on  a  structural  basis  retroviruses  may  have  a  preference  for  the 
major  groove  of  DNA  rather  than  the  minor  groove  that  is  curved  along  the 
nucleosomes.  The  major  groove  is  more  accessible,  providing  less  steric 
inhibition from DNA binding proteins. Retroviral integrations can in many ways 
be  considered  a  random  event.  However,  there  is  evidence  suggesting  that 
different  retroviruses  tend  to  integrate  in  different  areas  of  the  genome 
(Mitchell, Beitzel et al. 2004). The site of integration by JSRV or enJSRVs within 
the genome has not yet been defined.  
A recent study of integration target site selection by a “reconstituted” human 
endogenous  retrovirus  (HERV)-K  has  shown  that  new  integration  sites  were 
predominately found in active gene dense areas slightly enriched in transcription 
sites (Lee and Bieniasz 2007). This is in contrast to established HERV-K elements 
which are found mainly outside active gene rich areas. These data suggest that 
HERV-K integration that occurred in areas that negatively altered gene function 
were counter-selected during evolution. 
 
1.2.3 Transcription and viral mRNA processing and export 
 
1.2.3.1   Expression 
The successful integration of proviral DNA is essential as it provides a template 
for transcription (Rabson and Graves 1997). Non-integrated DNA produced during 
the  process  of  reverse  transcription  can  account  for  as  much  as  99%  of 
intracellular  viral  DNA  at  the  early  stages  of  infection  but  it  makes  no 
contribution to viral expression. Unintegrated DNA can be found as 1-LTR, 2-LTR 
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proviral  integration.  Generally,  successful  and  stable  integration  occurs  in 
transcriptionally  silent  regions  causing  minimal  disruption  to  the  host. 
Therefore,  successful  translation  often  does  not  just  depend  upon  the 
recruitment of transcription factors to the U3 of the 5’LTR, but in the depletion 
of those which are repressive and restricting access (Rabson and Graves 1997).  
The initiation site of transcription is defined within the 5’LTR at the beginning of 
the central short direct repeat “R” region. The U3, which precedes R, regulates 
transcription  and  contain  the  promoter  and  enhancer  regions.  The  promoter 
contains  the  initiating  TATA  binding  element  and  a  range  of  positive  binding 
regulatory  sequences,  while  upstream  the  enhancer  region  contains  positive 
acting transcription factor binding regulatory elements and negative regulatory 
elements. These positive binding regulatory transcription factors will often be 
related  to  the  viral  tropism  (Rabson  and  Graves  1997).  Cell  type  and 
differentiation status dictates the enhancing factors available to the provirus 
and obviously impacts its transcription levels. For example, the HIV LTR recruits 
the lymphocyte enhancer factor (LEF) to its promoter region which is commonly 
present in immature B cells and both immature and mature T cells (Waterman 
and  Jones  1990;  Waterman,  Fischer  et  al.  1991).  This  also  has  the  added 
advantage  of  assisting  with  promoter  accessibility  as  it  alters  the  promoter 
conformation (Giese, Cox et al. 1992). Related viruses might be expressed in 
different  cells/tissues  due  to  differences  in  their  LTRs.  For  example,  the 
exogenous  JSRV  transcription  is  promoted  by  the  lung  specific  hepatocyte 
nuclear factor 3β (HNF-3b)  (Palmarini, Datta et al. 2000; McGee-Estrada and Fan 
2006;  McGee-Estrada  and  Fan  2007)  while  enJSRVs  are  driven  by  hormone 
responsive  elements  (Palmarini,  Gray  et  al.  2001).  Similarly,  MMTV  has 
functional  hormone  responsive  elements  within  its  promoter  region  (Cato, 
Henderson et al. 1987). Retroviruses exploit the host RNA polymerase II to drive 
viral mRNA production.  
 
 
1.2.3.2   Viral mRNA processing 
The  provirus  exploits  the  host  cell  machinery  for  expression,  viral  mRNA 
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full length transcripts that are initially processed in order to have a 5’ 7-methyl-
guanosine cap (which assist with translation initiation) combined with cleavage 
and polyadenylation of the 3’ end within the R-U5 region, giving all transcripts 
identical 3’ ends and stability during transcription. 
All retroviruses use a full length viral mRNA (organised in 5’cap-R-U5-gag-pol-
env-u3-R-polyA)  for  the translation  of  both  Gag  and Pol  proteins  and  for  the 
genome of the viral progeny. For some retroviruses like HIV-2, it has been shown 
that  the  template  used  during  translation  can  also  be  packaged  (Rabson  and 
Graves 1997; Bolinger and Boris-Lawrie 2009).  
1.2.3.3   Splicing  
Splicing is an important general intracellular function. Env is instead translated 
from  a  single  spliced  mRNA  while  some  accessory  proteins  of  complex 
retroviruses  derive  from  multiple  spliced  mRNAs  (Rabson  and  Graves  1997). 
Through  splicing,  complex  genomes  can  produce  regulatory  proteins  that 
facilitate  transcription  to  maximise  successful  viral  particle  production.  For 
example  HIV  encodes  Tat,  which  trans  activates  the  viral  LTRs  and  help  to 
recruit  various  cellular  proteins  such  as  histone  acetylase  transferase  which 
acetylates histones therefore promoting access by transcription factors to the 
viral LTRs (Benkirane, Chun et al. 1998).  
Simple retroviruses, which only produce one splice variant for the production of 
Env,  utilise  standard  splicing  donor  and  acceptor  sites.  Complex  retroviruses 
produce multiple transcripts (e.g. HIV has been described to produce in excess 
of 40 splice mRNA variants) (Rabson and Graves 1997).  
1.2.3.4   Nuclear Export 
The full length unspliced mRNA must be exported from the nucleus in order to 
be available for translation and/or to be packaged in the virion genomic RNA. It 
is  important  that  the  correct  proportions  of  both  spliced  and  unspliced 
populations  are  maintained  in  order  to  optimise  viral  particle  production. 
Complex retroviruses encode additional proteins to assist with this process. For 
example,  the  transport  of  full  length  HIV  viral  mRNA  from  the  nucleus  is 
mediated  by  the  regulatory  protein  Rev  (Yi,  Bogerd  et  al.  2002).  Rev  is Chapter 1    33 
synthesized in the cytoplasm and transported back to the nucleus for action by 
its nuclear localisation signal (Truant and Cullen 1999).  Within the nucleus, Rev 
acts by binding RRE (Rev responsive element), a cis acting sequence within env. 
Rev-RRE  binding  masks  the  NLS  and  reveals  the  nuclear  export  signal  (NES) 
(Henderson  and  Percipalle  1997).  Rev  binds  the  cellular  export  factor  Crm1 
(Izaurralde,  Kutay  et  al.  1997;  Bogerd,  Echarri  et  al.  1998).  Once  successful 
export  of  RNA  has  occurred,  Crm1  is  dissociated  from  the  Rev-RRE  complex 
allowing Rev to interact with Importin B and cycle back into the nucleus. Rev-
like viral proteins are also found encoded for other retroviruses such as mouse 
mammary  tumour  virus  (MMTV)  (Mertz,  Simper  et  al.  2005)  and  human 
endogenous retrovirus-K (HERV-K) (Ruggieri, Maldener et al. 2009). However, the 
simple retrovirus M-PMV encodes no Rev-like protein and utilises a cis acting RNA 
element  (the  constitutive  transport  element,  CTE)  which  interacts  with  the 
cellular  nuclear  export  factor  Tap1/NFX1  to  promote  nuclear  export  (Braun, 
Rohrbach et al. 1999). Interestingly, JSRV is a simple retrovirus but the signal 
peptide  of  the  glycoprotein  Env  (Rej/SP)  functions  as  a  Rev-like  protein  and 
promotes full length viral RNA export by interacting with a cis acting responsive 
element within the 3’ end of the genome (Caporale, Arnaud et al. 2009; Nitta, 
Hofacre et al. 2009, Hofacre, 2009 #25).  
 
1.2.4  Viral assembly, budding and virion maturation 
 
1.2.4.1   Viral Proteins and Virion assembly 
The Env glycoproteins are synthesized specifically on the ER polysomes before 
being  modified  and  delivered  via  the  secretory  pathway  to  the  plasma 
membrane. In contrast, Gag and Gag-Pol protein precursors are produced within 
the  cytosol  on  free  polysomes  (Swanstrom  and  Wills  1997).  It  is  Gag  which 
supports  virion  assembly/release  and  the  various  subdomains  of  Gag  serve 
different functions during this process. The nucleocapsid (NC) domain of Gag is 
particularly important during the initial process of encapsidation of the viral RNA 
genome (Berkowitz, Ohagen et al. 1995). Recently, the presence of retroviral 
Gag  proteins  has  been  detected  in  some  cases  within  the  nucleus  and  this Chapter 1    34 
supports the idea that Gag has a key role in viral genomic RNA export (Parent 
2011).  
Viral gRNA has a packaging signal which drives the encapsidation process and 
likely gives viral RNA the selection specificity required in the presence of a large 
volume  of  cellular  mRNAs  (Adam  and  Miller  1988).  The  NC  domain  of  Gag  is 
capable of non-specifically binding RNA and DNA, however, it relies upon the 
encapsidation sequence to specifically associate with the viral gRNA. The viral 
gRNA is dimerized at the 5’ end providing an important evolutionary factor as 
this can aid the diversification of the genome (Onafuwa-Nuga and Telesnitsky 
2009). Furthermore, it is the contact between the NC and the viral gRNA, which 
leads to the formation of the virion inner core. The spontaneous assembly of Gag 
when  contacted  by  a  non-specific  single  stranded  nucleic  acid  highlights  its 
importance in driving virion assembly (Campbell and Vogt 1995). Mutations in 
both the NC and CA region demonstrate their importance during virion formation 
and release (Hansen, Jelinek et al. 1990, Dorfman, 1993 #510; Dorfman, Luban 
et  al.  1993).  Mutations  in  CA  affect  virion  formation  (Ganser-Pornillos,  von 
Schwedler  et  al.  2004)  and  it  is  the  oligomerisation  and  assembly  of  the  CA 
which encloses the gRNA genome associated with NC. Those virions which are 
formed initially are immature in structure, spherical and defined by a distinctive 
layer under the lipid envelope (Kurth 2010) Retroviral assembly and budding is 
thought to occur predominantly at the plasma membrane (Yeger, Kalnins et al. 
1978)  although  there  is  also  evidence  of  assembly  within  the  cytosol. 
Interestingly, Betaretroviruses are unique among retroviruses as their assembly 
occurs  within  the  cytoplasm  in  the  vicinity  of  the  mitochondrial  organizing 
centre (MTOC) independently of plasma membrane association (Payne, Verwoerd 
et al. 1983).  
 
 
1.2.4.2   Viral Budding 
The  matrix  (MA)  is  considered  important  for  Gag  membrane  targeting  during 
assembly and budding. In particular, it is the post-translational modification of 
MA by myristoylation (the attachment of a myristoyl group to the N terminal of 
the  Gag  protein)  which  influences  membrane  association  of  Gag  (Facke, 
Janetzko  et  al.  1993;  Ono,  Orenstein  et  al.  2000).  This  in  turn  affects  Env Chapter 1    35 
distribution as Gag – Env interaction is an important factor for the presence of 
Env within the lipid rafts of the plasma membrane and subsequent incorporation 
into  the  assembling  virions  as  they  exit  the  cell  (Bhattacharya,  Repik  et  al. 
2006).  
Mutational  analysis  of  Gag  revealed  that  there  exists  specific  position-
independent domains in Gag, the late (L) domains, which are common to many 
retroviruses and plays crucial roles in recruiting host factors during viral exit 
(Parent, Bennett et al. 1995). Several different L domains have been indentified 
for various retroviruses. For example, the P(T/S)AP L domain is present in both 
HIV-1  (Gottlinger,  Dorfman  et  al.  1991)  and  M-PMV  (Gottwein,  Bodem  et  al. 
2003)  while  the  PPxY  domain  is  found  in  Rous  Sarcoma  Virus  (RSV)  (Parent, 
Bennett et al. 1995) and M-PMV (Yasuda and Hunter 1998). Other late domains 
have been also identified within retroviruses (Morita and Sundquist 2004). Late 
domains allow assembling virions to engage with host cofactors in order to reach 
the  cell  membrane  for  viral  exit.  For  example  the  P(T/S)AP  domain  recruits 
TSG101 (Garrus, von Schwedler et al. 2001) and similarly PPxY allows interaction 
with  TSG101  and  AIP1  both  of  which  are  part  of  the  endosomal  ESCRTs 
(endosomal  sorting  complex  required  for  transport)  machinery  that  normally 
function at the surface of the endosome to induce the budding of vesicles into 
the multivescular bodies (MVB). During infection, retroviruses redirect the ESCRT 
machinery to the cell membrane in order to bud out  of the cell (Morita and 
Sundquist  2004).  During  exit  from  the  cell,  retroviruses  also  interact  with 
cellular  proteins  that  induce  a  curvature  of  the  plasma  membrane  observed 
during exit (Strack, Calistri et al. 2003; Morita and Sundquist 2004).  
The  virions  which  assemble  at  the  plasma  membrane  for  budding  are  still 
immature in morphology. The processing of Gag into MA, CA and NC domains and 
Gag-Pol cleavage by the viral protease occurs after viral budding from the cell 
and allows the morphological and functional maturation of the virion (see 1.1.4 
Figure 2B). Multiple interactions between Gag, the plasma membrane and gRNA 
are required for correct virion maturation (Datta, Heinrich et al. 2010).  
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Figure 5. Schematic diagram highlighting the two major routes of virion assembly. 
For the majority of retroviruses viral particle assembly occurs at the plasma membrane and virions 
acquire Env as they bud from lipid rafts. Betaretroviruses are unique as they appear to assemble at 
the centrosomal region prior to collecting the envelope as they exit via lipid rafts. 
 
 
 
1.2.4.3   Cell-to-cell vs. cell-free transmission  
Once successful replication has taken place, retroviruses must exit the cell in 
which  infection  is  established  and  enter  another  uninfected  cell  in  order  to 
spread infection within the host. In theory, cell free virus spreading provides the 
widest  potential  range  for  propagation  to  ensure  survival.  Virus  exits  the 
infected  cell  and  is  free  to  diffuse  within  the  host  infecting  both  close  and 
distant  tissues  and  cells.  However,  cell  free  transmission  of  virus  encounters 
physical and kinetic challenges during the process of viral entry (see viral entry). 
Steric hindrance is associated with cell-free infection. Similarly, the negative 
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invading  virions.  Indeed,  the  addition  of  polybrene  is  required  in  vitro  to 
increase  the  likelihood  of  successful  infections  (as  much  as  ten  fold  for 
retroviruses) by reducing electrostatic repulsion between the incoming virions 
and the host cell membrane (Coffin, Hughes et al. 1997). Virions also face an 
increasing repertoire of cell host factors which target unique features of the 
replication cycle both during exit and entry. In response to this, retroviruses and 
other enveloped viruses have developed a strategy to pass from an infected to 
an uninfected cell by cell-to-cell transmission. This mode of transmission has the 
advantage to avoid the physical barriers imposed by the host and the immune 
system, increasing viral kinetics and efficiency but it has the disadvantage of 
"travelling" only a short distance between infected and uninfected neighbouring 
cells.  Documented  retrovirus  cell  to  cell  transmission  occurs  via  the  plasma 
membrane, filopodial bridges, nanotubules and virological synapses (reviewed in 
(Sattentau 2008)). Plasma membrane based fusion may result in the formation of 
syncytia observed for both Human T cell leukaemia virus 1 (HTLV-1) and HIV-1 
although  the  ability  of  efficient  cell  to  cell  spread  by  this  method  is  still 
debated. Filopodia, are projections of actin from both infected and uninfected 
cells which support the movement of virus from an infected to an uninfected 
cell.  This  movement  is  driven  by  the  aggregation  of  viral  Env  and  the 
corresponding host cell receptor (Lehmann, Sherer et al. 2005; Sherer, Lehmann 
et al. 2007), HIV-1 transport along the exterior of T cell nanotubules has also 
been observed. Nanotubules can be multiple actin membrane based projections 
linking  infected  and  uninfected  cells  forming  after  the  formation  of  the 
virological synapse. Virions migrate along the exterior of the tubule before the 
interacting with the cellular receptor and entering the cell. Virological synapses, 
similar  to  immunological  synapses,  are  another  example  of  how  cell-to-cell 
transmission  of  retroviruses  and  have  been  observed  for  HIV-1  and  HTLV 
transmission between immune cells. (HTLV-1) infected T cells produce very few 
cell-free virions (Derse, Hill et al. 2001) in vivo and the virus is spread directly 
between lymphocytes via virological synapses (Jolly and Sattentau 2004). The 
budding  of  HTLV-1  virions  and  their  entry  into  surrounding  uninfected  cells 
occurs  at  cell  contact  zones  enriched  in  microtubules  and  adhesion  factors 
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The virological synapses are supermolecular complexes that are formed at the 
site of contact between an infected cell and a target cell expressing the viral 
receptor. The virological synapses require a functional actin cytoskeleton and 
the expression of viral receptor/s in the target cells (summarised by (Sattentau 
2008)).  
 
1.3 Exogenous retroviruses 
 
1.3.1  Overview of exogenous retroviruses and disease 
Retroviruses  were  first  associated  with  the  development  of  disease  over  a 
century ago  when  an  infectious,  filterable  agent  was  found to cause  chicken 
leukosis and sarcoma. The viral aetiology for these diseases was identified by 
Ellermann in 1908 and Rous in 1911 and the viruses they described were named 
avian  leukosis  virus  (ALV)  and  Rous  sarcoma  virus  (RSV),  respectively  (Vogt 
1997). Later, retroviruses were discovered to be the cause of cancers in many 
other  animal  species  including  mice,  cats,  sheep,  cattle  and  humans. 
Retroviruses  are  differentiated  in  “exogenous”  and  “endogenous”  viruses. 
Exogenous retroviruses are transmitted horizontally from an infected host to an 
uninfected host like any other virus (Rosenberg and Jolicoeur 1997). 
Oncogenic  retroviruses  can  be  divided  into  different  groups  based  on  the 
mechanism  of  transformation  they  follow:  acutely  transducing, cis-acting  and 
trans-acting retroviruses (Rosenberg and Jolicoeur 1997; Kurth 2010).  
Acutely transducing retroviruses, carry a host derived oncogene, for example, 
the  Alpharetrovirus  RSV  carries  the  host  derived  oncogene  src  (Duesberg  and 
Vogt 1970; Martin 2004). Acutely transducing retroviruses are usually replication 
defective and they need a “helper” virus for replication. They are capable of 
rapidly transforming an infected cell, once they integrate their genome (carrying 
an oncogene) within the infected cell.  
Cis-acting retroviruses lack an oncogene and do not directly transform cells in 
culture. Instead, transformation occurs during a period of latency as a result of 
mutagenesis of the host genome by proviral insertion (a process also known as Chapter 1    39 
“insertional activation”) (Rosenberg and Jolicoeur 1997). An example of a cis 
acting  retroviruses  is  MMTV  which  induces  mammary  tumours  in  mice  by 
insertional  mutagenesis  (Theodorou,  Kimm  et  al.  2007).  Tumours  induced  by 
insertional activation are monoclonal or oligoclonal. Different tumours induced 
by the same retroviruses acting by insertional activation are characterized by 
the  presence  of  common  integration  sites  (Rosenberg  and  Jolicoeur  1997; 
Cousens, Bishop et al. 2004; Philbey, Cousens et al. 2006). 
Trans-acting retroviruses are those which induce transformation by a viral gene 
product.  The  Betaretrovirus  of  interest  for  this  thesis,  JSRV,  has  a  trans-
activating Env and this mechanism will be discussed in detail below. Retroviruses 
have  also  been  linked  with  a  wider  range  of  diseases,  including  neurological 
(Ances and Ellis 2007), autoimmune (Ansari, Pattanapanyasat et al. 2007) and 
more notably immunodeficiency diseases (Moanna, Dunham et al. 2005) which 
affect a range of species including humans. 
1.3.2 Ovine pulmonary adenocarcinoma (OPA) 
 
Jaagsiekte sheep retrovirus (JSRV) is unique among retroviruses as it is the only 
virus  to  cause  a  naturally  occurring  lung  cancer,  Ovine  pulmonary 
adenocarcinoma (OPA) (Palmarini, Fan et al. 1997; Palmarini, Sharp et al. 1999; 
Palmarini and Fan 2001).  
OPA is a fatal disease and involves the development of lung adenocarcinoma as a 
result  of  infection  and  transformation  of  type  II  pneumatocytes  within  the 
bronchial and alveolar epithelium (Palmarini, Dewar et al. 1995; Palmarini, Fan 
et al. 1997; Murgia, Caporale et al. 2011; Yu, Linnerth-Petrik et al. 2011). JSRV 
is  an  “exogenous”  retrovirus  and  is  classically  transmitted  horizontally  from 
infected to uninfected sheep. More recently, an important natural transmission 
route  assisting  the  spread  of  OPA  has  been  identified  from  mothers  to  their 
young  via  colostrum,  although  the  respiratory  secretions  of  affected  animals 
remain the main cause of the contagium (Voigt, Kramer et al. 2007; Grego, De 
Meneghi et al. 2008) OPA is a veterinary disease that poses significant economic 
problems to several sheep-rearing countries. However, it also provides a large 
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bronchioloalveolar  adenocarcinoma  (BAC),  an  unusual  form  of  human 
adenocarcinoma  (Platt,  Kraipowich  et  al. 2002)  thus  making  it  an  interesting 
model for investigation.  
OPA is clinically identified through progressive acute respiratory distress of the 
host  due  to  the  development  of  multifocal  tumours.  In  addition,  secondary 
pulmonary  bacterial  infections  are  also  common  in  affected  animals.  The 
pulmonary  cells  from  which  the  tumours  originate  are  type  II  pneumocytes 
(Palmarini, Dewar et al. 1995; Palmarini, Fan et al. 1997). More recently, it has 
been shown that JSRV infects a population of proliferating type II pneumocytes 
which,  whilst  abundant  in  young  lambs,  are  relatively  rare  in  adult  sheep 
(Murgia, Caporale et al. 2011).  
Histologically, OPA generally manifests itself as multifocal tumours which extend 
from the lung surface and may be grouped into two distinct patterns classified as 
either  “typical”  or  “atypical”  forms  (Garcia-Goti,  Gonzalez  et al.  2000).  The 
secondary  bacterial  infections  which  occur  frequently  in  OPA  can  distort  the 
pathology  presented.  Sheep  affected  by  OPA  generally  produce  an  excess  of 
pulmonary surfactant which is an essential functional and protective component 
of the respiratory tract (De las Heras, Gonzalez et al. 2003; Johnson and Fan 
2011). 
In  vivo,  JSRV  is  found  to  be  expressed  preferentially  in  the  tumour  cells  of 
affected  animals.  Interestingly,  in  reporter  assays  in  vitro,  the  JSRV  LTRs 
(containing the viral promoter and enhancers) are expressed preferentially in 
type II pneumatocytes and in Clara cell derived MLE-15 and mtCCl-2 cell lines 
(Palmarini, Datta et al. 2000; McGee-Estrada, Palmarini et al. 2005). 
A major issue at present is the lack of a simple laboratory test to diagnose JSRV 
infection. Diagnosis is difficult at the preclinical stages due to the lack of an 
antibody response from the host against JSRV. This lack of immune response is 
explained  in  part  by  the  expression  of  enJSRVs  during  ontogeny  that  likely 
tolerize sheep against JSRV (Ortin, Minguijon et al. 1998). Early detection prior 
to OPA development is possible by highly sensitive nested PCR assays which are 
not  a  cost  effective  diagnostic  tool  (Palmarini,  Holland  et  al.  1996;  Holland, 
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al. 2005). In general, only 2-5% of the animals within an affected flock develop 
OPA. This suggests that JSRV may be expressed at low level in the majority of 
infected hosts (Caporale, Centorame et al. 2005) and low concentrations of viral 
DNA within blood during this latent period are linked with difficulty in accurate 
diagnosis (Lewis, Brulisauer et al.). OPA is experimentally reproducible in lambs 
by intratracheal inoculation using the JSRV21 molecular clone (or by using virus 
purified  from  lung  secretions  of  an  affected  animal).  The  rate  of  disease 
induction changes depending on the age of the infected animal. Lambs are most 
susceptible to experimental infection and may develop tumours in as little as ten 
days (Fan, Palmarini et al. 2003). 
 
1.3.3  JSRV taxonomy and genome 
JSRV  is  a  member  of  the  Betaretrovirus  genus  within  the  family  of  the 
Retroviridae,  subfamily,  Orthoretroviranae.  JSRV  has  the  classic  genomic 
organization of a simple retrovirus with gag, pro, pol, and env genes flanked at 
either side by the 5’ and 3’ long terminal repeats  (LTRs) (Palmarini and Fan 
2003). Within the JSRV genome there is an accessory open reading frame, orf-X, 
to which no function has yet been assigned. All strains of JSRV studied have 
maintained  this  open  reading  frame  intact  suggesting  that  it  may  have  an 
essential role for virus replication, although by mutational analysis it has been 
determined that Orf-X is not required for the process of transformation (Rosati, 
Pittau et al. 2000; Maeda, Palmarini et al. 2001).  
JSRV can infect a wide variety of cells in vitro and in vivo (Palmarini, Dewar et 
al.  1995;  Palmarini,  Holland  et  al.  1996;  Holland,  Palmarini  et  al.  1999; 
Palmarini, Sharp et al. 1999). However, in OPA-affected animals, viral antigens 
have  been  detected  mainly  if  not  almost  exclusively  in  the  tumour  cells 
(Palmarini, Dewar et al. 1995; Murgia, Caporale et al. 2011). Within the JSRV U3 
region there are enhancer-binding motifs for lung-specific transcription factors, 
such  as  HNF-3b   that  drives  the  expression  and  transformation  of  the  lung 
epithelial  cells  (McGee-Estrada,  Palmarini  et  al.  2002).  The  U3  region  also 
contains several sites that engage general transcription factors such as CEB/P, 
commonly required by most cell types (McGee-Estrada and Fan 2006; McGee-
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1.3.4 JSRV oncogenesis 
JSRV follows unique mechanisms to induce cell transformation. The JSRV Env is a 
dominant oncoprotein both in vitro and in vivo (Maeda, Palmarini et al. 2001; 
DeMartini, Platt et al. 2004; Wootton, Halbert et al. 2005; Caporale, Cousens et 
al. 2006). The JSRV envelope is a type 1 transmembrane protein approximately 
620 amino acids (aa) in length. Within the cytoplasmic tail of the TM domain 
there  is  an  important  SH2  binding  motif  (YXXM)  that  has  been  found  to  be 
critical for Env-induced cell transformation (Caporale, Cousens et al. 2006; Hull 
and Fan 2006; Cousens, Maeda et al. 2007). The JSRV Env induces the activation 
of  cellular  signalling  pathways  such  as  the  Ras-MEK-MAP  and  PI3-kinase-Akt-
mTOR  pathways,  although  the  relative  importance  of  these  pathways  for 
oncogenesis remains to be elucidated (Palmarini, Maeda et al. 2001; Liu, Duh et 
al. 2003; Liu, Lerman et al. 2003; Maeda, Inoshima et al. 2003; Zavala, Pretto et 
al. 2003; Liu and Miller 2005; Maeda, Fu et al. 2005; Liu and Miller 2007; Maeda 
and Fan 2008).  
 
1.3.5  Hyal2 mediates viral entry of both JSRV and related 
enJSRVs 
JSRV and the related enJSRVs utilize Hyaluronidase 2 (Hyal2) for cell entry (Rai, 
Duh  et  al.  2001).  Hyaluronidases  degrade  hyaluronidin,  a  glycosaminoglycan 
critical  to  maintain  the  integrity  of  the  extracellular  matrix  (Lepperdinger, 
Mullegger  et  al.  2001).  Hyal2  is  a  glycophosphatidylinositol  (GPI)  anchored 
protein with a weak hyaluronidase activity and it is the only member of the 
hyaluronidase  family  that  JSRV  utilises  for  cell  entry  (Miller  2003),  which 
suggests that the hyaluronidase activity per se is  not a requirement for viral 
receptor  function  (Vigdorovich,  Strong  et  al.  2005;  Vigdorovich,  Miller  et  al. 
2007).  JSRV  is  believed  to  enter  the  infected  cells  via  a  caveolar-dependent 
receptor-mediated endocytosis. Chapter 1    43 
 
Figure 6. Illustration outlining the proposed caveolae-mediated viral entry pathway. 
JSRV makes a non-specific interaction on the cell surface before surfing towards hotspots and 
entering via a caveolae mediated pathway (Bertrand, Cote et al. 2008). Caveolae are grooves on 
the plasma membrane associated with lipid rafts. The latter are regions of the plasma membrane 
high in sphingolipids and GPI anchored proteins. A prerequisite for caveolar-mediated entry of a 
virus  is the cluster  of lipid rafts on the cell plasma membrane. This may enhance infection  by 
concentrating virions and their receptors at a site prior to entry. The attachment of JSRV to Hyal2 
(a  GPI  and  lipid  raft  associated  protein)  may  occur  with  a  pre-existing  cluster  of  lipid  rafts,  or 
alternatively  clustering  may  be  induced  following  virion  binding  to  non-specific  receptors,  as 
described previously. Caveloae domains are very flexible regions of the plasma membrane and this 
clustering of lipid rafts combined with virus attachment to the host receptor distorts the membrane 
shape leading to its curvature. This curvature promotes cleavage of the forming caveolar vesicle 
from the plasma membrane via Dynamin to complete the internalisation of the virus.  
 
 
1.4  Endogenous retroviruses (ERVs) 
1.4.1  Overview of endogenous retroviruses 
 
Retroviruses must integrate their genomic DNA (“provirus”) into the host cell 
genome  in  order  to  carry  out  a  successful  replication  cycle.  Cell  division 
increases the capacity to produce viral particles and indirectly maximises viral 
infection and virus “survival” within the host. In turn, survival during evolution is 
dependent on the ability of the virus to be successfully transmitted between 
infected  and  uninfected  hosts.  Retroviruses  can  be  transmitted  either 
horizontally or vertically. “Exogenous” retroviruses are transmitted horizontally 
like  any  other  virus  and  include  many  common  pathogens  of  humans  and 
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leukemia virus (Hardy, Old et al. 1973), Jaagsiekte sheep retrovirus (Palmarini, 
Sharp  et  al.  1999)  and  several  others.  “Endogenous”  retroviruses  (ERVs)  are 
instead transmitted from generation to generation like any other Mendelian gene 
(Boeke and Stoye 1997). Some ERVs are derived from the integration of ancient 
and now extinct exogenous retroviruses within the germline cells of the host, for 
example Human endogenous retrovirus (HML-2) (Lee and Bieniasz 2007). Others, 
such as enJSRV, are regarded as modern ERVs as they are found to be highly 
related to current exogenous retroviruses which are still infectious (Palmarini, 
Hallwirth et al. 2000; Palmarini, Mura et al. 2004; Arnaud, Caporale et al. 2007; 
Arnaud, Varela et al. 2008; Varela, Spencer et al. 2009; Black, Arnaud et al. 
2010). Once present in the germline, the proviral DNA establishes itself as a 
permanent fixture within the host genome and is then vertically transmitted to 
future generations (Coffin, Hughes et al. 1997). ERVs are clearly an integral part 
of the mammalian genome as they represent approximately 8% of the human 
genome (Lander, Linton et al. 2001). 
ERVs originate from germline integration. The germline is a population of highly 
demethlyated,  undifferentiated  and  active  cells  which  provides  optimum 
conditions  for  successful  retroviral  integration  with  ample  unrestricted 
integration  sites  and  uninhibited  expression  patterns  thus  allowing  the  rapid 
expansion of integrated elements (Boeke and Stoye 1997). Due to the selection 
pressure the  host  exerts  over  non-self  sequences,  many ERVs are  silenced as 
they  accumulate  mutations  which  render  them  replication  incompetent. 
Generally, the majority of examples of replication competent genomes will be 
found to be recent integrations or transposition events. Several animal species, 
including mice and sheep, have active and intact ERVs capable of viral particle 
production while in higher species (primates) the majority are inactive (Kurth, 
Bannert 2010). It is fair to assume that the ERVs identified within host genomes 
represent a very small proportion of those which have challenged the germline 
during evolution. Proviruses that pose a deleterious effect to the host have been 
likely counter-selected during evolution. In many ways, ERVs provide clues as to 
the ancient and now extinct retroviruses which challenged the genome and the 
interplay  between  virus  and  host  during  co-evolution.  Several  attempts  have 
been  made  to  “resurrect”  endogenous  retroviral  sequences  in  order  to 
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opportunities  to  study  a  genome  that  is  instead  currently  under  invasion  by 
retroviruses and to date the koala and sheep represent good examples of these 
genomes (Tarlinton, Meers et al. 2006; Arnaud, Caporale et al. 2007). ERVs are 
not just “fossils” and redundant junk DNA (Bock and Stoye 2000) within the host 
genome, as several studies suggest that these elements play major roles in host 
physiology (see 1.4.5 Placental formation).  
Interestingly,  until  recently  retroviruses  were  considered  the  only  viruses 
present  in  vertebrate  genomes.  However,  analysis  of  a  variety  of  vertebrate 
genomes  has  revealed  that  both  RNA  (Bornaviruses  and  Filoviruses)  viruses 
(Horie,  Honda  et  al.  2010),  (Belyi,  Levine  et  al.  2011)  and  DNA  viruses 
(Densoviruses and Parvoviruses) have been endogenised during evolution (Belyi, 
Levine  et  al.  2010;  Liu,  Fu  et  al.  2011).  Thus,  the  contribution  to  genomic 
diversity provided by viruses is far greater than previously recognised.  
 
1.4.2  The discovery of endogenous retroviruses 
 
ERVs  were  first  highlighted  during  studies  in  the  1960s  which  focused  on 
maintaining Avian Sarcoma Leukaemia virus (ASLV)-free egg producing chickens. 
Uninfected  chickens  consistently  yielded  positive  results  for a  serologic  assay 
targeting the viral Gag (group specific antigen) (Dougherty and Di Stefano 1966). 
Additionally,  Gag  and  retroviral  like  particles  were  identified  within  healthy 
chicken tissues  (Dougherty,  Di  Stefano et al.  1967).  These  data  were  further 
validated when it was shown that Gag could be inherited following a Mendelian 
cross between Gag+ and negative breeds of chickens (Payne and Chubb 1968). 
However, at that time it was suspected that these data could be either due to a 
latent  retroviral  infection  or  cross  reactivity  with  a  host  gene.  It  was  later 
observed that the fibroblasts of chick embryos were capable of releasing Rous 
Sarcoma Virus (RSV) in the absence of helper virus (Weiss 1967). Until this point, 
RSV required complementation by the envelope of RSV in order to release viral 
particles from cells in culture (Hanafusa, Miyamoto et al. 1970). However, it was 
later  identified  that  virus  was  released  spontaneously  following  ionizing 
radiation of both embryo and somatic cells (Weiss, Friis et al. 1971). The data at 
that  time  therefore  revealed  two  fundamental  properties  of  endogenous 
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germline of the host and were inherited vertically by future generations, and 
secondly that, although they are predominately silent within the genome, they 
can be reactivated. The discovery of ERVs has been reviewed by Weiss (Weiss 
2006). 
 
1.4.3  Classification of ERVs 
 
Transposable elements are mobile DNA segments (McClintock 1956) which utilise 
cellular machinery to support replication. They constitute a large fraction of the 
mammalian  genome  and  represent  up  to  approximately  50%  of  the  human 
genome in comparison to the 3% of protein encoding genes identified to date, as 
described by (Coffin, Hughes et al. 1997). Transposable elements may be further 
categorized  into  Class  I  and  II  based  upon  structure  and  movement  patterns 
(Finnegan 1989). Class I are DNA transposons which cut and paste themselves 
within the genome, while Class II are retroelements which are capable of copy 
and paste movements within the genome. Furthermore, retroelements consist of 
either LTR based DNA sequences (ERVs) or non-LTR based DNA sequences (LINES, 
SINES) (Boeke and Stoye 1997).  
ERVs represent a subclass of transposable elements that are self sufficient and 
capable of efficiently copying and reinserting themselves into the genome. They 
are restricted to vertebrates and there are many examples. With the exception 
of  deltaretroviruses,  many  endogenous  retroviruses  have  closely  related 
exogenous  forms  (Boeke  and  Stoye  1997).  ERVs  are  further  categorized  into 
three classes. First those which resemble most exogenous gammaretrovirus like 
sequences,  the  second  Betaretrovirus  like  sequences  and  the  third  and  final 
those  which  share  homology  with  spumaretrovirus-like  elements.  This 
classification  is,  however,  now  deemed  insufficient  with  the  addition  of 
subgroups due to the discovery of endogenous lentiviral (Katzourakis, Tristem et 
al.  2007;  Gifford, Katzourakis  et al.  2008)  and  authenticated  spumaretroviral 
sequences (Lagaye, Vexiau et al. 1992; Coffin, Hughes et al. 1997). The rapidly 
expanding  abundance  and  knowledge  of  ERVs  has  lead  to  problems  with 
nomenclature and classification, as highlighted in a recent review by (Blomberg, 
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1.4.4  The effects of ERV expression on host function and 
genome plasticity 
 
Endogenous  retroviruses  have  overcome  several  barriers  in  order  to  achieve 
successful fixation in the host genome. Any given ERV must be able to infect 
reproductive  tissues  in  order  to  facilitate  the  infection  of  germline  cells.  In 
addition, it must also be able to evade any host restriction mechanisms (see 1.5 
Host vs Virus), successfully integrate and persist without any detriment to the 
host and, finally, transcend from an insertionally polymorphic trait to a fixed 
gene within the host species (Boeke and Stoye 1997).  
Most ERVs are defective and transcriptionally repressed but in rare occasions 
they  are  functional,  providing  useful  and  essential  functions  to  the  host. 
Recombination  between  related  ERV  loci  present  in  different  chromosomal 
locations  can  also  result  in  chromosomal  rearrangements  (Hughes  and  Coffin 
2001).  Thus,  ERV  integration  can  modulate  gene  function  and  provide  more 
plasticity for the genome of the host species (Eiden 2008). Whenever functional, 
ERVs are capable of exerting significant transcriptional control over host genes 
residing either as integral elements of the promoter or as enhancers from distal 
intergenic regions. For example, the salivary amylase promoter region contains 
several structures derived from retrotransposons (one of which is an ERV) that 
exert transcriptional control resulting in tissue specific expression of this gene 
(Ting, Rosenberg et al. 1992). An example of long range function is provided by 
ERV-9 which regulates fetal g and adult b globin genes from 40-70kB upstream. 
The ERV-9 LTR binds NF-Y and GATA2 and generates an LTR/RNA polymerase II 
complex  modulating  downstream  globin  promoters  (Pi,  Zhu  et  al.  2010).  In 
addition, ERVs have been reported to regulate particular host splicing events, 
for example an ERV derived from a human teratocarcinoma cell line promotes 
human PLA2L gene expression in these cells (Feuchter-Murthy, Freeman et al. 
1993).  ERVs  also  have  a  prominent  role in  placental  morphogensis  (see  1.4.5 
Placental formation) and host immunity (see 1.5 Host vs. Virus) which will be 
discussed in detail later. 
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1.4.5  Placental formation 
 
Despite the significant physiological differences in the reproductive biology of 
mammals, the placentas of various animal species have been found to express 
ERVs and in some cases viral particles. Electron microscopy (EM) studies as early 
as  the  1970s  indicated  the  presence  of  viral-like  particles  within  the 
reproductive tract of humans and animals (Kalter, Helmke et al. 1973; Kalter, 
Heberling et al. 1975). Further EM studies of suspected retroviral particles from 
placental tissue confirmed associated RT-activity with a density and size relative 
to that of C-type retroviruses (Lyden, Johnson et al. 1994). The placenta and the 
syncytiotrophoblast in particular, is the central point of exchange of nutrients 
between mother and child. Extensive HERV expression is detected within the 
human placenta (de Parseval and Heidmann 2005). In particular, expression of 
HERV-W Env protein Syncytin-1 is credited as the driving force behind the fusion 
event that leads to the formation of the syncytiotrophoblast during placental 
formation  (Frendo,  Vidaud  et  al.  2000;  Frendo,  Olivier  et  al.  2003).  Indeed, 
knockout  of  a  similar  protein  in  mice  (Syncytin-A)  is  embryo  lethal. 
Histopathology examination of embryos revealed a lack of trophoblast fusion to 
the maternal uterine epithelium (Dupressoir, Vernochet et al. 2009). In humans, 
abnormal expression of Syncytin has been linked to preeclampsia (Lee, Keith et 
al. 2001) highlighting the important role of ERVs during pregnancy. ERVs can also 
exhibit immunosuppressive properties and interfere with the replication cycle of 
exogenous related retroviruses, as will be discussed later (see 1.5 Host vs Virus). 
In summary, there is significant evidence which indicates that the continuous 
challenges posed by ERVs have shaped the evolution and development of several 
mammals in many different ways. Several ERV LTRs appear to exert control over 
host  genes  while  viral  proteins  have  been  found  to  be  involved  in  essential 
physiological processes.  
 
1.4.6  Endogenous JSRVs 
 
JSRV-related viruses also exist as inherent “endogenous” (enJSRV) viruses stably 
integrated  and  established  within  the  host  genome.  When  compared  to  their Chapter 1    49 
exogenous  counterpart,  enJSRVs  share  85-89%  identity  with  JSRV  along  the 
entire genome (Arnaud, Varela et al. 2008). Major differences are found across 
the U3 region of the LTRs as well within three variable regions, two of which 
reside  in  gag  (VR1/2)  and  in  the  other  within  env  (Bai,  Bishop  et  al.  1999; 
Palmarini, Hallwirth et al. 2000).  
There  are  at  least  27  enJSRV  loci  in  the  sheep  genome  which  have  been 
identified,  isolated  and  cloned  from  a  bacterial  artificial  chromosome  library 
which originates  from  a  single  Texel  ram (Figure  8)  (Arnaud, Caporale et al. 
2007). The 27 enJSRVs appear to be distributed across the sheep chromosomes 
(Carlson, Lyon et al. 2003; Armezzani, Arnaud et al. 2011) and first entered the 
genome approximately 5-7 million years ago. The invasion of the host genome by 
enJSRVs has continued throughout the evolution of the Caprinae (Fig. 7) as the 
youngest provirus is predicted to have entered the host genome less than 200 
years ago. Thus, enJSRV colonization of the ovine genome remains an ongoing 
process. The 27 enJSRVs identified to date were likely acquired during evolution 
from  multiple  infection  events  of  the  germline  by  JSRV-related  exogenous 
viruses or by reinfection of an existing active enJSRV locus. Most of the oldest 
enJSRV  proviruses  have  acquired  mutations  and  deletions  that  render  them 
replication deficient. However, several enJSRVs loci possess an intact genome 
and are indeed able to express intact viral particles (Arnaud, Caporale et al. 
2007).  
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                         Figure 7 – Distribution of the 27 enJSRVs within the Caprinae. 
The insertionally polymorphic nature of the more recent integration indicated in white within the 
Ovis aries. Reproduced with permission from PLoS Pathogens (Arnaud, Murcia et al. 2007). 
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Figure 8- The 27 enJSRV loci isolated from the sheep genome. 
Many  of  the  enJSRVs  have  accumulated  mutations  and  deletions  across  their  genome  which 
render them replication incompetent. Several more recent integrations have retained open reading 
frames  and  are  capable  of  viral  particle  production.  Reproduced  with  permission  from  PLoS 
Pathogens .(Arnaud, Murcia et al. 2007).  
 
 
 
 
1.4.7  Evolutionary history of enJSRVs  
 
The “age” of a provirus can initially be estimated by determining its presence in 
phylogenetically  related  species.  If  a  provirus  is  present  in  exactly  the  same 
chromosomal location in two phylogenetically related animal species then it is 
safe to assume that the original infection occurred before the divergence during 
the evolution of the two animal species in question (Boeke and Stoye 1997). As 
mentioned  above,  the  oldest  of  the  enJSRV  proviruses,  such  as  enJSRV-10, 
integrated  before  the  divergence  of  the  Ovis  and  Capra  genera  (Arnaud, 
Caporale et al. 2007). Another way to determine the age of a proviral sequence 
is by correlating the divergence between the 5’ and 3’LTRs, with the mutation 
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integration  of  the  proviral  sequence.  Therefore,  the  greater  the  level  of 
divergence between LTRs the older the provirus will likely be. Although these 
calculations  are  subject  to  a  wide  margin  of  error  due  to  homologous  and 
heterologous  recombination  of  the  LTRs  of  different  proviruses,  they  are 
nevertheless  a  useful  indication  of  the  age  of  any  given  provirus  (Arnaud, 
Caporale et al. 2007). 
The sheep genome contains several enJSRVs that are fixed within the domestic 
sheep population (i.e. every sheep contains these proviruses and their fixation 
within  the  genome  occurred prior  to  the domestication  of  sheep)  and  others 
(enJSRV7, 8, 15, 16, 18, 26 and enJS5F16) that are insertionally polymorphic. In 
other words these proviruses are younger and present only in a proportion of the 
domestic  sheep  population.  Five  of  the  insertionally  polymorphic  enJSRV 
proviruses  have,  as  expected,  identical  5’  and  3’  LTRs  sequences  (Arnaud, 
Caporale et al. 2007).  
Older  enJSRV  loci  such  as  enJS59A1,  enJSRV25  and  enJSRV17  contain  large 
deletions  within  the  env  gene.  Both  enJSRV6  and  enJSRV2  have  evidence  of 
recombination events with other proviruses and contain internal sequence in the 
opposite direction  to  the  general  5’  to  3’  sequence  (Arnaud,  Caporale  et  al. 
2007). It is thought that enJSRV2 derives from a recombination event as the 
flanking genomic regions lack the 6bp duplication at the site of chromosomal 
entry common to all proviral insertions (Arnaud, Caporale et al. 2007). Many 
enJSRV proviruses also have premature termination codons that “litter” their 
genome (e.g. enJSRV10 contains a premature stop codon in pro, pol, env and 
orf-X). Five of the recent enJSRVs maintain an intact genomic organization. Two 
loci,  enJSRV-16  and  18  are  identical  across  their  entire  genome  and  are 
therefore  only  distinguishable  by  the  location  of  their  integration.  The  most 
recently  integrated  provirus,  enJSRV-26,  is  believed  to  be  a  virus  that  has 
integrated in a single animal. All of the information derived from the genomic 
organization  of  enJSRVs  is  summarized  (Arnaud,  Murcia  et  al.  2007).  The 
genomes of all 27 enJSRVs identified to date are summarised in Figure 8. All of 
the insertionally polymorphic enJSRV loci with an intact genomic organization 
are able to produce virus particles in vitro and in vivo (Black, Arnaud et al. 
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1.4.8  enJSRVs play a critical role in the reproductive biology of 
the host 
 
Endogenous retroviruses are by definition non-pathogenic, otherwise they would 
be counter-selected during evolution. The exogenous JSRV is an oncogenic virus 
whose  Env  is  a  dominant  oncoprotein.  However,  as  expected,  none  of  the 
enJSRV Env glycoproteins are oncogenic and they all lack the SH2 binding domain 
within the cytoplasmic tail that has been found to be a major determinant of 
oncogenicity (Palmarini, Gray et al. 2001). In addition, the enJSRVs LTR lack 
those  enhancer  binding  regions  that  are  essential  to  drive  lung-specific 
expression  of  JSRV.  Expression  of  enJSRVs  is  widespread  throughout  the 
reproductive tract and has been detected within the oviduct, uterus, cervix and 
vagina (Palmarini, Gray et al. 2001). Thus, it appears that the high degree of 
divergence  between  the  LTRs  of  the  enJSRVs  and  JSRV  contribute  to  their 
different  patterns  of  expression.  Early  studies  of  enJS56A1,  enJS59A1  and 
enJS5F16 LTRs show that the HNF-3 and C/EBP binding sites (found important for 
JSRV  lung-specific  expression)  are  interrupted  by  an  insertion  of  13  and  15 
nucleotides respectively (Palmarini, Datta et al. 2000; McGee-Estrada and Fan 
2007). A comparison of the enJSRV LTRs with that of MMTV has also confirmed 
the  presence  of  hormone  responsive  elements  (HRE)  (Lieberman,  Bona  et  al. 
1993) within enJSRV LTRs. The enJSRVs HRE can be linked to their identified 
expression in vivo during pregnancy. In addition, another conserved transcription 
binding domain among the LTR of enJSRVs is Activator Protein 2 (AP2) which has 
been identified to regulate bovine binucleate trophoblast-specific genes during 
the placental development in pregnancy (Ushizawa, Takahashi et al. 2007). 
In vivo, enJSRV expression has been found to peak in correspondence to high 
levels of progesterone and progesterone receptor. In vitro, the LTR of various 
enJSRV  loci  have  shown  enhanced  expression  of  the  corresponding  enJSRV 
following  progesterone  treatment  (Palmarini,  Hallwirth  et  al.  2000;  Dunlap, 
Palmarini et al.  2006;  Spencer,  Sandra  et  al.  2008).  enJSRVs  are  particularly 
abundant within the luminial epithelium and glandular epithelium cells of the 
ovine  genital  tract  from  day  12  -18,  coinciding  with  an  upregulation  of 
progesterone. Expression of enJSRVs also coincides with that of Interferon-tau Chapter 1    54 
(IFNtau), the pregnancy recognition signal in ruminants (Bazer, Burghardt et al. 
2008). IFN-tau expression is crucial in order to prevent luteolysis from occurring 
and allows establishment of the developing conceptus (Spencer, Burghardt et al. 
2004).  The  involvement  of  HERV-W  Env  protein  Syncytin-1  expression  in  the 
fusion  event  that  leads  to  the  formation  of  the  syncytiotrophoblast  during 
placental  formation  has  already  been  shown  (Frendo,  Vidaud  et  al.  2000; 
Frendo,  Olivier  et al.  2003).  Although human and  ruminant  pregnancy  differs 
significantly in anatomy (Barry and Anthony 2008) it appears that they share the 
presence  of  ERVs  during  placental  morphogensis.  Inhibition  of  enJSRV  env 
transcription and translation from day 12 of pregnancy results in the incorrect 
expansion of the conceptus during pre-implantation development from a solid 
form to that of a filamentous. This results in no attachment to the uterine wall, 
(the correct process is summarised in Figure 9) demonstrating the essential role 
of enJSRVs in this process (Dunlap, Palmarini et al. 2006). In preparation for the 
implantation of the conceptus, mononuclear/binuclear cell fusion occurs leading 
to trinucleate cells which fuse in order to produce placentomes in support of 
conceptus development (see Figure 10 for summary). This occurs in the presence 
of enJSRV and HYAL2 expression and it is speculated that they play an important 
part in this process (Dunlap, Palmarini et al. 2005). How enJSRVs elicit their 
action  is  not  yet  fully  understood,  although  fusion  mediated  solely  by  the 
enJSRVs Env and HYAL-2 receptor seems unlikely, as to date enJSRV Env has not 
been found capable of inducing syncytia in vitro.  
Together, JSRV-enJSRVs and the domestic sheep provide a rare opportunity to 
study  the  on-going  co-evolution  of  retroviruses  and  their  host.  This  is  a  rare 
opportunity and the only other species for which there is evidence of ongoing 
endogenisation is the koalas (Tarlinton, Meers et al. 2006).  
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Figure 9. Schematic diagram illustrating the pattern of enJSRVs expression during early 
pregnancy. 
The  developing  conceptus  emits  IFNtau  as  a  signal  for  the  endometrium  to  prepare  for  the 
implantation event. enJSRVs are found expressed in the luminal and glandular epithelium of the 
endometrium as indicated in red as well as in the conceptus. A crucial part of development is the 
elongation  of  the  conceptus  into  a  filamentous  form  for  successful  implantation  mediated  by 
enJSRVs. 
 
 
Figure 10. Schematic diagram illustrating the major phases of placental morphogenesis. 
Fusion  of  mononucelate  and  binucleate  trophoblast  cells  of  the  conceptus  leads  to  trinucleate 
hybrid  cells  which  invade  the  endometrium.  This  is  a  prerequisite  for  placentome  formation 
necessary to support conceptus development and occurs during the expression of enJSRV and its 
receptor HYAL2.  Chapter 1    56 
 
 
 
 
1.5  Host vs. Virus 
 
Host  cells  possess  a  complex  array  of  antiviral  mechanisms  with  which  to 
respond to viral detection to fight virus infections. In addition to the constitutive 
expression of “intrinsic” antiviral factors, the recognition of a virus infection 
triggers  intracellular  signalling  pathways  that  result  in  the  induction  of  the 
“innate” immune response and subsequently an “adaptive” immune response. 
The continuous challenge to the host provided by pathogens results in a strong 
selective pressure to develop sophisticated barriers to infection which, in turn, 
has major evolutionary implications for viral populations. Thus, a key requisite 
for any successful virus is the ability to evade recognition by the host innate 
immune system (Bieniasz 2004). 
 
1.5.1  Intrinsic immunity 
 
Intrinsic  viral  restriction  factors  are  constitutively  expressed  proteins  which 
interfere  with  the  viral  lifecycle.  ‘Viral  interference’  is  a  form  of  intrinsic 
immunity  mediated  by  intact  or  defective  endogenous  retroviruses.  Viral 
interference  has  not  been  reported  in  humans  but  there  is  evidence  of  this 
process in both mice and sheep. In mice, Fv1 and Fv4 are two host genes which 
control susceptibility to the Friend strain of Murine Leukemia Virus (F-MLV). Fv1 
is derived from a resident endogenized retroviral Gag (Best, Le Tissier et al. 
1996). Fv1 has two alleles, Fv1n and Fv1b present in mice, which exert their 
action over specific subtypes of MLV (Hartley, Rowe et al. 1970) and block MLV 
infection  at  a  stage  after  reverse  transcription  but  before  integration  takes 
place by a mechanism that has not been entirely clarified (Bieniasz 2004). Fv4 
instead  is  closely  related  to  the  Env  of  MuLV  and  restricts  viral  infection  by 
blocking access to and downregulating the F-MLV receptor from the cell surface, 
as reviewed by (Bieniasz 2004).  Chapter 1    57 
The enJSRVs of sheep also provide a ‘viral interference’ restriction mechanism 
by engaging the HYAL-2 receptor (Spencer, Mura et al. 2003). Furthermore, two 
of  the  27  enJSRVs  identified  to  date,  enJSRV-20  and  en56A1,  provide  an 
additional  form  of  intrinsic  viral  restriction  mediated  by  their  Gag  protein. 
Unique  to  both  enJSRV-20  and  en56A1  is  a  tryptophan  in  position  21  of  Gag 
which results in a transdominant phenotype defective for exit (Mura, Murcia et 
al.  2004).  The  exogenous  JSRV  has  an  arginine  in  position  21  of  Gag  that  is 
considered  essential  for  directing  the  protein  towards  the  centrosome  for 
assembly. The presence of tryptophan at position 21 of Gag of the transdominant 
en56A1  results  in  a  significantly  different  intracellular  distribution  to  that  of 
exogenous  Gag.  It  is  suspected  that  both  of  these  transdominant  enJSRVs 
entered the germline with a tryptophan at position 21 in two distinct events. 
They then became fixed within the species thereafter due to the positive host 
function they are associated with. In the presence of en56A1, exogenous JSRV 
Gag does not assemble at the centrosome region. Instead the JSRV Gag is found 
to  colocalise  with  en56A1  Gag  and,  when  the  proteosomal  machinery  is 
inhibited, en56A1/JSRV Gag aggresomes are observed (Mura, Murcia et al. 2004). 
This restriction mechanism is independent of the Late domain and membrane 
binding domains of Gag and is called JSRV late restriction (JLR) in recognition of 
the effect it has over the late phase of the replication cycle (Arnaud, Murcia et 
al. 2007; Murcia, Arnaud et al. 2007). The most recent sheep ERV acquisition , 
enJSRV-26, , is capable of escaping the JLR and this is due to the substitution of 
a single amino acid in the signal peptide of its envelope protein (Armezzani, 
Arnaud et al. 2011). The JLR proves to be a mode of restriction unique to sheep 
which gives specific protection against the continuous challenge JSRV poses. The 
escape by enJSRV-26 is an excellent example of the continuous struggle between 
the host and virus for dominance. 
1.5.2  Innate Immunity  
 
Innate immunity is a mechanism with ancient origins established prior to the 
evolutionary division which formed the plant and animal kingdoms and, as such, 
it is represented in both. In its most concise definition, innate immunity is an 
immediate, uniform, potentially inducible response inherited from the germline 
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DNA/RNA (Janeway 1989). Innate immunity is distinguishable from intrinsic viral 
restriction  as  it  requires  induction  by  Interferon  (IFN)  to  elicit  widespread 
expression  and  effects,  unlike  intrinsic  factors  which  are  constitutively 
expressed.  Innate  immunity  is  regulated  predominately  by  plasmacytoid 
dendritic cells (pDC) which are a large source of IFN following viral infection 
(Barchet,  Cella  et  al.  2002).  The  innate  immune  response  bridges  the  gap 
between host detection of virus and the time taken for the adaptive immune 
system  to  respond  (Tough  2004).  IFN  induces  an  antiviral  state  in  nearby 
uninfected  cells  following  viral  detection,  upregulating  a  range  of  restriction 
factors which target various aspects of the retroviral lifecycle. Many studies on 
innate  immunity  have  been  conducted  in  the  fruit  fly  drosophila  due  to  the 
absence  of  an  adaptive  immune  response.  Simple  invertebrates,  such  as 
Drosophila melanogaster, rely on RNA interference (RNAi) as the major antiviral 
mechanism (Wang and Ligoxygakis 2006) 
In  contrast  to  the  adaptive  immunity,  the  innate  immune  response  is  an 
inherited uniform response “embedded” within the germline. In many ways the 
IFN response is therefore a uniform response. However, the IFN induced genes 
are by no means a static population with both positive and negative selection 
acting upon IFN stimulated genes (ISGs) and with many examples of the recent 
acquisition of further ISGs. The addition of further downstream genes activated 
by the innate immune response provides further antiviral related activity (see 
1.5.8  IFN  stimulated  genes  with  antiretroviral  activity).  Innate  immunity 
provides  a  first  line  of  defence  while  the  adaptive  response  generates  the 
potential to evade new and emerging viruses faster than the selective process to 
establish an innate response within the germline.  
1.5.3  Interferon (IFN)  
 
Interferons  (IFNs)  are  a  family  of  secreted  cytokines  that  induce  an  antiviral 
cellular state following viral infection as part of the innate immune response 
(Shirazi and Pitha 1993). IFNs can be distinguished into three classes: type I, II 
and III IFNs. The type I IFNs found within placental mammals include IFN-a, IFN-
b, IFN-w, IFN-d, IFN-e, IFN- t , IFN-k, IFN- z subtypes. The exact biological effect 
and  signalling  pathways  utilised  by  IFNs  varies  and  is  dependent  on  their Chapter 1    59 
expression pattern, local host environment and subtype cellular targets. IFN-a 
and  IFN-b  can  be  induced  in  most  cell  types  as  a  direct  response  to  viral 
infection. However, IFN-d is unique to pigs and IFN- z  is unique to mice whilst 
IFN-t is specific to ruminants. Within humans, IFN-a has expanded considerably 
during evolution leading to a family consisting of thirteen genes whilst IFN-b, 
IFN-w,   IFN-e,  IFN-k subtypes  maintain  only  one  gene  {Pestka2004  #558}. 
Amplification  of  the  IFN-a  gene  suggests  this  gene  is  of  pivotal  importance 
during initiation of innate immunity. Type II IFNs typically display less antiviral 
activity than that of IFN type 1. 
Although  the  majority  of  cell  types  are  capable  of  IFN  production  following 
antiviral detection, pDC cells are a specific subset of DCs (Fitzgerald-Bocarsly 
1993)  which  have  a  prominent  role  in  IFN  production.  They  produce  large 
quantities of type I IFN which in turn regulates the induction of both innate and 
adaptive immunity. In addition to IFN, pDCs also produce other cytokines with 
antiviral  function.  IFN  plus  IL-12  induces  the  secretion  of  IFN-g  from  natural 
killer (NK) cells, CD8+ T cells and CD4+ T helper cells (Avice, Demeure et al. 
1998; Berg, Cordes et al. 2002; Kamath, Sheasby et al. 2005), whereas memory B 
cells are stimulated to produce antibodies in the presence of IFN and IL-6 (Jego, 
Palucka et al. 2003). Furthermore, IFN leads to the stimulation of T cells as IFN 
promotes the development of pDCs to DCs (Grouard, Rissoan et al. 1997). In 
short  pDCs  have  three  major  functions:  the  production  of  IFN,  antigen 
presentation and T cell priming, as summarised by (Barchet, Blasius et al. 2005). 
 
1.5.4  Intracellular recognition of retroviruses via TLR and RIG-I  
 
Recognition  of  viral  entry  occurs  via  viral  “pathogen  associated  molecular 
patterns”  (PAMPs)  detected  by  cellular  host  ‘pattern  recognition  receptors’ 
(PRRs).  There  are  several  groups  of  PRRs  which  are  capable  of  recognizing 
different forms of viral DNA/RNA including Toll like receptors (TLRs), retinoic-
acid  inducible  gene  (RIG-I)  like  receptors  (RLR),  nucleotide  binding  domain, 
leucine-rich  repeat  containing  proteins  (NLR)  and  cytoplasmic  sensors 
(Yoneyama  and  Fujita  2010).  Of  particular  significance  to  retroviruses  is  the 
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pathway over the other for activation of an antiviral response following viral 
detection. RIG-I is utilised by a wide range of host cells while pDCs preferentially 
use TLR signalling as reviewed by (Kato, Sato et al. 2005). 
 
1.5.5 Toll like receptors  
TLRs  are  found  both  at  the  plasma  membrane  and  within  intracellular 
endosomes.  Those  members  of  the  TLR  family  which  are  most  significantly 
involved  in  the  detection  of  invading  retroviruses  are  those  found  within 
endosomes (TLRs 3, 4, 7, 8 and 9) with TLR3 and 4 specific to DCs and TLR7, 8 
and 9 for pDCs. Double stranded RNA (dsRNA) is a hallmark of viral infection and 
is recognised by TLR3, which is linked as a factor for DC maturation (Matsumoto 
and Seya 2008). In contrast, TLR7/8 are crucial for the recognition of ssRNA and 
TLR7/9  are  found  to  be  specific  to  pDCs.  TLRs  stimulate  cytokine  and  IFN 
production via the adaptor molecules TRIF for TLR3 and Myd88 for TLR7/8/9, 
which act upon the transcription factors IRF3/7 and NF-kB. It is specifically the 
expression of IRF-7 in pDCs which is linked with the rapid secretion of IFN-α/β, 
as reviewed by (Beutler, Eidenschenk et al. 2007) and summarised in Figure 11. 
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Figure 11. Schematic diagram illustrating intracellular recognition of retroviruses by TLRs. 
Reproduced with permission from Nature. 
 
 
 
 
1.5.6  Retinoic-acid inducible gene I (RIG-I) like receptors 
 
 
Unlike  the  endosome  based  TLRs,  RIG-I  like  receptors  (RLR)  which  include 
Retinoic-acid-inducible-protein  1  (RIG1)  and  Melanoma-differentiation-
associated gene 5 (MDA5) are cytosol based proteins. Similarly to TLRs, they are 
also involved in the recognition of RNA viruses leading to the upregulation of 
cytokines  and  induction  of  IFN.  It  has  been  proposed  that  RIG-I  recognizes 
intracellular viral non-capped ds/ssRNA, that is distinguishable from host capped 
mRNA.  In  addition,  the  identification  of  uridine  and  adenosine  rich  regions 
within  viral  sequences,  as  well  as  RNAseL  products,  upregulates  the  RLR 
response. RIG-I binds short viral RNAs, whilst MDA5 binds those longer than 1Kb. 
Both RIG-I and MDA5 remain within the cytoplasm in an inactive state until RNA 
binding triggers a conformational change and exposure of the Caspase activation 
and recruitment domain (CARD) for downstream signalling. The initiation of the 
RLR response is best understood to date for RIG-1 while the activation of MDA5 
has yet to be fully characterised. The CARD and repressor domain (RD) of RIG-I 
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domain of RIG-I recognises and engages with PAMPs. This leads to K63 linked 
ubiquitination of RIG-I by TRIM-25 and RING finger protein which switches RIG-I 
to  an  active  state  by  an  alteration  in  conformation.  The  new  conformation 
induces  a  signalling  cascade  involving  oligomerisation  of  RIG-I  and  a  CARD 
dependent interaction with IPS-1, resulting in IFN upregulation as summarized by 
(Loo and Gale 2011) in Figure 12. However, several studies with knockout mice 
have revealed that the requirement of RIG-I/MDA5 varies depending on the virus 
in question. Whether activation occurs by TLRs or by RLRs both pathways act on 
transcription factors NF-kB, IRF-3 and IRF-7 which in turn induces the expression 
of IFN-α/β, as reviewed by (Beutler, Eidenschenk et al. 2007).  
 
 
 
Figure 12. Schematic diagram illustrating the induction of IFN by RLR signalling via RIG-I. 
Reproduced with permission from Cell Press. 
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1.5.7  Propagation of the IFN response 
 
Upon upregulation, IFN-α/β is secreted and induces dimerization of the IFN-α/β 
receptor  (IFNAR-1  and  -2)  of  neighbouring  cells.  Ligand-induced  dimerization 
initiates  a  signalling  cascade  via  the  JAK/STAT  pathway  activating  ISGF-3 
(Interferon stimulated gene factor, a heterodimer of STAT1/2). ISGF-3 binds to 
the IFN-stimulated response element (ISRE), present in the promoters of most 
IFN stimulated genes (ISGs). IFN elicits a very broad regulation of gene response 
to viral infection.  There are hundreds of genes that are upregulated in response 
to  IFN  treatment  that,  in  combination,  determine  the  antiviral  state.  The 
INTERFEROME  database  (Samarajiwa,  Forster  et  al.  2009)  collects  all  the  IFN 
regulated genes. There are 1996 human genes thought to be influenced by IFN 
(1581 upregulated, while 415 appear to be downregulated). These gene products 
are  further  divided  as  roughly  676  being  nuclear,  626  cytoplasmic,  379  are 
membrane  based,  151  mitochondrial,  64  are  Golgi  based,  34  ribosomal  and 
finally 35 are lysosomal (Hertzog, Mansell et al. 2011). 
 
1.5.8  IFN-stimulated genes with antiretroviral activity 
 
Intrinsic and innate immunity have a significant impact on retroviral evolution. 
There are several examples of retroviruses which have refined their genome in 
order to overcome the action of restriction factors that threaten their existence. 
Similarly,  there  is  evidence  of  the  expansion  of  innate  immune  restriction 
factors  in  response  to  the  pressure  exerted  on  the  host  by  the  consistent 
challenge that retroviruses present. There are several IFN induced restriction 
factors which have a significant role in the antiviral response elicited by the host 
following the discovery of infection, including APOBEC, TRIM and BST-2 (Neil and 
Bieniasz 2009). 
 
1.5.8.1   APOBECs  
Apolipoprotein  B  mRNA-editing  enzyme  catalytic  polypeptide-like  proteins 
(APOBECs) are a group of RNA/DNA editing enzymes. Two proteins belonging to Chapter 1    64 
this  family  have  a  significant  role  in  the  antiviral  innate  immune  response, 
APOBEC3F(1-3) and 3G, are induced or maximised by IFNa signalling in T cells, 
macrophages and DCs, (Chen, Huang et al. 2006; Peng, Lei et al. 2006; Wang, 
Huang et al. 2008). APOBEC3F and 3G are cytosine deaminases that target the 
early stages of viral replication and are incorporated into viral particles exiting 
the  cell  (Figure  13).  Upon  infection  of  new  cells  APOBEC  exerts  its  antiviral 
effect during reverse transcription by editing cytosine residues to uracil. This has 
a significant impact on reverse transcription, creating a disproportionate amount 
of  uracil  in  minus  strand  DNA.  This  in  turn  creates  G  to  A  ‘hypermutations’ 
during  second  strand  synthesis  with a  negative  impact, eventually  inducing a 
‘crash’ in the viral population as reviewed by (Harris and Liddament 2004). 
There is evidence of the restriction of ancient gammaretroviruses by APOBEC3G 
as  significant  G  to  A  hypermutation  of  the  endogenous  retroviruses  of 
chimpanzee ERV-1 and 2 has been observed. These data led to the speculation 
that APOBEC had an impact on the evolution of these viruses and limited their 
host  range  (Perez-Caballero,  Soll  et  al.  2008).  Multiple  copies  of  APOBEC 
proteins are found within primate genomes, indicating the presence of antiviral 
genes under positive selection. 
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Figure 13.  Overview of the antiviral properties of APOBECs. 
Reproduced with permission from Nature. 
 
 
 
 
1.5.8.2   TRIMs  
Tripartite  motif  proteins  (TRIMs)  are  a  family  of  IFN-induced  proteins  with  a 
potent  antiretroviral  activity  (Figure  14).  Of  all  the  TRIM  proteins  the  most 
notable  is  TRIM5a,   which  acts  soon  after  viral  entry  but  before  reverse 
transcription (Asaoka, Ikeda et al. 2005). TRIM5a is composed of four distinct 
domains necessary for its function: an N-terminal RING domain involved with 
protein-protein  interactions,  two  central  B  box  domains  with  unspecified 
function  and  a  C  terminal  coiled-coil  domain  associated  with  protein 
oligomerization. This restriction factor interacts with the Capsid protein of viral 
particles  following  entry  (Sebastian  and  Luban  2005),  although  the  exact Chapter 1    66 
mechanism by which TRIM5a ‘disarms’ the entering virus is not completely clear. 
Whilst premature Capsid disassembly of entering viral particles, inhibition of RT 
and  inhibition  of  proteosome  activity  have  all  been  associated  with  TRIM5a 
activity, none of them alone appear to be essential for the antiviral function, 
reviewed by (Neil and Bieniasz 2009).  
The effect exerted by TRIM19 is an example of a nuclear antiviral mechanism. It 
has  several  isoforms  which  differ  in  their  C-terminal  regions  and  it  is  based 
within the nuclear bodies. The presence of different TRIM19 isoforms is linked to 
the  range  of  functions  that  has  been  associated  with  this  protein,  including 
transcription,  translation  and  signalling  for  cellular  functions,  reviewed  by 
(Nisole, Stoye et al. 2005). 
A rapid expansion of TRIM proteins among vertebrates has been observed to the 
extent  that  TRIM  is  believed  to  have  originated  primarily  as  an  antiviral 
mechanism rather than by subfunctionalization of a normal host physiological 
function. TRIM5a in primates has been under positive selection likely driven by 
episodes of retroviral infection within the species (Si, Vandegraaff et al. 2006). 
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Figure 14. An outline of the antiviral mechanisms induced by TRIM proteins. 
Reproduced with permission from Nature Reviews. 
 
 
 
 
1.5.9 Viral evasion of the host immune response 
 
Retroviruses  have  evolved  a  set  of  viral  proteins  and  tuned  their  replication 
cycle with unique characteristics that best equip them to counteract the host 
intrinsic, innate and adaptive immune response. Common to most retroviruses 
(especially lentiviruses) for example, is the intrinsic ability to rapidly evolve Env 
in  order  to  evade  the  host  humoral  immune  responses  and  HIV-1  shows  high 
variability within VR1 and VR2 as a result of host immune selection (Rambaut, 
Posada et al. 2004; Curlin, Zioni et al. 2010). Retroviral populations have a high 
turnover that is coupled with the genomic variability introduced by the reverse 
transcriptase  (approximately  1  every  10,000  bases).  This,  combined  with  the 
possibility of recombination events, results in poor immune recognition by the 
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Cell-to-cell transmission can also allow retroviruses to evade the host immune 
response.  For  example,  cell-to-cell  transmission  increases  viral  transfer 
efficiency from infected to uninfected cells in the presence of host restriction 
factors (Jolly, Booth et al. 2010{Jolly, 2011 #706; Jolly  2011) and allows the 
virus to “escape” from neutralising antibodies. 
Retroviruses may also target the immune cells that are responsible for driving 
the host response. For example, a significant clinical feature of HIV-1 infection 
during disease progression is the loss of both CD8 + and CD4+ T cells, both of 
which form part of the adaptive immune response of the host. In addition, it is 
suspected  that  for  simple  retroviruses  ERVs  also  offer  a  degree  of  immune 
evasion  through  tolerance  offered  by  the  mandatory  expression  of  enJSRVs 
during physiological processes which is tolerated by the host. 
It  is  possible  that  viral  proteins  may  evade  host  restriction  mechanisms  by 
directly  antagonising  host  restriction  factors.  Retroviruses  with  a  complex 
genome  have  evolved  a  variety  of  mechanisms  in  order  to  evade  immune 
recognition. HIV is probably one of the best understood examples of a retrovirus 
that  has  evolved  a  variety  of  countermeasures  that  allows  the  evasion  of 
recognition and elimination by the host immune system.  
The HIV accessory genes (nef, vif, vpu and vpr) have been acquired in order to 
evade the host restriction mechanisms. In particular, the HIV accessory protein 
Vif counteracts the antiviral action of APOBEC-3F and -3G by linking them with 
the ubiquitin dependent proteosomal degradation pathway (Conticello, Harris et 
al. 2003; Sheehy, Gaddis et al. 2003). Distinct domains of both APOBEC-3F and -
3G interact with separate regions of HIV Vif (Russell, Smith et al. 2009). SIV Vif 
mutants have demonstrated the impact of this protein in viral pathogenesis and 
its importance in evading G to A hypermutation induced by APOBEC (Schmidt, 
Fritz  et  al.  2011).  In  theory,  the  activity  of  APOBEC  is  damaging  to  viral 
replication, although it can also be considered an important factor in shaping 
viral adaptation and evolution following transmission (Wood, Bhattacharya et al. 
2009). 
Retroviruses  can  also  modify  global  cellular  transcription  levels,  not  only  for 
viral  particle  production  but  also  for  inhibiting  signalling  pathways  that  are Chapter 1    69 
involved in the induction of the innate immune response (Taylor, Ghorbel et al. 
2009). Certainly the response of IFN following infection appears to be delayed by 
HIV (Abel, Rocke et al. 2005).  
 
1.6  BST-2 /Tetherin 
 
Bone marrow stromal cell antigen 2 (BST-2) is a type II transmembrane protein 
with  unique  properties  and  potent  antiviral  activity.  During  viral  replication, 
BST-2 blocks viral particle release from cells by ‘tethering’ virions to the plasma 
membrane as they bud from it (Neil, Zang et al. 2008; Van Damme, Goff et al. 
2008). To date, one copy of the Bst-2 gene has been found in most vertebrates 
(splice variants have been identified in human and canines) with the exception 
of ruminants (see below). BST-2 has been termed over the past decade in several 
ways  including  CD317,  HM124  and,  more  recently,  tetherin.  In  light  of  its 
discovery  in  bone  marrow  stromal  cells,  the  original  term  Bst-2  will  be  used 
throughout this thesis (Goto, Kennel et al. 1994). 
 
1.6.1 Identification of BST-2 
 
BST-2  was  originally  identified  as  a  surface  protein  preferentially  expressed 
during B cell development in humans (Goto, Kennel et al. 1994; Ishikawa, Kaisho 
et al. 1995). Overexpression of BST-2 on the surface of terminally differentiated 
B cells was a consistent feature of multiple myeloma. For this reason, BST-2 was 
considered as a potential target for antibody-based therapy and considerable 
efforts  were  spent  by  several  groups  towards  this  goal  (Ozaki,  Kosaka  et  al. 
1997; Ozaki, Kosaka et al. 1998; Ohtomo, Sugamata et al. 1999; Ono, Ohtomo et 
al. 1999). These early studies were conducted before it was understood that 
BST-2 is an IFN-inducible gene that possess antiviral activity. However, at that 
time there were clues which indicated that BST-2 was involved in more than B 
cell development. The BST-2 promoter contains tandem repeats that can bind 
STAT3, known also to regulate the expression of IL-6, a differentiation factor of 
B cells. The binding region for STAT3 is highly conserved in the promoter regions Chapter 1    70 
of human, rhesus and murine BST-2 orthologs. IRF-1/2, ISGF3 and five potential 
AP2 binding sites are additional transcription factor binding regions identified for 
BST-2 (Ohtomo, Sugamata et al. 1999).  
 
1.6.2  BST-2 is an IFN induced restriction factor 
 
The identification of a link between IFN and BST-2 established the possibility 
that  BST-2  acted  as a  viral  restriction  factor  (Blasius,  Giurisato  et  al.  2006). 
Interestingly, the idea of a cellular restriction factor blocking HIV-1 exit was 
proposed  following  the  observation  that  the  HIV  accessory  protein  Vpu  was 
necessary for viral particle release in some cell lines, but dispensable in others 
(Neil,  Eastman  et  al.  2006).  Viral  exit  of  HIV-1∆Vpu  mutants  was  blocked  in    
IFN-a   induced  T  cells  and  macrophages  to  the  plasma  membrane  (Smith, 
Thresher  et  al.  1991).  Later,  it  was  shown  that  BST-2  was  an  IFN  induced 
restriction factor, capable of ‘tethering’ particles of HIV-1∆Vpu mutants to the 
plasma membrane (Neil, Zang et al. 2008; Van Damme, Goff et al. 2008). The 
restriction model proposed was that BST-2 restricted HIV-1 by  forming a link 
between the plasma membrane and the virion envelope thus preventing viral 
exit.  The  release  of  restricted  viral  particles  was  obtained  by  proteolytic 
treatment  of  cell  membranes,  strongly  suggesting  that  a  protein  tether  was 
active in the restriction process (Ohtomo, Sugamata et al. 1999). There is some 
evidence suggesting that BST-2 is incorporated into virions (Fitzpatrick, Skasko 
et al. 2010), although data with opposing conclusions are also present in the 
literature (Miyagi, Andrew et al. 2009).  
 
1.6.3  BST-2 has a broad restriction activity 
 
Human  BST-2  has  been  found  to  block  not  only  HIV  but  also  several  other 
retroviruses  belonging  to  different  genera  including  alpharetrovirus, 
Betaretrovirus, deltaretrovirus and spumaviruses (Jouvenet, Neil et al. 2009). In 
addition,  BST-2  has  been  shown  to  restrict  several  other  enveloped  viruses 
including Arenaviruses (Sakuma, Sakurai et al. 2009; Radoshitzky, Dong et al. 
2010)  and  Herpesviruses  (Mansouri,  Viswanathan  et  al.  2009).  There  are 
conflicting  data  available  for  Filoviruses  (Jouvenet,  Neil  et  al.  2009)  and Chapter 1    71 
Paramyxoviruses, while BST-2 clearly does not block the exit of Poxviruses and 
Bunyaviruses (Radoshitzky, Dong et al. 2010).  
The proposed model of BST-2 restriction is summarised in Figure 15 and will be 
discussed in more detail in Chapter 4. 
 
 
Figure 15. Schematic diagram illustrating the 'tethering' viral restriction model induced by 
BST-2. 
BST-2 is highlighted in blue. Adapted from (Evans, Serra-Moreno et al. 2010). Viral particles can 
be retained individually or in aggregates, reducing dissemination of virions within the host. 
 
 
1.6.4  Conserved features of BST-2 
 
A comparison of human, rhesus, rat and murine BST-2 orthologs revealed four 
major conserved features (Kupzig, Korolchuk et al. 2003). BST-2 is composed of 
a short N terminal cytoplasmic region preceding a transmembrane region and an 
ectodomain,  followed  by  C  terminal  GPI anchor.  The  ectodomain  has  several 
features  including  glycosylation  sites  and  cysteine  residues  involved  with 
dimerization and a coiled-coil motif.  
The hydrophobic transmembrane region and C terminal GPI anchor create two 
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this unique topology is the PrP (prion) protein. This unusual topology supports 
the hypothesis that BST-2 tethers fully formed infectious viral particles to the 
plasma membrane of host cells, ultimately by creating a bridge between the 
plasma  membrane  and  virion.  In  other  words,  BST-2  can  ‘crosslink’  both  the 
plasma membrane and virion creating a stable bridge resulting in the retention 
of the tethered particles at the plasma membrane. 
Interestingly, Paul Bienasz and colleagues (Perez-Caballero, Zang et al. 2009) 
demonstrated  that  the  configuration  of  BST-2  has  more  importance  than  the 
primary sequence for efficient restriction. An artificial ‘art tetherin’ with no 
sequence homology to BST-2 and yet still maintaining the configuration of BST-2 
is  still  capable  of  restricting  the  release  of  enveloped  viral  particles.  This  is 
significant evidence supporting the notion that it is the configuration of BST-2 
which leads to the efficient ‘tethering’ of viral particles on the cell surface. 
Whilst  there  are  clear  conserved  features  across  BST-2  orthologs,  there  are 
contrasting views on the importance of these different regions on the antiviral 
restriction mechanism (Andrew and Strebel 2011). It has been suggested that the 
discrepancies which have arisen in the literature may be due to the different 
experimental  settings  used  in  different  laboratories.  For  example,  (Andrew, 
Miyagi  et  al.  2009)  describe  the  necessity  of  glycosylation  for  the  BST-2 
mechanism, whereas it was reported as dispensable for its action in the study of 
(Perez-Caballero, Zang et al. 2009). The key difference between these studies is 
the  location  of  the  tag  used  for  detection  within  the  protein  (Andrew  and 
Strebel 2011). The major structural features and the predicted topology of hBST-
2 are summarised in Fig 14. 
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Figure 16. The four major conserved regions and membrane topology of BST-2. 
 
 
 
 
1.6.5  N-terminal Cytoplasmic tail  
The  N-terminal  cytoplasmic  tail  of  BST-2  is  important  for  the  internalisation 
from  the  plasma  membrane  surface  via  the  clathrin  mediated  pathway.  Two 
tyrosine residues are conserved in BST-2 orthologs  that may contribute to an 
internalisation  motif  influencing  the  intracellular  localisation  (see  below) 
(Kupzig, Korolchuk et al. 2003; Rollason, Korolchuk et al. 2007). 
 
1.6.6  Transmembrane region & C terminal GPI anchorage 
The model of BST-2 restriction predicts the formation of a bridge between the 
viral envelope and the plasma membrane (Neil, Zang et al. 2008). Based upon 
the  distinctive  topology  of  BST-2,  it  is  logical  to  assume  that  the  bridge  is 
provided  by  the  N  terminal  transmembrane  region  and  the  C  terminal  GPI 
anchorage.  Indeed,  mutagenesis  experiments  have  found  the  transmembrane 
region to be essential for the structure and restriction (Hinz 2010). In addition, 
the  mere  presence  of  a  GPI anchor is  a  strong indicator  of  a protein  with a Chapter 1    74 
plasma membrane association (Paulick and Bertozzi 2008). Introduction of a GPI 
anchor into a protein not of plasma membrane origin has been shown to result in 
its redistribution to the plasma membrane (Brown, Cowen et al. 2000). A BST-
2DGPI  mutant  localises  to  the  ER  and  it  appears  that  the  GPI  anchor  is  an 
essential factor for the correct folding and export of the BST-2 protein to the 
plasma membrane (Kupzig, Korolchuk et al. 2003). However, upon cleavage and 
disruption  of  the  GPI  anchor  by  the  enzyme  PI-PLC,  BST-2  still  maintains  its 
membrane association, confirming the presence of an additional transmembrane 
domain (Kupzig, Korolchuk et al. 2003). Cleavage of the GPI anchor of BST-2 
during viral ‘tethering’ does not release viral particles attached to the plasma 
membrane,  presumably  because  of  the  terminal  transmembrane  domain  and 
BST-2 dimers (Fitzpatrick, Skasko et al. 2010). Together, these data are highly 
supportive of the predicted mechanism of BST-2 restriction suggested by (Neil, 
Zang et al. 2008).  
 
1.6.7  Ectodomain- Glycosylation 
 
N-linked  glycosylation  is  feature  of  BST-2  that  appears  to  be  conserved. 
Glycosylation results in three isoforms of BST-2, (ranging from approximately 25-
35kDa)  commonly  observed  following  transient  transfection  and  western  blot 
analysis  with  BST-2  expression  plasmids.  These  were  confirmed  as  di-  and 
monoglycosylated forms following incubation with PNGase F, an enzyme which 
removes N-linked sugars from glycol proteins (Kupzig, Korolchuk et al. 2003). 
When human BST-2 was compared with isolates from rhesus, rat and mouse BST-
2,  two  similarly  positioned  N  glycosylation  sites  could  be  found  within  the 
extracellular domain. Glycosylation has not been considered an important factor 
of  function  as  studies  with  hBST-2  have  demonstrated  that  altering  the 
glycosylation status does not alter the distribution or impact upon the ability of 
BST-2 to restrict viral particle exit (Andrew, Miyagi et al. 2009; Sakuma, Sakurai 
et al. 2009). In contrast, others have reported that unglycosylated BST-2 is void 
of restrictive properties and suggests that this is likely as a result of trafficking 
defects (Perez-Caballero, Zang et al. 2009).  
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1.6.8  Ectodomain - Disulphide bond formation 
 
Human,  rhesus,  rat  and  murine  orthologs  of  BST-2  all  share  three  cysteine 
residues,  which  can  mediate  the  potential  dimer  formation  induced  by 
disulphide bonds (Ohtomo, Sugamata et al. 1999; Kupzig, Korolchuk et al. 2003). 
Interestingly, BST-2 dimerization has been shown to be essential in the block of 
HIV release induced by human BST-2 (Andrew, Miyagi et al. 2009) and yet it is 
dispensable for the restriction of Lassa or Marburg viruses (Sakuma, Sakurai et 
al. 2009).  
1.6.9  Ectodomain - Coiled-coil motif 
 
A comparison of murine and human BST-2 appears to suggest that the coiled-coil 
motif of the ectodomain is an evolutionary conserved feature (Swiecki, Scheaffer 
et  al.  2011).  This  motif  is  essential  for  virion  retention  and  it  provides  the 
flexibility  required  for  the  two  point  contact  model  envisaged  for  BST-2 
restriction (Hinz, Miguet et al. 2010; Yang, Lopez et al. 2010). The ectodomain 
region of tetherin forms a single α-helix which assists in the formation of parallel 
BST-2 homodimers (Yang, Lopez et al. 2010), as previously described (Ohtomo, 
Sugamata et al. 1999). The observation of BST-2 tetramers has been excluded 
from having any functional role in viral restriction and it is most probably the 
result of non-specific interactions. While there is the suggestion that tetramers 
may  confer  stability  to  BST-2,  it  appears  clear  that  dimerization  alone  is 
sufficient for viral particle retention (Schubert, Zhai et al. 2010).  
1.6.10  Bst-2 intracellular localisation and expression 
BST-2 is found to be expressed to varying degrees within a range of tissues in the 
absence  of  other  IFN  induced  proteins  (Erikson,  Adam  et  al.  2011).  BST-2  is 
constitutively expressed on the plasma membrane of cells which are targeted by 
retroviruses e.g. T cells. BST-2 can be induced on the surface of many other 
cells  in  response  to  IFN  (Blasius,  Giurisato  et  al.  2006).  BST-2  is  found 
concentrated within lipid rafts of the plasma membrane (Kupzig 2003). Indeed, 
plasma  membrane  based  localisation  of  BST-2  is  crucial  for  the  ‘tethering’ 
antiviral  effect  to  take  place.  BST-2  is  then  internalised  from  the  plasma Chapter 1    76 
membrane via clathrin mediated endocytosis (Rollason, Korolchuk et al. 2007; 
Masuyama,  Kuronita  et  al.  2009)  before  being  passed  to  the  Golgi  where  an 
independent pool of BST-2 has been identified (Kupzig, Korolchuk et al. 2003). 
The localisation of BST-2 is summarized in Figure 17 and will be discussed in 
more detail in Chapter 3. 
 
 
 
Figure 17. Illustration detailing the processing and localisation of BST-2. 
 Chapter 1    77 
 
1.6.11  Viral evasion of BST-2 restriction  
 
The  search  for  a  restriction  factor  blocking  HIV  exit  was  stimulated  by  the 
observation that the accessory protein Vpu was required for successful viral exit 
in  certain  cell  lines  (Van  Damme,  Goff  et  al.  2008).  In  addition  to 
downregulating  CD4  from  the  cell  surface,  Vpu  actively  engages  BST-2  and 
downregulates it from the plasma membrane (Iwabu, Fujita et al. 2009; Iwabu, 
Fujita et al. 2010; Ruiz, Guatelli et al. 2010). Vpu directs CD4 to the E3 ubiquitin 
ligase complex driven by a signal within the cytoplasmic domain (Andrew and 
Strebel 2010; Goffinet, Homann et al. 2010). Depletion of BST-2 by Vpu has been 
suggested to occur via proteosome degradation, (Goffinet, Allespach et al. 2009) 
also as a result of a combination of late endosomal targeting and degradation by 
lysosomes  (Mitchell,  Katsura  et  al.  2009).  Many  studies  have  considered  the 
interaction of BST-2 and Vpu in vitro with contrasting results. Vpu affects BST-2 
expression in HeLa cells and macrophages while BST-2 levels in H9 and CEMx174 
cells are unaffected (Andrew, Miyagi et al. 2009). The specificity of Vpu for BST-
2 is linked to three amino acid residues in the transmembrane domain of BST-2 
(Kobayashi, Ode et al. 2011; Lv, Wang et al. 2011). There is evidence that Vpu 
promotes release of HIV without affecting the turnover of BST-2. However, Vpu 
appears to slow down its transport to the plasma membrane and redistributes 
BST-2  to  the  intracellular  pool  located  within  the  trans-Golgi  network  (TGN) 
compartment by the recycling pathway common to BST-2 (Dube, Roy et al. 2010; 
Schmidt, Fritz et al. 2011). The antagonism Vpu provides is specific to human 
BST-2  and  it  does  not  antagonise  simian  BST-2  orthologs.  Indeed  Vpu  is  not 
present in many simian lentiviruses. Gain of function studies, which swapped 
domains between human and simian BST-2, concluded that the transmembrane 
region of BST-2 was responsible for the antagonism elicited by Vpu (Yoshida, Kao 
et  al.  2011).  Interestingly,  SIVtan  (but  not  SIVmac)  and  HIV-2  utilise  Env  to 
overcome human BST-2 restriction by sequestering it within the TGN (Gupta, 
Mlcochova et al. 2009; Le Tortorec and Neil 2009). The inability of SIVmac Env to 
overcome  human  BST-2  is  an  elegant  demonstration  of  the  species  specific 
nature  of  virus  and  host  factor  co-evolution.  SIVagm/blu/cpz/mac  utilise  the 
accessory  protein  Nef  in  a  species-specific  manner  to  counteract  BST-2 
restriction by the recruitment of the AP2 adaptor complex to downregulate BST-Chapter 1    78 
2 (Jia, Serra-Moreno et al. 2009; Zhang, Wilson et al. 2009; Zhang, Landford et 
al. 2011). In addition, the Ebola virus glycoprotein and the K5 protein of Kaposi’s 
sarcoma associated herpesvirus also facilitates escape from BST-2 restriction by 
mechanisms that have not been completely clarified (Lopez, Yang et al. 2010) 
(Mansouri, Viswanathan et al. 2009). 
The accessory proteins acquired by viruses to overcome BST-2 restriction have 
led  in  turn  to  the  selection  of  proteins  that  escape  virus  blockage.  This  is 
particularly  prominent  for  human  BST-2.  There  is  evidence  to  suggest  that 
deletion  of  5  amino  acid  residues  in  the  cytoplasmic  tail  of  hBST-2  (when 
compared with other simian primates) allows it to avoid the counteracting action 
of Nef. This is considered an important factor in preventing transmission of SIV 
to humans (Sauter, Vogl et al. 2011). In response, HIV-1 Vpu has developed a 
series of modifications within the N terminal region which account for the nature 
of  its  specifc  interaction  with  hBST-2  (Lim,  Malik  et  al.  2010).  In  a  manner 
similar  to  human  BST-2,  both  murine  and  rodent  orthologs  were  capable  of 
restricting  the  release  of  Vpu  deficient  HIV-1  when  expressed  in  293T  cells, 
although  this  restriction  was  not  overcome  in  the  presence  of  the  accessory 
protein Vpu. Murine and rodent BST-2 share 71% homology with each other but 
only 41% and 36% homology respectively with human BST-2 The critical regions of 
BST-2 for the evasion of Vpu are spread across the structural domains (Goffinet, 
Allespach et al. 2009). Sheep Betaretroviruses, have no accessory proteins to 
overcome the antiviral action of the ovine BST-2 (Arnaud, Black et al. 2010). The 
interaction of both exogenous and endogenous JSRVs with oBST-2 is the subject 
of this thesis. In addition, there are data suggesting that BST-2 is unable to block 
cell to cell transmission by retroviruses. This will also be discussed as part of this 
thesis. 
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2  Chapter 2 - Material and Methods 
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2.1 Cells  
 
 
HEK-293T  cells  are  immortalized  human  embryonic  kidney  cells  (referred 
throughout the text simply as 293T cells) and were maintained in Dulbecco’s 
modified  Eagle’s  medium  (DMEM)  Glutamax  (Gibco),  supplemented  with  10% 
fetal bovine serum (FBS, Hyclone) and 1% Penicillin-Streptomycin (Gibco). CPT-
tert cells (ovine choroid plexus cells immortalised with h-tert, a gift from David 
Griffiths,  Moredun)  were  maintained  in  Iscove’s  modified  Dulbecco’s  medium 
(IMDM Glutamax, Gibco) supplemented with 10% FBS + 1% Pen-Step. Cells were 
incubated at 37
oC, with 5% CO2 in 95% humidity. Cells were routinely cultured in 
10cm  diameter  tissue  culture  dishes  and  were  passaged  when  monolayers 
reached  ~95%  confluency.  All  adherent  cells  were  rinsed  three  times  with 
phosphate buffered saline (PBS) pH7.4 (Gibco), once with trypsin (Gibco) and 
then incubated with 1 millilitre (ml) of trypsin at 37
oC until detachment of the 
monolayer from the dish. Cells were resuspended in  10ml of the appropriate 
growth medium and pelleted by low speed centrifugation (Eppendorf Centrifuge 
5810)  at  1000g  for  5  minutes  (mins).  Cells  were  then  washed  twice  in  PBS, 
resuspended in 10ml of fresh growth media and seeded at the required density 
into a new 10cm Petri culture dish.  
For  the  long  term  storage,  cells  were  resuspended  in  1ml  of  90%  FBS/10% 
Dimethyl  sulfoxide  (DMSO,  Sigma  Aldrich)  and  aliquoted  into  fully  labelled 
cryovials  (Nunc).  Vials  were  frozen  at  -80 
oC  in  a  cryofreezer  (Mr  Frosty, 
Nalgene)  before being  transferred into  liquid nitrogen  storage 24h  later.  The 
recovery of cells stored in liquid nitrogen was initiated by thawing vials for the 
minimum time necessary at 37
oC. Cells were then added drop wise into 10 ml of 
suitable growth medium and pelleted by low speed centrifugation 1000g for 5 
mins.  The  resulting  pellet  was  resuspended  in  10mls  of  appropriate  growth 
medium  and  seeded  into  either  a  6  cm  or  10  cm  tissue  culture  dish  as 
appropriate. 
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2.2 Plasmids  
 
JSRV plasmids 
 
Table 1. Summary of the main JSRV and enJSRV expression plasmids employed in this 
study. 
 
Name  Description  Source/ 
reference 
pCMV2JSRV21  full length molecular clone of JSRV21  Palmarini 1999 
pCmv435024  full length molecular clone of 
enJSRV7 
Arnaud, 
Caporale et al. 
2007 
pCmv457M3  full length molecular clone of 
enJSRV15 
Arnaud, 
Caporale et al. 
2007 
pCmv46F9  full length molecular clone of 
enJSRV18 
Arnaud, 
Caporale et al. 
2007 
pCmv4102B15  full length molecular clone of 
enJSRV26 
Arnaud, 
Caporale et al. 
2007 
pCMV2JSRV21FLAG  pCMV2JSRV21 with HA tag between 
signal peptide and SU of Env 
This thesis 
pCMV5a-JS21Flag  JSRV Env with C terminal FLAG 
epitope 
Varela, 2008 
pCMV3DGPP2NFlag  JSRV Env with N terminal FLAG 
epitope 
Varela, 2008 
pCMVN-
FLAG57m4Env 
enJSRV18 Env tagged at the N 
terminal 
Dr. F Arnaud 
pCmv4js21XSstoM3  full length molecular clone of JSRV 
provirus with 2 stop codons before 
Env 
Dr. M. Caporale 
pCmv467f9ds  full length molecular clone of 
enJSRV-18 provirus with 2 stop 
codons before Env 
Dr. M. Caporale 
 
pCMV2JSRV21  is  a  full  length  molecular  clone  of  JSRV  driven  by  the 
Cytomegalovirus  (CMV)  immediate  early  promoter  and  has  been  described 
previously (Palmarini, Sharp et al. 1999). Similarly, full length proviral clones of 
enJSRV-7,  15,  18  &  26  (pCmv435024,  pCmv457M3,  pCmv46F9,  pCmv4102B15), 
driven by the CMV promoter, have also been described (Arnaud, Caporale et al. 
2007).  pCMV2JSRV21HA  is  a  construct  generated  from  pCMV2JSRV21  which 
contains  the  haemagglutinin  (HA)  epitope  inserted  within  the  Env  protein  of Chapter 2    82 
JSRV, preceding the SU and after the signal peptide in the context of the full 
length proviral clone. This epitope was inserted by site directed mutagenesis 
using  Fw  5‘-CCAGACTACGCTGCGGCTTTTTGGGCGTACATTCCTGATCC-3’  and  Rw 
5‘-GACGTCGTATGGGTAAGCTGCCCCATTTTGTACCCGCTGTAAC-3’ primers.  
pCMV5a-JS21Flag  and  pCMV3DGPP2NFlag  express  the  JSRV Env protein  tagged  
with the FLAG epitope at either the C or N terminus respectively, and have been 
described previously (Varela 2007). pCMVN-FLAG57m4Env (enJSRV-18 Env tagged 
at  the  N  terminal)  was  provided  by  Dr.  F.  Arnaud.  pCmv4js21XSstoM3  and 
pCmv467f9ds express the full length exogenous JSRV and enJSRV-18 proviruses 
respectively but contain two stop codons preceding the envelope open reading 
frame (provided by Dr. M Caporale).  
BST-2 plasmids 
Two ovine Bst-2 genes (designated oBST-2A and -2B) were isolated and cloned 
into the pCI mammalian expression vector (Promega) to obtain pCI-oBST2A and 
pCI-oBST2B  respectively  as  already  described  (Arnaud,  Black  et  al.  2010). 
pCIoBST2AHa  and  pCIoBST2BHa  express  oBST-2A  and  -2B  containing  an  HA 
epitope tag  prior to the predicted w site for GPI cleavage. 
The Vpu gene of HIV-1 within a mammalian expression vector was provided by 
Dr. S.J. Neil (Kings College). The empty pCI-DNA mammalian expression plasmid 
was used as a control for transfection to equilibrate DNA volumes. In addition, 
peGFP-C1, which expresses the enhanced green fluorescent protein (eGFP), was 
used as a control for transfection efficiency. Cav-1GFP is an expression plasmid 
for  Caveolin-1,  a  plasma  membrane  based  protein,  fused  with  GFP  at  the  C 
terminus (Addgene plasmid 14433). E-Cad-GFP–c1 is an expression plasmid for 
Cadherin-1, a plasma membrane based protein fused with GFP and was kindly 
provided by Dr. K. Anderson. 
oBST-2B mutants were generated by site directed mutagenesis (Figure 18 and 
Table 2). 
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Figure 18. Illustration of the oBST-2B mutants employed in this thesis 
 
 
 
 
Table 2. Summary of the primers employed for the construction of the oBST-2B mutants 
employed in this thesis 
 
Plasmid  Primers  5’-3’ 
oBST-2BGPIc-28   Fw  
gactacgctgctaggtccTGAttgttcgacgtgttcctc  
Rw  
gaggaacacgtcgaacaaTCAggacctagcagcgtagtc 
oBST-2Bc-25    Fw  
gctaggtccagcttgttcTAGgtgttcctctcctttttc 
Rw 
gaaaaaggagaggaacacCTAgaacaagctggacctagc 
oBST-2Bc-20   Fw 
tgttcgacgtgttcctctGATttttcgggggtgtggtga 
Rw 
tcaccacacccccgaaaaaTCAgaggaacacgtcgaaca 
oBST-2Bc-9 -   Fw 
cgggttgtgtccatcaccTGAaagtgtctgaagaaatga 
Rw 
tcatttcttcagacacttTCAggtgatggacacaacccg 
oBST-2Bc-6    Fw 
cgggttgtgtccatcaccTGAaagtgtctgaagaaatga 
Rw 
tcatttcttcagacacttTCAggtgatggacacaacccg 
oBST-2Bc-5   Fw 
gttgtgtccatcacccgcTAGtgtctgaagaaatgag 
Rw 
ctcatttcttcagacaCTAgcgggtgatggacacaac 
 
 
All PCR primers were purchased from MWG Biotech. For cloning purposes, all 
PCR reactions were performed using Hotstar Hifidelity (Qiagen) according to the 
manufacturer’s protocol.  
PCR  purification  and  Gel  extraction  was  performed  with  the  QIAquick  PCR 
purification  kit  (Qiagen)  or  QIAquick  Gel extraction  kit  (Qiagen)  respectively. 
Ligations were performed using the Rapid DNA Ligation Kit (Roche). Plasmids 
were  transformed  into  either  DH5a  or  TOP10  strains  of  E.Coli  (Invitrogen). 
Minipreps of plasmid were prepared using the QIAprep Miniprep kit (Qiagen), and Chapter 2    85 
Maxipreps  with  Purelink  HiPure  Plasmid  Maxiprep  kit  (Invitrogen).  DNA 
concentrations and quality were measured and verified using a Nanodrop 2000 
spectrometer. 
The authenticity of each plasmid was verified first by restriction digestion with 
appropriate  restriction  enzymes  (Roche)  and  subsequently  by  DNA  sequencing 
(Dundee Sequencing Service). 
All sequence predictions for oBST-2A/ -2B were made by submitting sequences to 
programs  available  on  the  Expasy  Proteomics  server  http://expasy.org/tools. 
TMHMM  Server  v2  predicted  potential  transmembrane  regions,  NetNGly  1.0 
Server  sites  for  possible  N-linked  glycosylation,  and  GPI-SOM  for  residues 
targeted for cleavage and GPI anchor addition. 
For  site  directed  mutagenesis,  PCR  reactions  were  performed  using  the 
Quikchange II site directed mutagenesis kit (Agilent Technologies) according to 
the manufacturer’s protocol. When necessary, PCR products were precipitated 
at -20
oC with isopropanol in the presence of 3M Sodium Acetate pH5.5 (Ambion). 
The  DNA  was  precipitated  by  centrifugation  at  20,000g  for  30mins  at  4 
oC 
(Eppendorf  Centrifuge  5810-R)  and  resuspended  in  double  deionized  water 
(ddH2O) (Millipore) prior to transformation into competent cells. 
 
2.3 Transient transfections 
 
Transient  transfections  for  western  blot  analysis  were  performed  using  the 
CalPhos™  mammalian  transfection  kit  (Clontech)  adhering  to  manufacturer’s 
protocol. 293T cells were plated 24 hours prior to transfection in 10cm plates so 
that  80%  confluency  was  achieved  prior  to  transfection.  An  hour  prior  to 
transfection  the  cells  were  washed  with  1X  PBS  and  maintained  in  media 
containing no antibiotics. Transfection complexes were formed by first mixing 
appropriate amounts of plasmid DNA (0.25-4mg) with 2M Calcium phosphate. This 
mixture was then added dropwise to a 2X Hepes-buffered saline solution and 
incubated for 20 mins at room temperature. Transfection complexes were then 
added to cells and incubated overnight at 37
oC. Following overnight incubation, 
the cells were washed with 1X PBS and fresh medium containing antibiotics was Chapter 2    86 
added.  Cells  were  incubated  for  a  further  24  hours  before  cell 
supernatant/lysates were harvested. 
 
 
2.4 Cell lysates 
 
Cells lysates were harvested in general 24 hours post transfection for protein 
analysis by standard molecular techniques. Briefly, cells were rinsed with cold 
PBS and lysed on ice for 10 minutes with modified RIPA buffer ((15mM Tris-HCl, 
pH  7.4;  1%  NP-40;  1mM  EDTA;  150mM  NaCl,  1mM  PMSF;  1mM  NaF;  protease 
inhibitors  cocktail  (COMPLETE-Roche)).  Cells  were  collected  by  scraping  and 
subsequently sonicated on ice. Protein concentration was measured using the 
BioRad protein assay kit according to manufacturer’s protocol.  
 
2.5 PNGaseF treatment of lysates 
 
Peptide N-Glycosidase F (PNGaseF, Sigma-Aldrich) is commonly used to study the 
glycosylation  status  of  proteins  as  it  removes  N-linked  carbohydrate  chains 
added  during  the  process  of  post  translation  modification.  293T  cells  were 
transfected as previously described using CalPhos with 1mg of pCI-oBST2A or -2B. 
24 h post-transfection, cell lysates were harvested in 1% NP-40 (Fisher). 200mg of 
the appropriate cell lysate (mock transfected, or transfected with expression 
plasmids for oBST-2A and oBST-2B) was aliquoted in duplicate. The samples were 
diluted to a final volume of 35ml before adding 10ml of 250mM PBS pH7.5, 2.5ml 
of 2% Sodium Dodecyl Sulphate, 1M 2-mercaptoethanol. The samples were then 
boiled at 100 
oC for 5 min and cooled on ice. 2.5ml of 15% Triton X100/PBS (v/v) 
was added before the addition of 2ml of PNGaseF solution, or PBS as a mock 
control. All samples were then incubated at 37
oC for 6h. Reactions were stopped 
by adding 4ml of 4x SDS-PAGE reducing buffer (250mM Tris-HCl pH6.8, 8% SDS, 
40%  Glycerol  (v/v),  0.008%  Bromophenol  Blue,  20%  2-Mercaptoethanol)  and 
boiling for 5 min prior to SDS-PAGE/western blot analysis. 
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2.6 Cell lysate fraction preparation 
 
293T  cells  were  transfected  as  described  above  with  expression  plasmids  for 
oBST-2A or -2B. The cells were then washed with PBS and treated for 30 min at 
room  temperature  with  3,3’-dithiobis  sulfosuccinumidylpropionate  (DTSSP) 
(Thermo Scientific). DTSSP crosslinks cellular proteins to membranes and this 
treatment  was  used  in  an  attempt  to  preserve  oBST-2A/-2B  in  their  native 
environment during the fractionation process. DTSSP treatment was stopped by 
the addition of 1M Tris (pH7.5) prior to harvesting the lysates.  The cells were 
then scraped from the Petri dish and washed with PBS. The cells were sheared 
using a 21G needle (BD Microlance) with 30 strokes per sample. Lysates were 
then processed using the Plasma Membrane Protein Extraction Kit (Biovision) as 
suggested  by  the  manufacturer.  Cytosolic  fractions  and  plasma  membrane 
fractions were retained for western blot analysis. 
2.7 Viral particle preparations 
 
Cell culture supernatants were collected 24 hours after transfection with the 
appropriate  plasmid.  The  viral  particles  were  concentrated  by 
ultracentrifugation at 35,000rpm (SW41 rotor Beckmann) for 60 minutes at 4
oC 
on  a  29%  sucrose  cushion.  Viral  pellets  were  resuspended  in  1x  TNE  buffer 
(diluted from 10X stock, 1M NaCl; 0.1M Tris; EDTA final solution pH 7.5) at a 
final  volume  200x  concentrated  compared  to  the  initial  volume  of  the 
centrifuged supernatants.  The viral pellets were resuspended overnight at 4
oC 
in  4ml  of  4x  SDS-PAGE  reducing  buffer  (250mM  Tris-HCl,  pH  6.8;  8%  Sodium 
Dodecyl  Sulphate;  40%  glycerol  (v/v);  0.008%  Bromophenol  Blue;  5%  b-
Mecarptoethanol)  and  boiled  for  5  minutes  prior  to  SDS-PAGE  western  blot 
analysis, or storage at -80
oC for subsequent use. 
In some cases, viral pellets were purified by isopycnic centrifugation on 20 to 
55% (w/w) sucrose gradients (25,000 rpm (SW41 rotor Beckmann) for 16h at 4
oC). 
Fractions  of  approximately  500  µl  were  then  collected  and  the  virus 
concentrated by ultracentrifugation prior to further analysis.  Chapter 2    88 
 
2.8 SDS-PAGE and western blotting 
 
200mg  of  cell  lysate  or  an  appropriate  volume  of  viral  pellet  material  was 
separated by SDS-PAGE before transferring to a Polyvinylidene Fluoride (PVDF) 
membrane (GE Healthcare). Membranes were then incubated in blocking buffer 
(5% milk in TBS-Tween (ddH2O, 10% Tris Buffered Saline (TBS) 10x, 0.1% Tween 
20))  for  1h  at  room  temperature  prior  to  incubation  overnight  at  4
oC  with 
primary antibodies. The primary antibodies used were anti JSRV/enJSRVs Gag 
(used at either 1:3000 dilution for lysates or 1:300,000 for viral pellet detection) 
and anti-HA (1:500) in blocking buffer, or anti-JSRV TM (1:500) in BSA blocking 
buffer (5% BSA, 5% milk, ddH2O, 10% TBS 10x, 0.1% Tween 20). Membranes were 
then washed three times with TBS-TWEEN solution and incubated with a species-
specific  horseradish  peroxidise-conjugated  secondary  antibody  diluted  in 
blocking buffer for 1h at room temperature. The secondary antibodies used were 
donkey anti rabbit F(ab’)2 fragment (1:30,000; GE Healthcare) or an anti mouse 
F(ab’)2  (1:30,000;  AbD  Serotec).  Detection  was  performed  by 
chemiluminescence (ECL, GE Healthcare). When redetection was necessary, the 
membranes were stripped with Restore Western Blot Stripping Buffer (Thermo 
Scientific)  at  37
oC  for  one  hour  and  washed  with  TBS-TWEEN  solution.  The 
stripped membranes were then used as before to blot using the required primary 
antibody.  Whenever  necessary,  the  band  strength  in  western  blots  was 
quantified using a Storm 640 (Molecular Dynamics) using ImageQUANT software 
(GE healthcare). 
2.9 Reverse Transcriptase Activity assay 
 
Reverse transcriptase (RT) activity from concentrated viral pellet/virus isolated 
on sucrose gradient was detected and quantified using the HS-Mg RT Activity Kit 
(Cavidi)  according  to  the  manufacturer’s  protocol.  Positive  RT  activity  was 
determined with values representing more than twice the negative controls. A 
rRT of HIV-1 was used to derive a standard curve.  
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2.10 Dynamic Light Scattering 
 
Dynamic Light Scattering (DLS) was used to estimate the size of viral particles 
released by enJSRV-18 and JSRV in the presence and absence of oBST-2A/-2B. All 
samples  were  checked  by  western  blot  prior  to  DLS  analysis  and  all 
measurements were made using the Zetasizer Nano zs90 (Malvern). Viral pellets 
produced  following  Calphos™  transfection  of  the  appropriate  plasmid(s)  were 
diluted to a final volume of 500ml in 1x TNE buffer. Samples were loaded into 
the cuvette provided with the apparatus, inserted into the Zetasizer Nano zs90 
and  a  run  was  initiated.  All  of  the  measurements  were  made  at  37
oC.  The 
Zetasizer Nano zs90 software compiled the data and generated a Z average and 
count  rate.  The  Z  average  is  representative  of  the  predicted  hydrophobic 
diameter and the count rate is indicative of sample quality, respectively. An 
average  value  and  standard  error  was  calculated  from  three  individual 
measurements per sample. 
 
2.11 Nanoparticle Tracking Analysis 
 
Nanoparticle tracking analysis (NTA) was performed with a Nanosight (LM-20). 
NTA was used to estimate the size of viral particles released by enJSRV-18 and 
JSRV  in  the  presence  and  absence  of  oBST-2B.  All  samples  were  checked  by 
western  blotting  prior  to  NTA  analysis.  Three  measurements  of  each  sample 
were  made  and  the  results  captured  and  analyzed  with  the  NTA  2.0  Build 
software (Nanosight). Mean values and standard errors for the average size of all 
particles within the sample were calculated. 
 
2.12 Confocal microscopy 
 
CPT-tert cells were plated 24 hours prior to transfection on 2-chamber slides 
(Cornell) in IMDM-Glutamax media (Invitrogen) supplemented with 10% FBS + 1% 
Penicillin-Streptomycin.  Cells were transfected with the appropriate plasmids 
using Lipofectamine 2000 as recommended by the manufacturer. Transfection 
mixtures  were  incubated  at  room  temperature  for  20  minutes  to  allow Chapter 2    90 
Lipofectamine 2000 complexes to form before each reaction was added dropwise 
to the chamber. The cells were incubated for 5 h at 37
oC before replacing the 
media  containing  transfection  mixture  with  fresh  complete  media.  18h  post-
transfection the cell monolayer was washed twice with cold PBS, fixed with 5% 
formaldehyde  in  PBS  at  4
oC  for  20  min,  and  quenched  in  10mM  ammonium 
chloride.  
For  the  analysis  of  intracellular  protein  distribution,  the  cells  were 
permeabilised with PBT (PBS + 0.5% Trition X-100; Sigma-Aldrich) for 10 min at 
room  temperature  and  then  blocked  with  solutions  1  and  2  (Table  3) 
consecutively for 5 minutes each to minimise non-specific antibody binding. The 
appropriate primary antibodies (Table 4) were then  diluted in solution 2 and 
incubated overnight at 4
oC in a lightproof container.  
Table 3.  Composition of blocking solutions used for confocal microscopy. 
 
Solution 1  Solution 2 
200ml Fish Gelatin (Sigma-Aldrich ) 
+ 50mls 1%PBS + 2% Tween20 
1250 ml Goat Serum (Biosera)             
+ 50mls 1%PBS + 2% Tween20 
 
 
 
Table 4. Primary and secondary antibodies used in this thesis. 
 
Primary Antibody  Antibody species and 
type 
Dilution 
p23 GAG  polyclonal anti-rabbit  1:200 
FLAG  polyclonal anti-rabbit 
(Sigma) 
1:750 
HA  monoclonal anti-mouse 
(Covance) 
1:100 
TGN46  polyclonal anti-rabbit 
(Abcam) 
1:1000 
Golgi -Giantin  polyclonal anti-rabbit 
(Abcam) 
1:100 
Golgi - p115  anti-rabbit (Abcam)  1:100 
Rab7  Polyclonal anti-rabbit 
(Abcam) 
1:100 
GFP  polyclonal anti rabbit 
(Abcam) 
1:500 
Secondary Antibody     
Alexa Fluor 488  goat anti-rabbit 
(Invitrogen) 
1:3000 
Alexa Fluro 594  donkey anti-mouse 
(Invitrogen) 
1:3000 Chapter 2    91 
 
 
 
The next day, the cells were washed three times in PBS-T (PBS + 2% Tween20) 
before repeating the blocking step with solutions 1 and 2. The cells were then 
incubated with the appropriate secondary antibodies in Solution 2 (as indicated 
below)  at  37
oC  for  30  min  and  then  washed  again  three  times  with  PBS-T 
solution.  Finally,  the  chamber  walls  and  adhesive  were  removed  from  slides 
before  adding  one  drop  of  Vectashield  with  4’,  6-diamidino-2-phenylindole 
dihydrochloride  DAPI  (Vector  Laboratories).  Coverslips  (22x22mm,  BDH 
Laboratory Supplies) were then applied and sealed with nail varnish. Cells were 
examined and imaged with a Leica TCS SP2 confocal microscope. Image analysis 
was performed with Image Pro Analyzer 7.0 (Media Cybernetics). 
Colocalisation was measured using Pearson’s Correlation (a value reflecting the 
degree of overlap between two channels) calculated by Image Pro Plus software 
(Media  Cybernetics). The  value ranges  from  -1  to  1.  Anything  below  0.5  was 
considered  non-significant  and  anything  above  as  a  significant  degree  of 
colocalisation. At least fifty cells were measured for each experiment. All values 
presented represent an average percent and include standard error values. 
 
 
2.13 Brefeldin A treatment 
Whenever necessary cells  were  treated  with  Brefeldin-A,  a  fungal  metabolite 
which fragments the Golgi stacks leading to the concentration of proteins within 
the endoplasmic reticulum and redistribution of Golgi based proteins. Brefeldin-
A  was  used  at  a  concentration  of  200ng/ml.  Transient  transfections  were 
performed as described in section 2.12. At the point where the medium was 
changed,  the  replacement  media  was  either  serum  free  medium  (SFM)  alone 
(control), or SFM containing 200ng/ml Brefeldin A. The cells were incubated for 
90mins before fixation and immunolabelling for confocal microscopy (see 2.12 
Confocal microscopy). 
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3  Chapter 3 - Investigating the intracellular 
distribution of the oBST-2 paralogs 
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3.1 Summary 
In  this  chapter,  we  defined  their  intracellular  distribution  of  the  oBST-2 
paralogs. We also highlight key differences between the oBST-2A/ -2B proteins 
which may contribute to the difference in intracellular localisation observed.  
 
3.2 Introduction 
3.2.1 BST-2 localisation and intracellular trafficking.  
 
As  discussed in  Chapter  1, BST-2  is a cellular  restriction  factor  with  a  broad 
antiviral activity. To date, the majority of knowledge of BST-2 expression and 
mode of action has been derived from studies involving the human ortholog. In 
vivo, human BST-2 is found constitutively expressed to varying degrees on the 
surface of a range of cells including hepatocytes,  pneumocytes, Leydig cells, 
plasma cells and bone marrow stromal cells (Erikson, Adam et al. 2011). This is 
in  direct  contrast  to  the  original  reports  following  its  discovery  when  it  was 
considered a surface marker of terminally differentiated human B cells (Goto, 
Kennel et al. 1994). It is not found to be constitutively expressed on the surface 
of T cells, B cells, macrophages, monocytes or plasmacytoid dendritic cells (pDC) 
in humans. There is strong evidence to suggest that constitutive expression is 
species specific as it is found expressed on the surface of murine pDCs (Swiecki 
and Colonna 2010), but is absent from human pDCs (Erikson, Adam et al. 2011). 
BST-2  is  found  expressed  in  a  wide  variety  of  cells  including  pDCs  following 
treatment  with  IFN  (Kupzig,  Korolchuk  et  al.  2003;  Blasius,  Giurisato  et  al. 
2006), although in vivo it may only partially regulate expression (Erikson, Adam 
et al. 2011). In vitro studies have shown that BST-2 is constitutively expressed in 
HeLa and Jurkat cells but its expression can also be induced in 293T and HT1080 
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BST-2  appears  to  reside  specifically  within  the  lipid  rafts  of  the  plasma 
membrane (Kupzig, Korolchuk et al. 2003). Lipid rafts or ‘membrane rafts’ are 
small heterogenous regions of the plasma membrane (10-200 nm in diameter) 
with a high content of sterol and sphingolipids. They are essential for efficient 
membrane segregation, protein trafficking and signalling (Viola and Gupta 2007). 
Interestingly, lipid rafts are considered hotspots for viral particle release during 
the retroviral replication cycle (Nguyen and Hildreth 2000). The localisation of 
BST-2  at  the  plasma  membrane  is  fundamental  for  the  ‘tethering’  antiviral 
mechanism.  
As previously mentioned, BST-2 is composed of a short N terminal cytoplasmic 
region preceding a transmembrane domain and an ectodomain followed by a C-
terminal GPI anchor (Kupzig, Korolchuk et al. 2003). GPI anchorage is a major 
determinant of BST-2 localisation. BST-2 mutants with the GPI signal deleted 
localise to the ER. Thus, the GPI signal is essential for the correct export of BST-
2 to the plasma membrane and for its restriction capability. The property of 
BST-2 to make two connections with the plasma membrane, provided by the N-
terminal  transmembrane  region  and  GPI  anchorage,  forms  the  basis  of  the 
‘tethering’ restriction mechanism. BST-2 inserts one end of the protein within 
the host plasma membrane and the other within the virion envelope, in this way 
creating a bridge of retention (Neil, Zang et al. 2008).  
BST-2 has been shown to be internalised via clathrin-mediated endocytosis into 
early recycling endosomes (not late) before passing to the trans-Golgi network 
(TGN). The N-terminal region of BST-2 contains two conserved tyrosine residues 
that  likely  form  part  of  an  internalisation  motif  (Rollason,  Korolchuk  et  al. 
2007). Pull down experiments demonstrated the specific interaction of the N-
terminal cytosolic region of BST-2 with the m2 subunit of the adaptor protein AP2 
(Masuyama,  Kuronita  et  al.  2009).  Adaptor  protein  complexes  are  cytosolic 
heterodimers  that  regulate  protein  sorting  in  the  post  Golgi  network.  AP2 
mediates  endocytosis  from  the  plasma  membrane  whilst  AP1/2  and  4  are 
involved in endosomal/lysosomal pathways (Nakatsu and Ohno 2003). Disruption 
of  the GPI anchor  alters  the  internalisation  pathway  of  BST-2, demonstrating 
that  the  GPI/lipid  raft  association  is  an  important  and  established  factor  for Chapter 3    95 
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successful internalisation (Rollason, Korolchuk et al. 2007; Masuyama, Kuronita 
et al. 2009).  
As  mentioned  above,  BST-2  has  been  found  to  localise  also  at  the  TGN,  an 
unusual property for a GPI anchored protein. The localisation of a second pool of 
BST-2 to the TGN raises the question of whether this pool is independent from 
the one recycling from the plasma membrane and TGN. 
 
 
 
3.2.2 The Golgi and Trans Golgi Network 
 
The Golgi is formed by several layers of membranous stacks arranged in ribbon 
like  structures  juxtaposed  to  the  centrosome  (cis  and  medial  cisternae)  in 
eukaryotic  cells  (Sengupta  and  Linstedt  2011).  Newly  synthesized  membrane 
proteins bud from the ER and concentrate within COP II vesicles. The COP II 
vesicles bud directly from the ER and target the Golgi for cargo delivery (Haucke 
2003).  Upon  arrival  at  the  Golgi,  proteins  undergo  post-translational 
modification,  progressing  through  the cis and  medial Golgi  via  COP  I  vesicles 
before finally entering the trans-Golgi network (TGN). Arrangement of the Golgi 
as  stacked  cisternae  is  an  important  feature  of  its  function,  promoting  an 
optimum environment for sequential post-transcriptional processing events such 
as glycosylation and sorting of cargo (Sengupta and Linstedt 2011). The Golgi 
contains numerous resident proteins (Golgins) which provide structural support 
and  function.  For  example,  p115  is  localised  to  the  cis  Golgi  stack  and  is  a 
vesicle docking protein assisting COP I cargo entering the Golgi. In addition, p115 
also  plays  a  role  as  a  Golgin  protein  for  mitosis  and  apoptosis  (Radulescu, 
Mukherjee et al. 2011). Giantin is also a Golgin but is found within COP I vesicles 
moving cargo between Golgi stacks and is involved in vesicles docking to Golgi 
membranes (Sonnichsen, Lowe et al. 1998), whilst TGN46 is an example of a 
resident TGN protein.  
The  TGN  is  the  final  sorting  compartment  which  determines  the  final 
intracellular  location  of  membrane  proteins.  The  Golgi  and  TGN  should  be 
considered  as  separate  structural  entities  which  perform  unique  functions, Chapter 3    96 
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although  they  are  closely  associated  (Sengupta  and  Linstedt  2011).  This  is 
emphasised by the differences observed following treatment with Brefeldin-A a 
fungal metabolite which fragments the Golgi. Upon treatment with Brefeldin-A, 
the Golgi stacks form tubules that fuse with the ER resulting in the redistribution 
of all Golgi based proteins to the ER. Similarly, the TGN is also fragmented by 
Brefeldin A but the resulting tubules fuse with the endosomal network and all 
TGN based proteins are redistributed to the MTOC (Gu, Crump et al. 2001).  
The TGN forms the sorting station for newly synthesized membrane proteins. It 
differs from the Golgi stacks in that it is a structure with an extensive series of 
membranes  rather  than  organized  stacks  and  varies  in  size  and  structure 
depending on the cell type. Like the Golgi, it is a highly diverse, mobile element 
with a high level of protein renewal and not a static structure of the cell. It is 
absent altogether from cells which have a high turnover of very large secretory 
granules  but  it  does  form  extensive  multilayer  interconnecting  stacks  in  cell 
types which have a more moderate level of granules for secretion (Sengupta and 
Linstedt 2011). Once located within the TGN, proteins will be sorted for delivery 
to  their  final  destination  based  on  protein  binding  domains  and  motifs.  This 
results in them either being retained as TGN proteins, trafficked back to the 
Golgi stacks/E.R./nucleus or onwards to endosomes, ubiquitin proteosome or the 
plasma membrane (Tekirian 2002). The TGN is also the receiving centre for a 
select  set  of  proteins  (approximately  5%)  via  retrograde  transport  from  the 
plasma membrane (Chege and Pfeffer 1990) 
 
3.2.3 Interplay between ovine BST-2 and sheep Betaretroviruses 
 
The enJSRVs are abundantly expressed within the reproductive tract of sheep 
and  have  a  prominent  role  in  placental  morphogenesis  (see  Chapter  1.4.8). 
enJSRV expression during pregnancy coincides with that of IFNtau, a type I IFN 
which, as well as having antiviral activity, is the pregnancy recognition signal in 
ruminants. Previously, a study conducted by Frederick Arnaud in our laboratory, 
showed that IFNtau upregulates the expression of BST-2 both in vitro and in vivo 
(Arnaud, Black et al. 2010). Interestingly, he also found that the BST-2 gene is 
duplicated  in  ruminants  and  designated  these  paralogs  oBST-2A  and  -2B. 
Duplication  of  an  IFN-induced  BST-2  has  not  been  reported  for  any  other Chapter 3    97 
  97 
ortholog to date (although splice variants have been identified for human and 
canine orthologs). The date of this duplication event is unknown but as it is 
present in both cows and sheep it has occurred prior to their speciation. Both 
paralogs block JSRV/enJSRVs viral exit, although oBST-2A appears to be more 
efficient than oBST-2B based on Gag exit (Arnaud, Black et al. 2010). In vivo, the 
expression of oBST-2 and enJSRVs was found to be mutually exclusive leading to 
the speculation that the interplay between the host restriction factors such as 
oBST-2 and enJSRVs may have influenced the tropism of these viruses. 
 
3.3 Results 
 
3.3.1 Sheep Betaretroviruses are restricted by human BST-2 
(hBST-2)  
 
Betaretroviruses, including sheep Betaretroviruses, assemble in the cytoplasm in 
the vicinity of the MTOC, and not at the cell membrane like the great majority 
of retroviruses. In order to investigate the relationship between ovine BST-2 and 
sheep Betaretroviruses we first assessed whether the human ortholog (hBST-2) is 
able to block these viruses. Studies were conducted with the exogenous JSRV 
and one of its endogenous counterparts, enJSRV-18. As mentioned in Chapter 1, 
enJSRV-18  has  intact  open  reading  frames  and  is  abundantly  expressed  in 
transfected cells in vitro (Chessa, Pereira et al. 2009). 
We  transiently  transfected  293T  cells  with  expression  plasmids  for  either 
enJSRV-18  or  JSRV  in  the  presence  and  absence  of  hBST-2  (Figure  19).  We 
observed that hBST-2 induced an efficient block on virion release based on the 
presence of pelletable Gag in the supernatants of transfected cells.  
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Figure 19. JSRV and enJSRV-18 viral exit is blocked by hBST-2 but rescued by the addition 
of Vpu in trans. 
Western  blot  analysis  on  concentrated  supernatants  of  293T  co-transfected  with  expression 
plasmids for viruses and BST-2/Vpu proteins as indicated in each panel. Cells were transfected in 
a  6  well  plate  with  0.5mg  of  JSRV  (panel  A)  /  enJSRV-18  (panel  B)  and  0.1mg  of  HA  tagged 
expression plasmids for hBST-2 and Vpu. Blots were incubated with the Gag antisera against the 
CA domain, indicated in each panel. Viral particle release based on CA release was quantified, and 
values represent arbitrary units relative to the values of each virus transfected in the absence of 
BST-2 (which was assigned a value of 100). Representative experiments are shown and  were 
repeated at least three times independently. 
 
 
 
 
In order to determine the specificity of the BST-2 restriction, we also confirmed 
a  similar  level  of  efficiency  of  restriction  for  several  other  insertionally 
polymorphic, replication competent enJSRVs, including enJSRV-7, 15 and 26, by 
hBST-2  (Figure  20).  As  expected  based  upon  previously  published  data  (Neil, 
Zang et al. 2008), in all cases the provision of the HIV accessory protein Vpu in 
trans efficiently counteracted the restriction by hBST-2. 
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Figure 20. Viral exit of enJSRV-7, 15 and 26 is blocked by hBST-2 but rescued by the 
addition of Vpu in trans. 
Western blot analysis on concentrated supernatants of 293T cells cotransfected with expression 
plasmids for viruses and BST-2/Vpu proteins as indicated in each panel. Cells were transfected in 
a 6 well plate with 1.5, 0.5 and 4 mg of enJSRV-7, 15 and 26 respectively, and 0.1mg of HA tagged 
expression plasmids for hBST-2 and Vpu. Blots were incubated with the Gag antisera against the 
CA domain, indicated in each panel. Viral particle release was quantified based on CA release, and 
values represent arbitrary units relative to the values of each virus transfected in the absence of 
BST-2 (which was assigned a value of 100). Representative experiments are shown and  were 
repeated at least three times independently. 
 
 
 
 
As  mentioned  previously,  studies  conducted  by  Frederick  Arnaud  in  our 
laboratory  showed  that  the  BST-2  gene  is  duplicated  in  ruminants.  oBST-2A 
blocks JSRV/enJSRVs viral particle exit more efficiently than oBST-2B (Arnaud, 
Black et al. 2010). In concordance with these data, enJSRV-18 exit was found to 
be blocked very efficiently in the presence of both oBST-2A and -2B (Figure 21). 
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Figure 21. enJSRV-18 viral exit is blocked by oBST-2A/ -2B. 
(A)  Cells  were  transfected  in  10cm  diameter  Petri  dishes  with  1mg  of  a  plasmid  expressing 
enJSRV-18  and a gradient of HA tagged expression plasmids for oBST-2A and -2B ranging from 
0.1- 1.4 mg. A ratio of 3:1 for oBST-2A/ -2B respectively was transfected to reflect the expression 
pattern  previously  identified  in  vivo  (Arnaud,  Black  et  al.  2010).  Blots  were  incubated  with  the 
appropriate antisera, indicated in each panel. (B) Quantification of western blotting of concentrated 
viral particles from supernatants of 293T co-transfected with expression plasmids for enJSRV-18 
and  oBST-2A/  -2B.  Viral  particle  release  was  quantified,  and  values  represent  arbitrary  units 
relative to the values of each virus transfected in the absence of BST-2 (which was assigned a 
value of 100). 
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3.3.2 oBST-2A and -2B proteins have different glycosylation 
patterns 
Next, we compared the structural features between the ovine BST-2 paralogs 
and human BST-2. oBST-2A retains many of the structural features typical of the 
BST-2  proteins  including  a  predicted  N-terminal  transmembrane  region,  a  C-
terminal  coiled  coil  domain,  a  GPI-Signal  Peptide  (SP,  for  cleavage  and  GPI 
anchor addition within the ER), as well as N-linked glycosylation sites similarly to 
hBST-2. In contrast, oBST-2B possesses only an N-terminal transmembrane region 
and a C-terminal coiled coil region like oBST-2A and hBST-2, and does not appear 
to  contain  a  GPI-SP.  In  addition,  oBST-2B  appears  to  contain  a  putative  ER 
retention  motif  at  the  C-terminal.  Interestingly,  no  glycosylation  sites  are 
predicted in oBST-2B (Figure 22). 
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Figure 22. The main features of the BST-2 proteins. 
(A) A sequence alignment of oBST-2A/-2B  where X depicts non conserved residues. oBST-2B 
does not contain N-linked glycosylation sites and lacks a GPI-SP yet maintains the omega site for 
GPI  anchorage.  (B)  A  schematic  diagram  illustrating  the  main  structural  features  and  post-
translational modification of hBST-2 and those predicted for oBST-2A/ -2B.  
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We next experimentally addressed whether the ovine BST-2 paralogs possess a 
different  glycosylation  pattern  as  suggested  by  the  lack  of  predicted  N-
glycosylation sites in the latter. Previously, it was observed that oBST-2A and -2B 
display a different migration pattern by western blotting (Arnaud, Black et al. 
2010).  oBST-2A  appears  as  a  triple  band  whilst  oBST-2B  shows  a  single  band 
(Figure 23).  
To  establish  whether  oBST-2A  and  -2B  are  glycosylated  we  transiently 
transfected 293T cells with expression plasmids for oBST-2A/ -2B (tagged with an 
HA epitope) and cell lysates were harvested in 1% NP-40 prior to incubation in 
the presence or absence of PNGaseF (peptide N-glycosidase F), an amidase that 
removes carbohydrate side chains from N-linked glycosylated proteins. Following 
overnight  incubation,  proteins  were  separated  by  SDS-PAGE  and  analysed  by 
western  blotting,  using  an  anti-HA  antibody  for  oBST-2A/  -2B  detection.  The 
migration  patterns  of  oBST-2A/  -2B  in  the  presence  and  absence  of  PNGaseF 
confirmed a different glycosylation pattern. We found that oBST-2A migrated as 
a triple band and was reduced to a single band in the presence of PNGaseF, 
confirming that the observed isoforms were a result of glycosylation as reported 
for other orthologs (Kupzig, Korolchuk et al. 2003) (Figure 23). In contrast, we 
observed no difference in the migration pattern of oBST-2B following PNGaseF 
treatment.  Therefore,  these  data  confirm  the  hypothesis  that  oBST-2A  is  a 
glycosylated protein whilst oBST-2B remains unglycosylated.  
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Figure 23. Ovine Bst-2 paralogs show a different glycosylation pattern. 
293T cells were transiently transfected with expression plasmids for oBST-2A or -2B. Cell lysates 
were harvested and incubated in the presence and absence of PNGaseF overnight. Proteins were 
then separated by SDS-PAGE and visualized by western blotting. Migration patterns indicate that 
oBST-2A is a glycosylated protein as it is reduced to a single band by PNGaseF. oBST-2B appears 
to  be  unaffected  by  PNGaseF  treatment.  g-tubulin  was  used  as  a  sample  quality  and  loading 
control.  
 
 
 
 
3.3.3 The oBST-2A and -2B paralogs display a different 
intracellular localisation 
 
The presence of BST-2 at the plasma membrane is a key factor for the antiviral 
restriction  mechanism  displayed  by  this  protein  (Neil,  Zang  et  al.  2008;  Van 
Damme, Goff et al. 2008). Although GPI anchorage is a determinant of protein 
localisation to the lipid rafts of the plasma membrane, we predicted that only 
oBST-2A has a functional GPI-SP (Figure 22). 
We next investigated the intracellular localisation of both oBST-2A and -2B to 
assess the importance of GPI anchorage for oBST-2. Experiments were performed 
in sheep CPT-tert cells transiently transfected with oBST-2A or -2B expression 
plasmids (Arnaud, Black et al. 2010) and analysed by confocal microscopy.  
The detection of the BST-2 paralogs with an HA antibody revealed two different 
staining patterns: (i) a "dispersed", broad based internal and plasma membrane 
localisation and (ii) a "concentrated" perinuclear staining pattern (Figure 24 (A)). Chapter 3    105 
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We noticed that oBST-2A existed primarily as a dispersed localisation whilst in 
contrast oBST-2B appeared mainly as a significantly concentrated, perinuclear 
form. We quantified the data by randomly counting the oBST-2A/ -2B staining 
pattern in 100 cells in two independent experiments (Figure 24 (B)). The results 
were  very  consistent  in  both  experiments  with  more  than  90%  of  the  cells 
transfected with oBST-2A displaying a dispersed phenotype while 90% of the cells 
transfected with oBST-2B displayed a concentrated phenotype (Figure 24, (B)). 
 
 
Figure 24. Ovine BST-2 paralogs display a different intracellular localisation. 
(A)  Confocal  microscopy  of  oBST-2A  /  -2B  in  CPT-tert  cells  transiently  transfected  with  either 
oBST-2A or -2B expressing plasmids display two different staining patterns: (i) dispersed within the 
cytoplasm  and  cell  membrane  and  (ii)  concentrated  in  a  perinuclear  region.  (B)  Data  were 
quantified by counting the staining phenotype of 100 cells in random fields. More than 90% of 
oBST-2A positive cells have a significant dispersed localisation whilst oBST-2B transfected cells 
display mostly a concentrated, perinuclear association. 
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3.3.4 oBST-2B has remnants of a once functional GPI anchorage 
 
GPI anchorage ensures protein incorporation within the lipid rafts of the plasma 
membrane  by  post  translational  modification  within  the  ER  involving  protein 
cleavage and addition of a GPI anchor at the omega  site. Sequence analyses 
show that oBST-2A has a predicted GPI-SP. oBST-2B lacks a GPI-SP but it has a 
conserved serine residue. This residue, in the presence of a functional signal 
peptide,  would  constitute  the  ‘omega’  cleavage  site  (w)  similar  to  oBST-2A 
where cleavage and addition of the GPI anchor would typically occur. To confirm 
if the presence of a serine omega cleavage site is indicative of a functional site 
for  GPI  anchorage  addition,  we  designed  an  oBST-2B  mutant  (termed  oBST-
2BGPIc-28)  possessing  a  premature  stop  codon  in  place  of  the  second  serine 
following the omega site (Figure 25). We predicted that insertion of a stop codon 
at this site would mimic cleavage that would ordinarily occur in the presence of 
a  functional  GPI-SP  within  the  ER  facilitating  GPI  anchor  addition  and 
consequently modify the oBST-2B protein trafficking patterns.  
 
 
Figure 25. Schematic diagram of the oBST-2B truncated mutant where a stop codon was 
inserted at w w w w site . 
In order to assess the impact of introducing the premature stop codon, we first transfected CPT-tert 
cells with oBST-2B (control) or oBST-2BGPIc-28 expression plasmids. Subsequently, we quantified 
the phenotype of oBST-2B localisation (or the truncation mutant) by confocal microscopy as either 
concentrated  or  dispersed  (Figure  26A).  We  found  that  oBST-2BGPIc-28  had  a  significant 
dispersed localisation in comparison to the concentrated perinuclear localisation characteristic of 
oBST-2B (Figure 26 (B)).  
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Figure 26. Ovine BST-2GPIc-28 displays an intracellular localisation different to that of 
oBST-2B. 
(A) Confocal microscopy of CPT-tert cells transiently transfected with oBST-2B/oBST-2BGPIc-28 
revealed two different staining patterns: (i) dispersed within the cytoplasm and cell membrane and 
(ii)  concentrated  in  a  perinuclear  region.  (B)  Data  were  quantified  by  counting  the  staining 
phenotype of 100 cells in random fields. oBST-2B transfected cells display mostly a concentrated, 
perinuclear association whilst oBST-2BGPIc-28 is found as both dispersed and concentrated in 
roughly equal amounts. 
 
We found that oBST-2GPIc-28 displays an intracellular localisation different to 
that of oBST-2B, switching from a concentrated to a dispersed phenotype (Figure 
26). During the course of these experiments, we also found evidence suggesting 
that oBST-2BGPIc-28 was able to accumulate at the plasma membrane (Figure 27 
(a) and (d)). Thus, oBST-2BGPIc-28 shows a similar phenotype to oBST-2A. Chapter 3    108 
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Figure 27. oBST-2B truncation mutants display a distinct localization pattern from oBST-2B 
CPT-tert cells transfected with oBST-2BGPIc-28 were fixed 18h after transfection and analyzed by 
confocal  microscopy  using  antibodies  against  the  HA  epitope  and  appropriate  secondary 
conjugated antibodies. In addition to the ‘wild-type’ oBST-2B concentrated perinuclear distribution, 
oBST-2BGPIc-28  also  shows  a  dispersed  intracellular  localisation  (B  and  C)  with  plasma 
membrane association noted (A and D). 
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3.3.5 oBST-2B has an ER retention motif  
 
Above, we showed that truncation of the last 28 amino acid residues of oBST-2B 
result in its re-distribution within the cell and the switch from a concentrated to 
a dispersed phenotype. Perinuclear localization of oBST-2B might be due to a 
dysfunctional GPI-SP and/or to a predicted ER retention motif (KLCKK) that is 
present in the C terminal region. In order to test this point we made multiple 
truncated  mutants  in  oBST-2B  after  the  predicted  omega  site,  as  illustrated 
schematically in Figure 28.  
 
 
Figure 28. Schematic diagram of the oBST-2B C truncation mutants generated in this study.  
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To assess the influence of the differing truncations upon oBST-2B distribution, 
we transfected each mutant into CPT-tert cells and assessed their intracellular 
localisation as described above. We found that all of the C-terminal truncated 
mutants,  with  the  exception  of  oBST-2Bc-5,  had  a  dispersed  intracellular 
localisation whereas oBST-2Bc-5 maintained the localisation typical of the native 
oBST-2B, predominately concentrated and perinuclear (Figure 29).  
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Figure 29. Ovine BST-2 C truncation mutants display a different intracellular localisation 
from oBST-2B. 
Confocal microscopy of CPT-tert transiently transfected with oBST -2B and C terminal mutants 
display two different staining patterns: A(i) dispersed within the cytoplasm and cell membrane and 
A(ii)  concentrated  in  a  perinuclear  region.  (B)  Data  were  quantified  by  counting  the  staining 
phenotype of 100 cells in random fields. oBST-2Bc-25, 20, 9 and 6 positive cells have a significant 
dispersed  localisation  whilst  oBST-2Bc-5  transfected  cells  display  mostly  a  concentrated, 
perinuclear association typical of the native oBST-2B protein. 
 
Interestingly, we also observed that, although oBST-2Bc-5 (deleted of the KLCKK 
motif) maintains a predominantly perinuclear localisation, it appears to have a 
more punctuated distribution surrounding the nucleus (Figure 30 panels E and F) 
rather than the tightly concentrated mass characteristic of oBST-2B (Figure 30, 
panels A and B). Nevertheless, oBST-2Bc-5, like oBST-2B, could be found in a 
dispersed  form  (Figure  30  C  and  D).  It  was  frequently  observed  that  the 
punctuated distribution of oBST-2Bc-5 was observed as small individual spherical 
aggregates,  O-rings,  around  the  nucleus  (Figure  30,  panels  G  and  H).  We 
currently have no explanation as to why this occurs. We conclude that the KLCKK 
motif is  functional  and  likely  represents one of  the  K(X)KXX retention  motifs 
previously described (Teasdale and Jackson 1996).  
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Figure 30. oBST-2Bc-5 truncation mutant displays a similar intracellular localisation pattern with oBST-2B. 
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Figure 30. oBST-2Bc-5 truncation mutant displays a similar intracellular localisation 
pattern with oBST-2B. 
CP  tert  cells  transfected  oBST-2Bc-5  and  oBST-2B  were  fixed  18h  after  transfection  and 
analyzed by confocal microscopy using antibodies against the HA epitopes and appropriate 
secondary conjugated antibodies. oBST-2Bc-5 shows a concentrated intracellular localisation 
(e and f) similar to oBST-2B (a and b) but with a more punctuate appearance around the 
nucleus. oBST-2Bc-5 is frequently observed with small circular aggregates, O rings (g and h). 
A small proportion of cells transfected with oBST-2Bc-5 show a dispersed localisation (c and 
d). 
 
 
3.3.6 oBST-2B co-localises with Golgi based markers  
 
We have established above that oBST-2B has no functional GPI-SP, it is not 
glycosylated  and  displays  mostly  a  perinuclear  concentrated  intracellular 
distribution, primarily due to a KLCKK ER retention motif at the C-terminal 
of the protein. Next, using confocal microscopy we assessed whether oBST-
2B localises in the Golgi using different cellular markers: p115, Giantin and 
TGN46; that localise in the cis, medial and trans-Golgi network respectively 
(Figure. 31, 32, 33, 34, 35, 36, 37).  
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Figure 31. Schematic representation of the Golgi and the cellular markers used in this 
study. 
We transfected CPT-tert cells with  expression plasmids for either oBST-2A or -2B and 24h 
post-transfection  cells  were  fixed  and  analysed  by  confocal  microscopy  using  antibodies 
against the HA epitope (detecting oBST-2A and -2B) and p115 (Figures 32 and 33), Giantin 
(Figures 34 and 35) or TGN46 (Figures 36 and 37). The extent of co-localisation between 
oBST-2 and each of the Golgi markers indicated above was performed by calculating the 
Pearson’s correlation coefficient using Image-Pro software (Media Cybernetics).  
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Figure 32. oBST-2A does not co-localise significantly with p115 Chapter 3    116 
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Figure 33. oBST-2B co-localises with p115 Chapter 3    117 
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Figure 34. oBST-2A does not co-localise with Giantin Chapter 3    118 
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Figure 35. oBST-2B co-localises with Giantin 
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Figure 36. oBST-2A does not co-localise with TGN46 Chapter 3    120 
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Figure 37. oBST-2B co-localises with TGN46 Chapter 3    121 
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Figure 32. oBST-2A does not c-localise significantly with p115. 
CPT-tert cells transfected with oBST-2A were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based p115 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and no significant colocalisation between p115 and oBST-2A was 
observed. Co-localisation can also be assessed visually for images with a greyscale merge of 
individual images (d, h and l) the absence of white areas indicates there is no significant 
colocalisation between oBST-2A and p115. 
 
 
Figure 33. oBST-2B co-localises with p115. 
CPT-tert cells transfected with oBST-2B were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based p115 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and the yellow areas indicate significant colocalisation between 
p115 and oBST-2B. Co-localisation can also be assessed visually for images with a greyscale 
merge of individual images (d, h and l) with white areas indicating significant association. 
 
 
Figure 34 oBST-2A does not co-localise with Giantin. 
CPT-tert cells transfected with oBST-2A were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based Giantin (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and no significant colocalisation was observed between Giantin and 
oBST-2A.,Co-localisation can also be assessed visually for images with a greyscale merge of 
individual images (d, h and l) with the absence of white areas indicating there is no significant 
colocalisation between Giantin and oBST-2A. 
 
 
Figure 35 oBST-2B co-localises with Giantin. 
CP tert cells transfected  with  oBST-2B  were fixed  18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based Giantin (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and yellow indicates areas of significant colocalisation between 
Giantin  and  oBST-2B.  Co-localisation  can  also  be  assessed  visually  for  images  with  a 
greyscale merge of individual images (d, h and l) with white indicating areas of significant 
association Giantin and oBST-2B. 
 
 
Figure 36 oBST-2A does not co-localise with TGN46. 
CP tert cells transfected  with  oBST-2A  were fixed  18h after transfection and analyzed by 
confocal microscopy using antibodies against TGN based TGN46 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and no significant colocalisation was observed between TGN46 and 
oBST-2A. Co-localisation can also be assessed visually for images with a greyscale merge of 
individual images (d, h and l) the absence of white areas indicates no significant association 
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Figure 37 oBST-2B colocalises with TGN46 
CP tert cells transfected  with  oBST-2B  were fixed  18h after transfection and analyzed by 
confocal microscopy using antibodies against TGN based TGN46 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and yellow indicates areas of significant colocalisation between 
TGN46  and  oBST-2B.  Co-localisation  can  also  be  assessed  visually  for  images  with  a 
greyscale merge of individual images (d, h and l) with white indicating areas of significant 
association. 
 
Data  are  shown  in  Figure  38  as  the  average  Pearson’s  correlation  values 
obtained in 50 random images representative of cells expressing oBST-2A or 
-2B and incubated with antibodies towards each of the Golgi markers. The 
Pearson’s  correlation is  a  value  ranging  from  -1  to  1,  which  in  this  case 
indicates the degree of co-localisation between the Golgi marker in question 
and  oBST-2A/  -2B.  We  considered  0.5  as  our  threshold  for  significant 
association. oBST-2B, and not oBST-2A, displayed a significant degree of co-
localisation with all three Golgi-based markers (Fig. 38). 
 
Figure 38. oBST-2B co-localises with Golgi based markers 
This  figure  displays  the  quantification  of  the  data  shown  in  Figures  32-37.  The  values 
represent the average of the Pearson’s correlation coefficient. Any values obtained above 0.5 
were regarded as representing significant co-localisation.  
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Next, we used confocal microscopy to assess the localisation of oBST-2B in 
the presence or absence of Brefeldin-A, a drug which fragments the Golgi 
apparatus.  We  observed  that  oBST-2B  behaved  in  a  similar  manner  to 
Giantin  in  the  presence  of  Brefeldin-A  as  its  distribution  pattern  was 
redistributed from a predominantly concentrated form (Figure 39) to that of 
a  more  dispersed  one  (Figure  40)  results  are  summarised  in  Figure  41. 
Collectively,  the  data  obtained  suggest  that  oBST-2B  is  a  Golgi  based 
protein. 
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Figure 39. Giantin and oBST-2B have a concentrated, perinuclear distribution Chapter 3    125 
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Figure 40. Giantin and oBST-2B localisation is altered by treatment with Brefeldin A Chapter 3    126 
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Figure  39.  Giantin  and  oBST-2B  have  a  concentrated,  perinuclear 
distribution.  
CPT-tert cells were transfected with the oBST-2B expression plasmid. The cells were fixed and 
analysed  by  confocal  microscopy  using  antibodies  towards  the  Giantin  Golgi  marker  and  HA 
epitope  as  indicated.  These  images  were  also  merged.  oBST-2B  and  Giantin  display  a 
concentrated localisation with a high degree of colocalisation as shown in the merge indicated by 
yellow and within the Image-Pro greyscale images indicated in white. 
 
Figure 40. Giantin and oBST-2B localisation is altered by treatment with 
Brefeldin-A. 
CPT-tert cells were transfected with either oBST-2A or -2B expression plasmids. Eighteen hours 
after transfection, the cells were treated in the presence and absence of 200ng/ml of Brefeldin-A for 
90mins, fixed and analysed by confocal microscopy using antibodies towards the Giantin Golgi 
marker and HA epitope as indicated. These images were also merged. Both Giantin and oBST-2B 
localisation is altered by treatment with Brefeldin-A. 
 
 
 
 
Figure 41. Brefeldin-A treatment leads to an intracellular redistribution of oBST-2B. 
This figure displays the quantification data for the images shown in Figures 39 and 40. Data were 
quantified by counting the staining phenotype of 100 cells in random fields. Cells were grouped as 
(i) dispersed within the cytoplasm and cell membrane and (ii) concentrated in a perinuclear region. 
In  the  absence  of  Brefeldin-A  both  Giantin  and  oBST-2B  have  a  predominantly  concentrated 
localisation.  Following  treatment  with  200ng/ml  of  Brefeldin-A  for  90  mins  post  transfection  the 
localisation of both Giantin and oBST-2B is altered to be predominantly dispersed pattern. 
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3.4 Discussion 
 
The  Bst-2  gene  is  an  IFN  inducible  gene  with  a  broad  antiviral  activity. 
Interestingly, the Bst-2 gene is duplicated in sheep and in cattle, suggesting that 
duplication occurred more than 25 million years ago before speciation within the 
Bovinae subfamily. The fixation and maintenance of oBST-2B in the ruminant 
genome  suggests  a  biological  function  for  this  gene.  However,  in  a  previous 
study, we found oBST-2B to have only a moderate antiviral activity compared to 
oBST-2A (Arnaud, Black et al. 2010). In this chapter, we aimed to characterise 
key  differences  between  the  ovine  BST-2  paralogs,  and  in  particular  we 
investigated their intracellular distribution.  
Although oBST-2B appears to have a limited antiviral activity, in co-transfection 
assays  we  ruled  out  that  it acts  as  a  negative  regulator  of oBST-2A.  Indeed, 
sheep Betaretroviruses were efficiently inhibited in the presence of oBST-2A and 
oBST-2B. 
We revealed several properties that are unique to oBST-2B and that might be at 
the basis of the different biological properties observed in the ovine paralogs. 
We  found  oBST-2B  not  to  be  glycosylated,  to  lack  a  predicted  GPI  anchor 
attachment signal and to possess an ER retention motif (KLCKK) at its C-terminal 
portion.  
A lack of glycosylation alone would not seem to be the main reason underlining 
the  different  biological  properties  of  oBST-2A  and  -2B.  Mutation  of  the 
glycosylation  sites  in  hBST-2  did  not  affect  its  distribution  nor  its  common 
‘tethering’  antiviral  function  (Perez-Caballero,  Zang  et  al.  2009).  N-linked 
glycosylation is a common form of protein modification, predicted for more than 
half  of  all  eukaryotic  proteins.  It  is  reported  to  be  involved  in  a  number  of 
processes including protein orientation relative to membranes, protein turnover 
and  regulation  of  stabilisation  against  denaturation/proteolysis,  enhanced 
solubility and modulation of immune responses (Helenius and Aebi 2004). Thus, a 
lack of glycosylation may have a profound impact on BST-2B structure and in 
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We  found  that  oBST-2B  is  present  mainly  in  a  concentrated  form  in  a 
perinucleolar region while oBST-2A is dispersed throughout the cytoplasm and 
the  cell  membrane.  oBST-2A,  similarly  to  other  BST-2  orthologs,  appears  to 
maintain a functional GPI-SP and adopt the current “tethering” model where 
BST-2 is directed via its GPI anchorage to the plasma membrane. However, oBST-
2B does not seem to possess a canonical GPI-SP (or at least it is not predicted by 
current  bioinformatic  tools),  and  does  not  localise  to  the  cell  membrane. 
Consequently, it is difficult to envisage how this protein could restrict viral exit 
by the classic ‘tethering’ mechanism.  
Despite the importance of GPI anchorage for the BST-2 membrane localisation, 
this can only account for its absence from the plasma membrane and does not 
fully explain the differing patterns of intracellular localization that we observed. 
oBST-2A and -2B share a transmembrane domain but the latter contains a non-
canonical ER retention motif (KLCKK). Deletion of this region (e.g. mutant oBST-
2Bc-6)  resulted  in  the  redistribution  of  oBST-2B  from  the  characteristic 
concentrated form to that of a more dispersed form. The KLCKK motif of oBST-
2B is similar to the classic K(X)KXX motif, one of several C-terminal ER retention 
motifs  identified.  It  differs  slightly  from  the  standard  consensus  sequence 
described which has three lysine residues found at positions -1/-2 and -5 relative 
to the C-terminus. Therefore, the lack of the KLCKK retention motif may explain 
the potential redistribution to the plasma membrane rather than the possibility 
of GPI anchorage. 
Proteins with ER retention motifs often require post translational modifications 
carried out at the Golgi, where they traffic before feeding back to the ER where 
they are based. ER retention motifs allow re-circulation to the ER from the Golgi 
and TGN (Jackson, Nilsson et al. 1993). It was puzzling that mutant oBST-2Bc-5 
(with a premature termination codon replacing the K residue in position -5) had 
an apparently concentrated localisation. However, the distribution pattern of 
oBST-2c-5 was notably different from wild type oBST-2B. Wild type oBST-2B was 
usually  localised  mainly  in  a  single  perinuclear  region  while  oBST-2c-5  had  a 
series  of  punctuate  dots  surrounding  the  nucleus  which  may  indicate  that  it Chapter 3    129 
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remains  trapped  within  the  ER,  although  further  studies  will  be  needed  to 
confirm this point.  
Using confocal microscopy, we established that oBST-2B localises in the Golgi 
stacks. This is not a novel concept for BST-2 as an independent intracellular pool 
localising at the TGN for hBST-2 has already been described (Kupzig, Korolchuk 
et al. 2003) and, interestingly, a Golgi based localisation has also recently been 
described for a BST-2 homolog (GREG) derived from CHO cells (Li, Kaloyanova et 
al. 2007). oBST-2B localisation was also confirmed by a functional assay. In the 
presence  of  Brefeldin-A,  oBST-2B  is  redistributed  in  the  same manner  as  the 
Golgi based protein Giantin. Therefore, we conclude from these data that oBST-
2B does not progress beyond the Golgi and behaves as a resident Golgin closely 
associated with the cis/medial cisternae of this organelle. oBST-2A showed a 
distinct localisation from oBST-2B. 
As  mentioned  above,  we  noticed  a  similar  intracellular  localisation  between 
oBST-2B  and  GREG  (Li,  Kaloyanova  et  al.  2007)  However,  we  find  that 
intracellular localisation is the only feature that these two proteins share. GREG 
is  a  constitutively  expressed  protein  which  appears  to  be  important  for 
maintaining Golgi structure, while oBST-2B is induced by IFN and displays some 
antiviral activity (see also Chapter 4). Structurally, GREG and oBST-2B do not 
share many features. GREG has GPI anchorage like all other BST-2 orthologs and 
several sites for N-linked glycosylation, but neither of these features are found 
in oBST-2B. GREG and oBST-2B share a predicted coiled coil region linked to 
functionality  and  retention  motifs  which  determine  intracellular  localisation 
patterns. GREG possesses a central EQ tandem repeat that is essential for Golgi 
localisation. oBST-2B has a C-terminal retention motif which we have shown is 
the determinant of perinuclear localisation. 
Therefore we conclude that oBST-2B has some but not all the features conserved 
for most BST-2 orthologs. oBST-2A is clearly a plasma membrane based protein 
bearing  many  of  the features  of  other  classical  ‘tethering’  BST-2  proteins.  If 
oBST-2B is absent from the plasma membrane, then we expect that it would be 
difficult  to  understand  how  it  can  contribute  to  the  traditional  mode  of 
tethering viral particles to the plasma membrane. However, (Arnaud, Black et Chapter 3    130 
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al.  2010)  have  shown  oBST-2B  to  possess  only  limited  antiviral  activity, 
prompting us to question how oBST-2B can block viral particle release. 
A limitation of our studies is that they are conducted by transient transfections. 
Unfortunately,  there  is  no  cell  culture  system  for  the  propagation  of  sheep 
Betaretroviruses.  
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4  Chapter 4 - Investigating the antiviral restriction 
mechanism of the oBST-2 paralogs 
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4.1 Summary 
In this chapter we aimed to identify the antiviral mechanism of the ovine BST-2 
paralogs  to  determine  if  oBST-2B  shared  the  classical  ‘tethering’  antiviral 
restriction common to other BST-2 orthologs. 
 
4.2 Introduction 
4.2.1 Overview of BST-2 induced antiviral restriction.  
 
The discovery of BST-2 as a restriction factor was inspired by the observations 
that Vpu was mandatory for HIV viral particle release in certain cell lines while it 
was dispensable in others. These data suggested the presence of a host cellular 
factor which prevented viral particle release (Smith, Thresher et al. 1991). BST-
2 restricts viral replication by ‘tethering’ HIV (and other enveloped viruses) viral 
particles at the cell membrane, preventing their final release (Van Damme, Goff 
et al. 2008), (Neil, Zang et al. 2008). Fully formed viral particles are tethered to 
the cell membrane by BST-2, which creates a bridge of retention between the 
plasma membrane and virions exiting the cell (Neil, Zang et al. 2008). BST-2 
restriction is essentially independent from the cell line in which the assays are 
carried  out,  thus  ruling  out  the  involvement  of  essential  cofactors  for  its 
function (Sato, Yamamoto et al. 2009). There is also evidence to indicate that 
BST-2 reduces infectivity of the small number of virions released in its presence 
potentially by interfering with the maturation process (Zhang and Liang 2010). 
There are conflicting observations regarding the importance of conserved BST-2 
structural  elements  in  the  tethering  mechanism  (reviewed  by  (Andrew  and 
Strebel 2011)). However, it has been demonstrated by mutational analysis of 
BST-2  with  ‘art-tetherin’  (a  protein  which  bears  no  sequence  homology  to 
tetherin  but  maintains  the  structural  arrangement  conserved  within  BST-2 
homologs)  that  protein  configuration  is  more  important  than  the  primary 
sequence for efficient restriction (Perez-Caballero, Zang et al. 2009).  Chapter 4    133 
 
Human BST-2 possesses a broad antiviral activity extending beyond HIV-1. Human 
BST-2 has been shown to block the exit of a range of diverse retroviral genera 
including  alpharetroviruses,  Betaretroviruses,  deltaretroviruses  and 
spumaviruses (Jouvenet, Neil et al. 2009). Further evidence of the restriction of 
enveloped arenaviruses (Sakuma, Sakurai et al. 2009; Radoshitzky, Dong et al. 
2010), herpesviruses (Mansouri, Viswanathan et al. 2009), filoviruses (Jouvenet, 
Neil et al. 2009) and paramyxoviruses (Radoshitzky, Dong et al. 2010) by human 
BST-2  has  also  been  demonstrated,  although  conflicting  results  have  been 
published  in  the  case  of  filoviruses  (Jouvenet,  Neil  et  al.  2009;  Kaletsky, 
Francica et al. 2009; Radoshitzky, Dong et al. 2010).  
Although BST-2 is very efficient in blocking viral exit, some doubts have been 
cast as to whether this protein can efficiently block viral dissemination within a 
host. In addition to the ability of BST-2 to ‘tether’ viral particles to the plasma 
membrane and thus inhibit cell-free virus transmission, there is also evidence 
which  supports  the  idea  that  BST-2  efficiently  restricts  cell-to-cell  virus 
transmission (Casartelli, Sourisseau et al. 2010). However, it is intriguing that, in 
contrast to idea that BST-2 may reduce the formation of virological synapses and 
therefore  reduce  cell-to-cell  transfer,  BST-2  does  not  appear  to  inhibit  their 
formation and may even promote them (Jolly, Booth et al. 2010). Furthermore, 
the transfer of virions from an infected to an uninfected cell via a synapse has 
been observed (Jolly, Booth et al. 2010), although virions that successfully pass 
through the virological synapses in the presence of BST-2 appear to be heavily 
aggregated (Casartelli, Sourisseau et al. 2010). The efficient restriction of cell-
to-cell transmission by BST-2 has been further disputed by the evidence that 
∆Vpu HIV-1 mutant viruses switch from cell free to a cell-to-cell transmission 
mode in the presence of BST-2 (Jolly, Booth et al. 2010). Thus, BST-2 may even 
promote  cell-to-cell  virus  transmission.  An  increase  in  the  formation  of  the 
virological synapse and cell-to-cell transmission is possibly linked to an increase 
of virus at the plasma membrane in the presence of BST-2 compared to wild type 
virus (Jolly, Booth et al. 2010). However, BST-2 restriction may also result in 
positive selection for viral variants which can spread more efficiently by cell-to-
cell transmission, as shown for FIV (Dietrich, McMonagle et al. 2011). Overall, it 
is important to stress that the antiviral action promoted by BST-2 occurs in vivo Chapter 4    134 
 
in parallel with a range of antiviral factors which target various stages of the 
replication cycle (Neil and Bieniasz 2009).  
Different studies have provided evidence for the positive selection of BST-2 and 
other restriction factors such as APOBEC-3G and TRIM5a (Sawyer, Emerman et 
al. 2004; McNatt, Zang et al. 2009). However, these studies have also highlighted 
the fact that BST-2 does not appear to be as strongly selected as other host 
restriction factors (Bozek and Lengauer 2010). 
 
 
 
 
4.3 Results 
 
 
4.3.1 oBST-2A and –2B both redistribute intracellular viral Gag 
localisation. 
 
In Chapter 3 we established the intracellular localisation of oBST-2B while here 
we  wanted to  investigate  specifically  the  effect  that  they  exerted  over  viral 
structural proteins. Firstly, using confocal microscopy we looked at the effects 
of  oBST-2A/  -2B  on  the  localisation  of  enJSRV  Gag.  Expression  plasmids  for 
enJSRV-18 were co-transfected with expression plasmids for either oBST-2A or -
2B.  Cells  were  then  fixed,  permeabilised  and  subsequently  analysed  for  Gag 
localisation with a rabbit polyclonal antisera against the capsid (CA) protein. The 
intracellular distribution pattern of exogenous JSRV and enJSRV-18 Gag proteins, 
in the presence and absence of oBST-2A and -2B, was based on three previously 
established  distributions:  concentrated,  dispersed  and  dispersed  with  plasma 
membrane association (Arnaud, Black et al. 2010). We found that both oBST-2A 
and -2B influence the distribution of intracellular viral Gag proteins, although in 
apparently different ways. We found a clear redistribution of enJSRV Gag to the 
plasma membrane in the presence of oBST-2A (Figure  42). These data are in 
accordance  with  the  ‘tethering’  mechanism  of  action  displayed  by  BST-2 
orthologs.  However,  we  found  that  a  significant  proportion  of  enJSRV  Gag 
displayed a concentrated distribution in the perinuclear region in the presence Chapter 4    135 
 
of  oBST-2B  compared  to  cells  expressing  enJSRV-18  alone.  This  concentrated 
perinuclear  distribution  observed  for  Gag  is  reminiscent  of  the  Golgi-based 
localisation defined for oBST-2B in Chapter 3. 
 
 
Figure 42. The ovine BST-2 paralogs redistribute enJSRV-18 Gag in different ways. 
CPT-tert cells were transfected with expression plasmids for enJSRV-18 alone or with either oBST-
2A or -2B (0.25mg of each plasmid). A. The intracellular distribution of Gag (green) was categorised 
as  either  concentrated,  dispersed  or  reaching  the  plasma  membrane  by  confocal  microscopy. 
(Please note the picture representing plasma membrane based distribution was provided by Dr. 
Frederick  Arnaud).  B.  The  phenotype  of  intracellular  gag  distribution  was  counted  in  100  cells 
randomly  including  blind  counts.  In  the  presence  of  oBST-2A,  enJSRV-18  Gag  appears  to 
accumulate at the plasma membrane. In the presence of oBST-2B, more than 80% of transfected Chapter 4    136 
 
cells  display  enJSRV-18  with  a  concentrated  phenotype.  Western  blotting  of  ultracentrifuged 
supernatants (virus) confirms that oBST-2A/ -2B is actively  restricting the release of enJSRV-18 
viral particles in those cells counted. 
 
 
 
4.3.2 oBST-2B redistributes intracellular Env  
Next we sought to determine if oBST-2A/ -2B were also capable of affecting the 
intracellular distribution of the viral Env protein. This was done by transiently 
transfecting CPT-tert cells with an expression plasmid for the exogenous JSRV 
Env (tagged with a Flag epitope at the C-terminus) in the presence or absence of 
oBST-2A  or  -2B  expression  plasmids.  The  cells  were  fixed  and  analysed  by 
confocal microscopy using an anti-Flag antibody to detect Env. The localisation 
of  Env  was  quantified  by  confocal  microscopy  by  counting  its  distribution  as 
‘concentrated’, ‘dispersed’ or ‘reaching the plasma membrane’ (Figure 43 (A)). 
This time we found that oBST-2A had no influence over the distribution of viral 
Env  compared  to  Env  alone.  However,  in  the  presence  of  oBST-2B  we  again 
observed  a  notable  redistribution  of  viral  Env  to  the  perinuclear  region  as 
summarized in Figure 43 (B). We also noted that Env that is localised in the 
perinuclear  region  co-localises  with  oBST-2B,  as  determined  by  Pearson’s 
correlation 0.62 (+/- 0.02), illustrated in Figure 44. 
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Figure 43. oBST-2B redistributes the intracellular distribution of Env. 
CPT-tert cells were transfected with 1mg of JSRV Env in the presence or absence of oBST-2A/ -2B 
(0.25mg). A. The intracellular pattern of Env (green) was classed and counted as concentrated, 
dispersed or plasma membrane associated by confocal microscopy. B. oBST-2A had no influence 
over Env distribution. However, oBST-2B holds a significant proportion of Env in a concentrated 
form upon comparison to the Env counted alone 
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Figure 44. Env held in a perinuclear localisation shows a significant degree of co-localisation with oBST-2B. Chapter 4    139 
 
Figure 44. Env held in a perinuclear localisation shows a significant degree of co-
localisation with oBST-2B. 
CPT-tert cells were transfected with 1mg of JSRV Env in the presence or absence of 
oBST-2B (0.25mg). Eighteen hours after transfection the cells were fixed and analysed by 
confocal microscopy using antibodies against the Flag (a, e and i) and HA (b, f and j) 
epitopes. These images were also merged. Env and oBST-2B display a concentrated 
localisation  with  a  high  degree  of  colocalisation  as  shown  in  the  merge  indicated  by 
yellow (c, g and k) and within the Image-Pro greyscale images indicated in white (d, h 
and l). The Pearson’s correlation value of 0.62 is above the 0.5 threshold and is therefore 
considered to confirm a significant degree of co-localisation between Env and oBST-2B. 
 
 
 
 
4.3.3 oBST-2B potentially exerts not just an effect over viral 
proteins but creates a general inhibition of intracellular 
trafficking  
 
Thus far we have shown that oBST-2B had a significant effect on the 
trafficking/intracellular localisation of the Gag and Env proteins of both 
an exogenous and an endogenous sheep Betaretrovirus. Next, we sought 
to confirm if the influence on protein distribution due to oBST-2B was 
confined  specifically  to  viral  proteins  or  if  it  extended  to  cellular 
membrane proteins. This would determine if the mode of restriction was 
virus  specific  or  reflected  a  more  general  control  over  intracellular 
trafficking of membrane proteins exerted by oBST-2B. We used a GFP 
tagged form of Caveolin-1 expressed from a plasmid transfected in the 
presence or absence of either oBST-2A /-2B expression plasmids. Once 
again, quantification of the intracellular protein localisation was made 
by  confocal  microscopy  by  grouping  the  expressed  proteins  as  either 
concentrated, dispersed or based at the plasma membrane (Figure 45 
(A)). Caveolin-1 proteins in isolation were found to traffic to the plasma 
membrane.  We  found  no  significant  difference  in  the  intracellular 
distribution  of  Caveolin-1  in  the  presence  or  absence  of  oBST-2A. 
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of Caveolin-1 being retained in a more concentrated form, as illustrated 
in Figure 45 (B). 
 
 
 
Figure 45. oBST-2B redistributes the intracellular localisation of non viral proteins. 
CPT-tert cells were transfected with 1mg of a Caveolin-1-GFP expression plasmid in the 
presence and absence of oBST-2A/ -2B (0.25mg of each plasmid). A. Internalisation was 
classed and counted as ‘concentrated’, ‘dispersed’ or ‘plasma membrane based’. B. No 
significant  redistribution  of  Caveolin-1  in  the  presence  of  oBST-2A  was  observed. 
However in the presence of oBST-2B we found an increased proportion of Caveolin-1 to 
be in a concentrated form. Chapter 4    141 
 
 
 
 
4.3.4 oBST-2B reduces the incorporation of Env into viral 
particles  
oBST-2A  was  found  to  redistribute  intracellular  Gag  to  the  plasma 
membrane,  supporting  the  "tethering"  restriction  model. However, we 
found  that  oBST-2B  blocked  intracellular  trafficking  of  both 
Betaretrovirus  Gag  and  Env  proteins  by  retaining  them  within  a 
perinuclear area which is highly likely to impact viral particle assembly. 
Given this observation, we next investigated the ratio of Gag and Env 
being incorporated into the small number of viral particles released in 
the  presence  of  the  oBST-2A  or  -2B.  We  performed  transient 
transfections of 293T cells with an expression plasmid for enJSRV-18 in 
the  presence  or  absence  of  different  amounts  of  oBST-2A  or  -2B 
expression plasmids. 24 hours post-transfection, cell supernatants were 
collected  and  concentrated  by  ultracentrifugation.  Viral  pellets  were 
separated by SDS-PAGE and both Gag and Env were detected by western 
blotting using appropriate antibodies.  
There  are  wide  differences  in  the  stoichiometry  of  Gag  and  Env  in a 
retroviral  particle.  Each  virion  contains  far  more  Gag  than  Env. 
Consequently, we took great care in optimising the dilutions of anti-Gag 
and Env antibodies to be used in western blotting so that we could be 
confident that these proteins were detected with similar sensitivity in 
our assays. Figure 46 (A) shows that serial dilutions of enJSRV-18 viral 
particles are detected with similar sensitivity by both anti-Gag and anti-
Env antibodies. As expected, in the presence of oBST-2A enJSRV-18 viral 
particle release is greatly inhibited (Figure 46 (B)). On the other hand, 
inhibition of enJSRV-18 particle release appears to be only moderately 
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performed  independently  three  times  and  the  blots  shown  are 
representative of the trend observed. A comparison of Env incorporation 
of into enJSRV-18 viral particles is based on a visual reading from the 
blots. It may be suggested in Figure 46 that, in the presence of oBST-2B, 
Env  incorporation  into  viral  particles  is  reduced  compared  to  viral 
particles expressed in the absence of oBST-2B. Similar data were also 
obtained with exogenous JSRV in the presence or absence of oBST-2A 
and -2B and is shown in Figure 47. We attempted to confirm this data 
using standard DLS technology and Nanoparticle tracking analysis (NTA) 
to estimate the size (diameter) of virions released by JSRV/ enJSRV-18 
in  the  presence  and  absence  of  oBST-2A/  -2B.  To  do  this  we  first 
estimated the size of virions released following transfection of 293T cells 
with JSRV/ enJSRV-18 and JSRVDEnv/ enJSRV-18DEnv. Each experiment 
was  performed  independently  three  times  and  an  average  result 
representative of the trend observed is shown in Figure 48. We found 
that standard DLS technology did not produce accurate or reproducible 
results for the size of JSRV/enJSRV-18 particles (data not shown). NTA 
was able to detect particles at the 100nm size predicted for JSRV (but 
not  enJSRV-18).  No  difference  was  observed  between  ‘complete’ 
JSRV/enJSRV-18 virions and those devoid of Env.  
 
 Chapter 4    143 
 
 
Figure 46. oBST-2B blocks Env incorporation by enJSRV-18 viral particles. 
A.  Western  blotting  of  serial  dilutions  of  concentrated  supernatants  of  293T  cells 
transfected with an expression plasmid for enJSRV-18. Dilutions of anti-Gag (CA) and 
anti-Env (TM) sera used in this series of experiments were pre-determined in order to 
obtain  approximately  the  same  levels  of  sensitivity.  B-C.  Western  blotting  of 
ultracentrifuged  supernatants  (virus)  from  293T  cells  cotransfected  with  1  mg  of  an 
expression plasmid for enJSRV-18 and variable amounts (0.25 – 1 µg) of expression 
plasmids  for  either  oBST-2A  or  oBST-2B.  Blots  were  incubated  with  the  appropriate Chapter 4    144 
 
antisera  as  indicated  beside  each  panel.  Gag  associated  with  the  viral  particles  was 
quantified by chemifluorescence using a Molecular Dynamics Storm 840 imaging system 
using  ImageQuant  TL  software  (Molecular  Dynamics).  The  numbers  indicated  below 
each  panel  quantify  Gag  release  in  the  presence  of  oBST-2A/  -2B  compared  to  the 
standard  virus  transfected  alone  (100).  Each  experiment  was  repeated  at  least  three 
times. D-E The corresponding cell lysates are also shown γ-tubulin was used as loading 
control while a cotransfected plasmid expressing GFP was used as transfection control.  
 
 
 
 
Figure 47. oBST-2B reduces envelope incorporation by JSRV viral particles. 
A.  Western  blotting  of  serial  dilutions  of  concentrated  supernatants  of  293T  cells 
transfected with an expression plasmid for JSRV. Dilutions of anti-Gag (CA) and anti-Env 
(SU) sera used in these series of experiments where pre-determined in order to obtain 
approximately  the  same  levels  of  sensitivity.  B-C.  Western  blotting  of  ultracentrifuged 
supernatants (virus) of 293T cells co-transfected with 4 mg of an expression plasmid for 
JSRV, and variable amounts (0.05 – 0.5 µg) of expression plasmids for either oBST-2A 
or oBST-2B. Blots were incubated with the appropriate antisera as indicated beside each 
panel. Gag and Env associated with viral particles was quantified by chemifluorescence 
using a Molecular Dynamics Storm 840 imaging system using ImageQuant TL software 
(Molecular  Dynamics)  and  numbers  are  indicated  below  each  relevant  panel.  The Chapter 4    145 
 
numbers indicated below each panel quantify Gag and Env release in the presence of 
oBST-2A/ -2B compared to the standard virus transfected alone (100).  
 
 
 
 
 
Figure 48. NTA analysis of exogenous and endogenous JSRV virions and those 
released devoid of Env. 
Nanoparticle  Tracking  Analysis  (NTA)  was  employed  to  measure  the  hydrophobic 
diameter  of  ultracentrifuged  supernatants  of  293T  cells  transfected  with  1  mg  of 
expression plasmid for enJSRV-18/enJSRVDEnv, or 4 mg of JSRV/ JSRVDEnv. NTA of 
JSRV virions revealed an average particle size of 96.7nm while JSRVDEnv virions were 
smaller at 82.7nm (red) with a background reading of particles averaging at 75nm (grey). 
For enJSRV-18 the average particle size was larger at 95nm and enJSRVDEnv virions 
were 92nm (red) with a background reading of particles averaging at 119nm (grey). 
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4.3.5 oBST-2B C-terminal truncated mutants do not affect 
the incorporation of Env into sheep Betaretrovirus viral 
particles.  
 
Having confirmed the effects of oBST-2A/ -2B on Gag and Env, we then 
focused on determining whether the function of oBST-2B relied on its 
localisation in the Golgi. In order to experimentally address this point we 
used the previously described truncation mutant oBST-2BGPIc-28, which 
no longer retained the predominately concentrated localisation exclusive 
to oBST-2B and displayed instead a more dispersed localisation (Figure 
25 from Chapter 3). We performed transient transfections of the enJSRV-
18  expression  plasmid  in  the  presence  of  variable  amounts  of  oBST-
2BGPIc-28 as described above and once again assessed the incorporation 
of Gag and Env into viral particles by western blotting. We found that, 
unlike wild type oBST-2B, oBST-2GPIc-28 was not able to deplete Env 
incorporation  into  enJSRV-18  viral  particles  (Figure  49).  We  conclude 
that  the  C-terminal  portion  of  oBST-2B  and  its  characteristic 
concentrated  perinuclear  localisation  appear  to  be  essential  for  its 
antiviral function.  
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Figure 49. The C terminal portion of oBST-2B is essential for inhibiting Env 
incorporation. 
 
A. Western blotting of ultracentrifuged supernatants (virus) and cell extracts (B) of 293T 
cells  co-transfected  with  1  mg  of  an  expression  plasmid  for  enJSRV-18  and  variable 
amounts (0.25 – 1 µg) of oBST-2BGPIc-28. Blots were incubated with the appropriate 
antisera as indicated beside each panel. Data show that the C-terminal truncation mutant 
has no effect on either Gag (CA) or Env (TM) release.  
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4.4  Discussion 
 
It  is  well  established  that  BST-2  proteins  directly  antagonise  the  late 
phases of the retroviral lifecycle by engaging with viral particles as they 
exit  from  the  cell  and  retain  them  by  tethering  them  to  the  plasma 
membrane. BST-2 resides within the lipid rafts of the host membrane, 
which are known to be hotspots for viral release, and the various BST-2 
orthologs isolated from different animal species seem to restrict viral 
replication in a similar manner. 
Sheep (and other ruminants within the sub-family of the Bovinae) have a 
duplicated  BST-2  gene  (termed  oBST-2B)  that  has  been  conserved 
throughout evolution. In a previous study, it has been shown that oBST-
2B  blocks  viral  exit  less  efficiently  than  oBST-2A  as  judged  by  the 
relative amount of Gag released in the supernatants of cells transfected 
with  plasmids  expressing  retroviral  constructs  (Arnaud,  Black  et  al. 
2010). Indeed, in this current study we showed that oBST-2B localises 
mainly  in  the  Golgi  and  possesses  different  structural  characteristics 
from oBST2-A.  
Within this Chapter, we found that oBST-2A and -2B both redistribute 
ovine Betaretrovirus structural proteins, although in a different manner. 
oBST-2A increases the concentration of Gag at the plasma membrane, 
similarly  to  what has been observed  for  the  classic  ‘tethering’ model 
with  other  BST-2  orthologs  that  retain  virions  to  the  cell  surface.  In 
contrast, oBST-2B induces Gag accumulation in a concentrated form in a 
perinucleolar  region.  Furthermore,  oBST-2B  also  co-localises  with  Env 
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These  data  strongly  suggested  that  oBST-2A  and  -2B  acted  in 
substantially different ways. Previous studies have shown that the Gag of 
Betaretroviruses, including Mason-Pfizer monkey retrovirus (M-PMV) and 
sheep Betaretroviruses (Sfakianos and Hunter 2003; Sfakianos, LaCasse 
et  al.  2003;  Arnaud,  Murcia  et  al.  2007;  Murcia,  Arnaud  et  al.  2007) 
concentrate in the pericentrosomal area in a dynein and microtubule-
dependent fashion. The assembled viral particles then traffic to the cell 
membrane  by  a  mechanism  that  is  influenced  by  the  pericentriolar 
recycling endosomes and by Env (Arnaud, Murcia et al. 2007). Thus, the 
data obtained in this chapter could be explained with a model whereby 
oBST-2B interacts (directly or indirectly) with the betaretroviral Env and 
inhibits  its  trafficking  to  the  cell  membrane.  As  the  Env  protein 
influences  the  assembly  and  trafficking  of  virions,  inhibition  of  Env 
trafficking  would  in  turn  lead  to  the  accumulation  of  Gag  in  a 
pericentrosomal area. Betaretroviral particles can exit transfected cells 
in the absence of viral Env although it is expected that this would occur 
in a slower manner than in the presence of Env. 
Consistent  with  this  model,  western  blotting  suggested  that  in  the 
presence  of  oBST-2B  there  may  be  a  reduction  of  Env  protein 
incorporation into viral particles.  
The data obtained in this Chapter suggest that the antiviral action of 
oBST-2B  might  be  based  on  a  mechanism  not  previously  reported  for 
other BST-2 orthologs. In the presence of oBST-2B, Env appears to be 
sequestered  in  a  cellular  compartment  (likely  the  Golgi,  although  we 
have  not  formally  assessed  this  point)  and  does  not  reach  the  cell 
membrane  and  consequently  reduces  viral  incorporation  of  Env.  The 
retention  of  Caveolin-1  in  a  concentrated  perinuclear  region  in  the 
presence of oBST-2B suggests that BST-2B may have similar effects on 
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effect on trafficking of certain proteins rather than target specifically 
the  retroviral  Env. oBST-2B  may act indirectly by inhibiting  a general 
cellular  function  which  results  in  Env  (and  other  proteins)  being 
physically sequestered within the Golgi. These data suggest that oBST-2B 
interferes with a fundamental requirement for Golgi trafficking, rather 
than being based on any specific interaction/recognition event with viral 
proteins. However, in this Thesis we only tested Caveolin-1. Attempts 
were  made  with  a  Cadherin-GFP  fused  protein  but  the  construct  was 
considerably  cytotoxic  in  CPT-tert  cells.  Further  experiments  are 
required with other host endogenous proteins which traffic and leave the 
Golgi.  
Previously,  we  observed  close  association  of  oBST-2B  with  p115  and 
Giantin  (Chapter  3).  Both  p115  and  Giantin  have  been  linked  with 
cargo/vesicle movement between stacks (Sonnichsen, Lowe et al. 1998; 
Sengupta and Linstedt 2011). We may speculate that it is possible for 
oBST-2B to interact with and disrupt the flow of protein cargo passing 
between the Golgi stacks and exiting the TGN, which could also explain 
the retention of Env within the Golgi. Co-immunoprecipatation studies 
followed by proteomic screens would be required to confirm particular 
associations of oBST-2B with Golgi-based proteins which could suggest 
particular modes of function. Although the exact nature of the oBST-2 
interaction within the Golgi was outside the scope of this study, we can 
conclude with confidence that the antiviral restriction induced by oBST-
2B does not follow the pattern of the classic ‘tethering’ mechanism.  
We tested the lack of Env incorporation into the sheep betaretroviral 
particles in the presence of oBST-2B by western blotting. As mentioned 
in the results section of this Chapter, we took care in optimising the 
dilutions of anti-Gag and anti-Env antibodies in order to equilibrate the 
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detailed  measurements  of virion size and weight in  the presence and 
absence  of  oBST-2B.  Both  dynamic  light  scattering  and  NTA  were 
employed  to  measure  virion  size.  Nanosight  technology  proved  to  be 
more sensitive at accurately measuring the virion size of JSRV/enJSRV-
18 than DLS, but did not reveal any significant, reproducible differences 
between the size of JSRV/enJSRV-18 virions and the VLPs produced by 
transfection of enJSRV-18/JSRV∆Env truncation mutants (Figure 48). This 
is likely due to the incorporation of plasma membrane proteins into VLPs 
during exit of viral particles from the cell (Hammarstedt, Wallengren et 
al. 2000; Hammarstedt and Garoff 2004; Cantin, Methot et al. 2005).  
There is some debate as to whether BST-2 is able to effectively restrict 
viral infection in vivo. While human BST-2 actively reduces cell free virus 
transmission, it appears  to have little influence  over  cell-to-cell  virus 
transmission (Jolly, Booth et al. 2010). The latter has been evolved by 
retroviruses  as  an  efficient  way  to  evade  host  defences.  Thus,  the 
different mechanism of antiviral restriction employed by oBST-2B may 
have  an  impact  on  cell-to-cell  viral  spread.  There  are  different 
mechanisms  that  have  been  envisaged  for  cell-to-cell  virus  spread 
including plasma membrane based fusion, use of filopodia, nanotubules 
or  formation  of  the  virological  synapse  (Jolly  and  Sattentau  2004; 
Sherer,  Lehmann  et  al.  2007).  All  of  these  mechanisms  share  the 
common  feature  of  viral  transfer  directly  from  an  infected  to  an 
uninfected cell largely driven by Env-receptor(s) interaction. We suspect 
oBST-2B would prevent cell-to-cell transmission by retaining Env within 
the Golgi. Thus, the unique duplication of BST-2 in ruminants potentially 
induces  a  novel  and  more  stringent  antiviral  mechanism  for 
Betaretroviruses. 
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Figure 50. Models of oBST-2A and -2B viral restriction. Chapter 4    153 
 
Figure 50. Models of oBST-2A (panel A) and oBST-2B viral restriction (panel B). 
We suspect that oBST-2A restricts virion release by the ‘classical tethering mechanism’. However, 
we predict that a different strategy is employed by BST-2. Betaretroviral particles assemble in the 
pericentrosomal area and exit through the recycling endosomes by a mechanism that is influenced 
by the pericentriolar recycling endosomes and Env. We predict that oBST-2B inhibits trafficking of 
the  betaretroviral  Env  the  cell  membrane.  As  the  Env  protein  influences  the  assembly  and 
trafficking of virions, inhibition of Env trafficking would in turn lead to the accumulation of Gag in a 
pericentrosomal area. Betaretroviral particles in the presence of oBST-2B exit the cell void of Env 
are deemed non infectious VLPs. 
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5.1 General Discussion 
 
 
There is a delicate evolutionary balance between viruses and their hosts. The 
hosts have evolved innate, intrinsic and adaptive immunity in order to fight viral 
(including  retroviral)  invasion.  At  the  same  time,  viruses  have  evolved 
counteracting measures in order to evade such host defences in order to survive 
and propagate.  
Betaretroviruses of sheep have represented a unique model to study virus-host 
over long evolutionary periods (Arnaud, Caporale et al. 2007; Arnaud, Murcia et 
al. 2007; Arnaud, Varela et al. 2008; Chessa, Pereira et al. 2009; Varela, Spencer 
et al.  2009).  The  sheep  genome  has  been  invaded  by  Betaretroviruses  for at 
least the last 5-7 million years, before the divergence of the genera Ovis and 
Capra.  During  evolution,  two  enJSRV  loci  (enJS56A1  and  enJSRV-20)  have 
acquired  a  mutation  in  Gag  (R21W)  that  renders  them  defective  as  they 
assemble viral particles that are not able to exit the cells (Mura, Murcia et al. 
2004). Interestingly, it has been shown that this mutation has been positively 
selected  and  is  transdominant  over  other  endogenous  and  exogenous 
Betaretroviruses  with  a  process  termed  “JLR”  for  JSRV  late  restriction,  and 
estimates  based  upon  evolutionary  rates  suggest  that  these  transdominant 
enJSRV proviruses became fixed in the genome of the host around the time of 
domestication  (Arnaud,  Murcia  et  al.  2007;  Murcia,  Arnaud  et  al.  2007; 
Armezzani, Arnaud et al. 2011). However, viruses always appear to possess an 
answer to the host defences and a recently integrated provirus, enJSRV-26, was 
found to be able to escape viral restriction due to a single point mutation in the 
signal peptide of the enJSRV-26 viral Env protein. Thus, sheep Betaretroviruses 
have  left  “fossils”  that  have  allowed  us  to  trace  the  evolutionary  arms  race 
between viruses and hosts.  
Cellular restriction factors have also been positively selected during evolution. 
In this thesis we have investigated the interplay between the two oBST-2 genes 
and sheep Betaretroviruses. BST-2 is an IFN-inducible restriction factor, with a 
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ruminants  BST-2  is  duplicated,  resulting  in  the  paralogs  oBST-2A  and  -2B 
(Arnaud, Black et al. 2010). Whilst oBST-2A possesses an antiviral activity similar 
to  other  BST-2  orthologs,  we  found  oBST-2  B  to  possess  distinct  biological 
properties.  
Gene duplication offers the possibility to produce  a large number of “novel” 
genes  to  bacteria,  archaebacteria  and  eukaryotes  and  it  is  linked  to  the 
development of species-specific functions. Duplication of a gene is most often 
generated  by  unequal  cross  over,  retroposition  or  chromosomal  duplication 
events  within the  genome (Zhang  2003).  In  the  majority of cases  duplication 
creates an identical copy of the gene. This process is beneficial to the host for 
strongly expressed genes, but where there is no requirement for additional gene 
expression  duplicated  genes  may  undergo  “subfunctionalization”  or 
“neofunctionalization”. Subfunctionalization involves the original gene and its 
paralog sharing only small parts of the original gene function, resulting in two 
genes which perform individually refined functions in place of a previous gene. 
On the other hand, neofunctionalization involves the duplicated gene taking on 
an entirely novel function altogether. It is difficult to envisage how a gene could 
undergo  rapid  modification  to  adopt  an  entirely  new  function  within  the 
constraints of the host genome.  
Two models are suggested to explain how this may have arisen within the host. 
The first model proposes that extensive mutations may accumulate within the 
duplicated  gene  over  time  without  the  pressure  of  positive  selection  as  it  is 
functionally redundant. The second model suggests that the duplicated genes 
have been subject to positive selection where even a few mutations induce a 
weak but novel function, which is then positively selected or that the original 
gene had dual action which mutations followed by selection result in this action 
being shared and refined between the current paralogs (Zhang 2003). 
Recent analysis of the history of gene duplication and loss within fungi yielded 
important information with regard to the significance of duplication within the 
host (Wapinski, Pfeffer et al. 2007). It highlighted that there was little evidence 
of  duplication  of  genes  with  a  fundamental  physiological  importance  to  cell 
function.  Those  genes  which  were  continually  subjected  to  ‘environmental 
stress’  were  found  to  be  more  frequently  duplicated  within  the  genome. Chapter 5    157 
 
Interestingly, hosts which have undergone whole genome duplication appeared 
to favour the addition and loss of genes for the majority of gene duplications 
observed  (Flintoft  2007).  Gene  duplication  has  been  implicated  in  the 
development and function of major intracellular organelles such as the Golgi 
(Klute, Melancon et al. 2011). In addition it is considered to resolve intralocus 
sexually  antagonistic  variation.  This  is  the  presence  of  genes  on  the  X 
chromosome shared in both males and females which are under selection in both 
species  in  opposing  directions  (Gibson,  Chippindale  et  al.  2002;  Gallach  and 
Betran  2011).  There  is  evidence  to  suggest  that  gene  duplication  has  also 
contributed to the evolution of placental pregnancy (Hughes, Green et al. 2000).  
We  suggest  that  oBST-2B  could  be  seen  as  a  rare  example  of 
neofunctionalization,  a  gene  duplication  event  which  occurred  prior  to  the 
speciation of the bovinae and which has resulted in an entirely novel function for 
oBST-2. This is novel in that oBST-2B appears to restrict Betaretroviruses with a 
mechanism entirely different from oBST-2A.  
Genes involved in host immunity are among those under the most significant 
evolutionary pressure. We did not address in this thesis whether oBST-2B has or 
is under positive selection. The extensive lifespan of primates is at odds with the 
rapid  turnover  of  retroviral  populations  and  inevitably  gives  the  virus  the 
evolutionary advantage with more chances to generate ways to defeat the host 
immune system. Therefore, oBST-2B represents a rare example of the unique 
forms of positive selection occurring within the host in response to the continual 
challenge  a  particular  retrovirus  infecting  a  particular  animal  species. 
Betaretroviruses,  unlike  other  retroviruses,  assemble  at  the  pericentrosomal 
area, a unique feature of the Betaretrovirus lifecycle. Viral particles then exit 
with a process that is influenced by Env and by the recycling endosomes. oBST-
2B appears to co-localise strongly with Env and in turn reduce Env incorporation 
into the envelope of nascent virions. In light of the BST-2 gene duplication event 
having occurred prior to divergence of cattle and sheep, the challenge posed by 
ancient  betaretroviral  ancestors  to  enJSRVs  may  have  lead  to  the  positive 
selection of a second oBST-2 gene. The cattle genome has been shown to contain 
Betaretroviruses  that  are  distinct  from  enJSRVs.  The  pattern  of  restriction 
observed for oBST-2B is unique amongst all the BST-2 orthologs known. Chapter 5    158 
 
As  mentioned  before,  oBST-2A  is  a  glycosylated  protein  with  a  broad  based 
internal/plasma membrane based distribution while we found oBST-2B appears 
to  be  unglycosylated  with  a  concentrated  perinuclear  localisation.  The 
perinuclear accumulation of oBST-2B was shown to localise to the Golgi stacks 
and TGN. In addition, functional experiments with Brefeldin-A confirmed that 
oBST-2B is localised with the Golgi and behaved like a Golgin. Interestingly, this 
is the first description of a perinuclear based location for an IFN induced BST-2 
protein. Given the striking differences we observed between the oBST-2A and -
2B localisation, it was difficult to envisage how both paralogs were capable of 
restricting viral replication by the same mechanism. Furthermore, the classical 
tethering mechanism is dependent upon the residence of BST-2 within the lipid 
rafts of the plasma membrane where it engages with viral particles exiting the 
cell. The unusual location for oBST-2B did not fit with this model of restriction 
and led us to question if another mode of restriction was utilised by oBST-2B. 
In  concurrence  with  the  classical  tethering  model  we  found  that  oBST-2A 
redistributed Gag protein to the plasma membrane. This is consistent with the 
fundamental idea that viral particles are tethered to the plasma membrane in 
order to prevent exit (Neil, Zang et al. 2008). oBST-2A had no effect over Env 
distribution.  However,  oBST-2B  redistributed  both  Gag  and  Env  proteins  in  a 
concentrated perinuclear pattern. Previously, it was observed that oBST-2A was 
more efficient at blocking virion exit than oBST-2B based on viral Gag exit levels 
(Arnaud, Black et al. 2010). During this thesis we found that that oBST-2A is a 
highly  efficient  restriction  factor  for  both  Gag  and  Env.  oBST-2B  in  contrast 
appears inefficient at blocking Gag exit but we obtained data suggesting that 
oBST-2B substantially reduced the presence of Env in the virions released into 
the supernatants. We suspect in the presence of oBST-2B uninfectious VLPs are 
released. 
Thus, in this thesis we suggest that oBST-2B is in fact, an efficient restriction 
factor which blocks Betaretroviruses by a unique method of restriction, different 
from  oBST-2A  and  one  not  previously  described  for  any  other  BST-2  protein. 
oBST-2B  appears  to  exert  its  restriction  by  sequestering  Env  in  a  perinuclear 
compartment,  most  likely  the  Golgi,  preventing  trafficking  and  reducing  the 
incorporation of Env into assembling virions. The virions released are devoid of 
Env and therefore we suspect are non-infectious VLPs. We speculate that oBST-Chapter 5    159 
 
2B,  unlike  oBST-2A,  may  provide  an  efficient  restriction  mechanism  by 
preventing cell-to-cell transmission which is driven by the interaction between 
Env and the host receptor. This interaction would be unable to occur due the 
unique pattern of Env perinuclear localisation in the presence of oBST-2B.  
Unfortunately  there  are  inherent  difficulties  in  our  experimental  system  that 
makes  it  difficult  to  firmly  establish  that  indeed  oBST-2B  blocks  Env 
incorporation.  Because  there  is  less  Env  than  Gag  in  viral  particles,  western 
blotting could provide misleading results although (i) we carefully titrated anti-
Gag and anti-Env antibodies in order to obtain a similar sensitivity in this test 
and (ii) confocal microscopy also showed an accumulation of Env in the Golgi.  
It was assumed that viral particles devoid of Env would be a different diameter 
to wild type particles with a full complement of Env. We therefore attempted to 
measure the size of the viral particles in the presence or absence of oBST-2B by 
dynamic light-scattering methods. Our results revealed no difference in the size 
of  sheep  betaretroviral  particles  in  the  presence  or  absence  of  oBST-2B. 
However, using the same technique we could not detect a difference in size 
between our positive controls (wild type JSRV/enJSRV-18) and the respective 
Env truncation mutants. The reason for these data is that betaretoviral particles 
formed by Gag alone are still enveloped by the cell membrane. Consequently it 
is very difficult to resolve the size of a betaretroviral particle with Env from one 
without  Env.  An  alternative  approach  would  be  to  visualise  intracellular  or 
budding particles by transmission electron microscopy with immunogold labelling 
for Env detection.  
There is no tissue culture system for the propagation of JSRV/enJSRVs. During 
this  thesis  we  also  tried  to  develop  infectious  assays  for  JSRV/enJSRVs  but 
without  success  and  therefore  it  has  proven  difficult  to  corroborate  oBST-2B 
restriction by infectious assays. 
Overall, we suggest that oBST-2B provides another example of a host restriction 
factor.  Future  experiments  need  to  be  directed  to  prove  lack  of  Env 
incorporation  with  other  techniques.  Use  of  other  Betaretroviruses,  such  as 
Mason-Pfizer  monkey  virus  may  help  to  develop  infectious  assays  that  could 
further corroborate our studies.  Chapter 5    160  160 
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